BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 011696
(479 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|D Chain D, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|G Chain G, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|H Chain H, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
Length = 349
Score = 91.7 bits (226), Expect = 8e-19, Method: Compositional matrix adjust.
Identities = 51/118 (43%), Positives = 73/118 (61%), Gaps = 3/118 (2%)
Query: 336 PGSDFVNSP--QDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGRE 393
P F + P +DP F+ EL A+D F+++N+LG GGFG VYKG L DG
Sbjct: 5 PQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTL 64
Query: 394 VAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL 450
VA+K+LK Q GE +F+ EVE+IS HR+L+ L G+C++ RLL+Y Y+ N ++
Sbjct: 65 VAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 122
>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On
Plant Receptor- Like Kinase Bak1 Activation
pdb|3ULZ|A Chain A, Crystal Structure Of Apo Bak1
Length = 326
Score = 90.1 bits (222), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 49/111 (44%), Positives = 70/111 (63%), Gaps = 1/111 (0%)
Query: 341 VNSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLK 400
V + +DP F+ EL A+D F ++N+LG GGFG VYKG L DG VA+K+LK
Sbjct: 4 VPAEEDPEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLK 63
Query: 401 IGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL 450
Q GE +F+ EVE+IS HR+L+ L G+C++ RLL+Y Y+ N ++
Sbjct: 64 EERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 114
>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By
Bacterial Effector Protein Avrpto
Length = 321
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 43/96 (44%), Positives = 60/96 (62%)
Query: 361 ELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRI 420
+L +AT+ F + L+G G FG VYKG L DG +VA+K+ QG EF+ E+E +S
Sbjct: 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHG 456
H HLVSL+G+C + +LIY Y+ N L HL+G
Sbjct: 93 RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYG 128
>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|B Chain B, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|C Chain C, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|D Chain D, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
Length = 327
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 43/96 (44%), Positives = 60/96 (62%)
Query: 361 ELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRI 420
+L +AT+ F + L+G G FG VYKG L DG +VA+K+ QG EF+ E+E +S
Sbjct: 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHG 456
H HLVSL+G+C + +LIY Y+ N L HL+G
Sbjct: 93 RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYG 128
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 65.9 bits (159), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 36/104 (34%), Positives = 62/104 (59%), Gaps = 11/104 (10%)
Query: 357 FTYEELVKATDGFADQ------NLLGEGGFGSVYKGYLPDGREVAIKQL----KIGGGQG 406
F++ EL T+ F ++ N +GEGGFG VYKGY+ + VA+K+L I +
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 407 EREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL 450
+++F E++++++ H +LV L+G+ D L+Y Y+PN +L
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 117
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 65.9 bits (159), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 36/104 (34%), Positives = 62/104 (59%), Gaps = 11/104 (10%)
Query: 357 FTYEELVKATDGFADQ------NLLGEGGFGSVYKGYLPDGREVAIKQL----KIGGGQG 406
F++ EL T+ F ++ N +GEGGFG VYKGY+ + VA+K+L I +
Sbjct: 9 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 67
Query: 407 EREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL 450
+++F E++++++ H +LV L+G+ D L+Y Y+PN +L
Sbjct: 68 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 111
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 65.5 bits (158), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 36/104 (34%), Positives = 62/104 (59%), Gaps = 11/104 (10%)
Query: 357 FTYEELVKATDGFADQ------NLLGEGGFGSVYKGYLPDGREVAIKQL----KIGGGQG 406
F++ EL T+ F ++ N +GEGGFG VYKGY+ + VA+K+L I +
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 407 EREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL 450
+++F E++++++ H +LV L+G+ D L+Y Y+PN +L
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 117
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 62.0 bits (149), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 36/104 (34%), Positives = 59/104 (56%), Gaps = 11/104 (10%)
Query: 357 FTYEELVKATDGFADQ------NLLGEGGFGSVYKGYLPDGREVAIKQL----KIGGGQG 406
F++ EL T+ F ++ N GEGGFG VYKGY+ + VA+K+L I +
Sbjct: 6 FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 64
Query: 407 EREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL 450
+++F E+++ ++ H +LV L+G+ D L+Y Y PN +L
Sbjct: 65 KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSL 108
>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain
pdb|4AT3|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Cpd5n
pdb|4AT4|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Ex429
pdb|4AT5|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Gw2580
Length = 299
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 26/90 (28%), Positives = 44/90 (48%), Gaps = 8/90 (8%)
Query: 375 LGEGGFGSVYKGYL------PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSL 428
LGEG FG V+ D VA+K LK ++F E E+++ + H H+V
Sbjct: 21 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 429 VGYCISDDRRLLIYDYVPNNTL--YFHLHG 456
G C+ D +++++Y+ + L + HG
Sbjct: 81 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHG 110
>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
pdb|2R4B|B Chain B, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
Length = 321
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 38/119 (31%), Positives = 62/119 (52%), Gaps = 11/119 (9%)
Query: 343 SPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKG-YLPDGREV----AIK 397
P P G +++ ++K T+ +LG G FG+VYKG ++P+G V AIK
Sbjct: 18 EPLTPSGTAPNQAQL---RILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIK 73
Query: 398 QL-KIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLH 455
L + G + EF E I++ + H HLV L+G C+S + L+ +P+ L ++H
Sbjct: 74 ILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVH 131
>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To
Appcp From D. Discoideum
pdb|4F0G|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum
pdb|4F1T|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum Bound To The Rock Inhibitor H1152
Length = 287
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 36/101 (35%), Positives = 55/101 (54%), Gaps = 10/101 (9%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGE-------REFKAEVEI 416
A + + +G+GGFG V+KG L D VAIK L +G +GE +EF+ EV I
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 417 ISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGK 457
+S ++H ++V L G + R ++ ++VP LY L K
Sbjct: 77 MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDK 115
>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound
To Appcp From D. Discoideum
Length = 287
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 36/101 (35%), Positives = 55/101 (54%), Gaps = 10/101 (9%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGE-------REFKAEVEI 416
A + + +G+GGFG V+KG L D VAIK L +G +GE +EF+ EV I
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 417 ISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGK 457
+S ++H ++V L G + R ++ ++VP LY L K
Sbjct: 77 MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDK 115
>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain
From D. Discoideum Bound To Appcp
Length = 287
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 36/101 (35%), Positives = 55/101 (54%), Gaps = 10/101 (9%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGE-------REFKAEVEI 416
A + + +G+GGFG V+KG L D VAIK L +G +GE +EF+ EV I
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 417 ISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGK 457
+S ++H ++V L G + R ++ ++VP LY L K
Sbjct: 77 MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDK 115
>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBT|D Chain D, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBW|B Chain B, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BBW|A Chain A, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BCE|A Chain A, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|B Chain B, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|C Chain C, Crystal Structure Of The Erbb4 Kinase
Length = 328
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 33/89 (37%), Positives = 51/89 (57%), Gaps = 7/89 (7%)
Query: 373 NLLGEGGFGSVYKG-YLPDGREV----AIKQL-KIGGGQGEREFKAEVEIISRIHHRHLV 426
+LG G FG+VYKG ++P+G V AIK L + G + EF E I++ + H HLV
Sbjct: 21 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLH 455
L+G C+S + L+ +P+ L ++H
Sbjct: 81 RLLGVCLSPTIQ-LVTQLMPHGCLLEYVH 108
>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain
Length = 306
Score = 49.3 bits (116), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 375 LGEGGFGSVY----KGYLP--DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSL 428
LGEG FG V+ LP D VA+K LK ++F+ E E+++ + H+H+V
Sbjct: 26 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 429 VGYCISDDRRLLIYDYVPNNTL--YFHLHG 456
G C L++++Y+ + L + HG
Sbjct: 86 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHG 115
>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka
pdb|4F0I|B Chain B, Crystal Structure Of Apo Trka
Length = 300
Score = 49.3 bits (116), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 375 LGEGGFGSVY----KGYLP--DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSL 428
LGEG FG V+ LP D VA+K LK ++F+ E E+++ + H+H+V
Sbjct: 20 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 429 VGYCISDDRRLLIYDYVPNNTL--YFHLHG 456
G C L++++Y+ + L + HG
Sbjct: 80 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHG 109
>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|B Chain B, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|C Chain C, Human Trka In Complex With The Inhibitor Az-23
Length = 329
Score = 49.3 bits (116), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 375 LGEGGFGSVY----KGYLP--DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSL 428
LGEG FG V+ LP D VA+K LK ++F+ E E+++ + H+H+V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 429 VGYCISDDRRLLIYDYVPNNTL--YFHLHG 456
G C L++++Y+ + L + HG
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHG 138
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 45/83 (54%), Gaps = 1/83 (1%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
+G G FG V+ GY + +VAIK +K G E +F E E++ ++ H LV L G C+
Sbjct: 35 IGSGQFGLVHLGYWLNKDKVAIKTIK-EGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 435 DDRRLLIYDYVPNNTLYFHLHGK 457
L+++++ + L +L +
Sbjct: 94 QAPICLVFEFMEHGCLSDYLRTQ 116
>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MIY|B Chain B, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MJ1|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Ro5191614
pdb|3MJ2|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Bms-509744
Length = 266
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 25/83 (30%), Positives = 45/83 (54%), Gaps = 1/83 (1%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
+G G FG V+ GY + +VAIK ++ G E +F E E++ ++ H LV L G C+
Sbjct: 15 IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 435 DDRRLLIYDYVPNNTLYFHLHGK 457
L+++++ + L +L +
Sbjct: 74 QAPICLVFEFMEHGCLSDYLRTQ 96
>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SM2|B Chain B, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|A Chain A, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|B Chain B, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNX|A Chain A, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
pdb|1SNX|B Chain B, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
Length = 264
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 25/83 (30%), Positives = 45/83 (54%), Gaps = 1/83 (1%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
+G G FG V+ GY + +VAIK ++ G E +F E E++ ++ H LV L G C+
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 435 DDRRLLIYDYVPNNTLYFHLHGK 457
L+++++ + L +L +
Sbjct: 72 QAPICLVFEFMEHGCLSDYLRTQ 94
>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5J|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5L|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|C Chain C, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|D Chain D, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V8T|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8T|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8W|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
pdb|3V8W|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
Length = 266
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 25/83 (30%), Positives = 45/83 (54%), Gaps = 1/83 (1%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
+G G FG V+ GY + +VAIK ++ G E +F E E++ ++ H LV L G C+
Sbjct: 15 IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 435 DDRRLLIYDYVPNNTLYFHLHGK 457
L+++++ + L +L +
Sbjct: 74 QAPICLVFEFMEHGCLSDYLRTQ 96
>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52
pdb|4HCU|A Chain A, Crystal Structure Of Itk In Complext With Compound 40
pdb|4HCV|A Chain A, Crystal Structure Of Itk In Complex With Compound 53
Length = 269
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 25/83 (30%), Positives = 45/83 (54%), Gaps = 1/83 (1%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
+G G FG V+ GY + +VAIK ++ G E +F E E++ ++ H LV L G C+
Sbjct: 18 IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 435 DDRRLLIYDYVPNNTLYFHLHGK 457
L+++++ + L +L +
Sbjct: 77 QAPICLVFEFMEHGCLSDYLRTQ 99
>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
pdb|3V5Q|B Chain B, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
Length = 297
Score = 47.4 bits (111), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 26/90 (28%), Positives = 44/90 (48%), Gaps = 8/90 (8%)
Query: 375 LGEGGFGSVYKGYL------PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSL 428
LGEG FG V+ D VA+K LK ++F+ E E+++ + H H+V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 429 VGYCISDDRRLLIYDYVPNNTL--YFHLHG 456
G C D +++++Y+ + L + HG
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHG 112
>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain
pdb|2XA4|B Chain B, Inhibitors Of Jak2 Kinase Domain
Length = 298
Score = 46.6 bits (109), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 9/92 (9%)
Query: 375 LGEGGFGSVYKG-YLP----DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LG+G FGSV Y P G VA+K+L+ + R+F+ E+EI+ + H ++V
Sbjct: 21 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 430 GYCISDDRR--LLIYDYVPNNTL--YFHLHGK 457
G C S RR LI +Y+P +L Y H +
Sbjct: 81 GVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAE 112
>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed
With Imidazo[1,5-A]quinoxaline
Length = 267
Score = 46.2 bits (108), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 25/83 (30%), Positives = 44/83 (53%), Gaps = 1/83 (1%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
+G G FG V+ GY + +VAIK ++ G E +F E E++ ++ H LV L G C+
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 435 DDRRLLIYDYVPNNTLYFHLHGK 457
L+ +++ + L +L +
Sbjct: 75 QAPICLVTEFMEHGCLSDYLRTQ 97
>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1I|B Chain B, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 326
Score = 46.2 bits (108), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 32/88 (36%), Positives = 48/88 (54%), Gaps = 7/88 (7%)
Query: 375 LGEGGFGSVYKG-YLP----DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LG+G FGSV Y P G VA+K+L+ + R+F+ E+EI+ + H ++V
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 430 GYCISDDRR--LLIYDYVPNNTLYFHLH 455
G C S RR LI +Y+P +L +L
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ 136
>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJC|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJD|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 19
pdb|3TJD|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 19
Length = 298
Score = 46.2 bits (108), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 32/88 (36%), Positives = 48/88 (54%), Gaps = 7/88 (7%)
Query: 375 LGEGGFGSVYKG-YLP----DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LG+G FGSV Y P G VA+K+L+ + R+F+ E+EI+ + H ++V
Sbjct: 21 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 430 GYCISDDRR--LLIYDYVPNNTLYFHLH 455
G C S RR LI +Y+P +L +L
Sbjct: 81 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ 108
>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
pdb|4HGE|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
Length = 300
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 32/88 (36%), Positives = 48/88 (54%), Gaps = 7/88 (7%)
Query: 375 LGEGGFGSVYKG-YLP----DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LG+G FGSV Y P G VA+K+L+ + R+F+ E+EI+ + H ++V
Sbjct: 23 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 430 GYCISDDRR--LLIYDYVPNNTLYFHLH 455
G C S RR LI +Y+P +L +L
Sbjct: 83 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ 110
>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii
Inhibtor Nvp-Bbt594
Length = 295
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 32/88 (36%), Positives = 48/88 (54%), Gaps = 7/88 (7%)
Query: 375 LGEGGFGSVYKG-YLP----DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LG+G FGSV Y P G VA+K+L+ + R+F+ E+EI+ + H ++V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 430 GYCISDDRR--LLIYDYVPNNTLYFHLH 455
G C S RR LI +Y+P +L +L
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ 105
>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol
Length = 315
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 31/97 (31%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSLVG 430
+ ++G G FG V K ++VAIKQ++ + ER+ F E+ +SR++H ++V L G
Sbjct: 14 EEVVGRGAFGVVCKAKW-RAKDVAIKQIE---SESERKAFIVELRQLSRVNHPNIVKLYG 69
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGKWQLGFDIRNH 467
C+ + L+ +Y +LY LHG L + H
Sbjct: 70 ACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAH 104
>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|D Chain D, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|E Chain E, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4F08|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F08|B Chain B, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F09|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
Length = 302
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 32/88 (36%), Positives = 48/88 (54%), Gaps = 7/88 (7%)
Query: 375 LGEGGFGSVYKG-YLP----DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LG+G FGSV Y P G VA+K+L+ + R+F+ E+EI+ + H ++V
Sbjct: 25 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 430 GYCISDDRR--LLIYDYVPNNTLYFHLH 455
G C S RR LI +Y+P +L +L
Sbjct: 85 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ 112
>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3KCK|A Chain A, A Novel Chemotype Of Kinase Inhibitors
Length = 313
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 32/88 (36%), Positives = 48/88 (54%), Gaps = 7/88 (7%)
Query: 375 LGEGGFGSVYKG-YLP----DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LG+G FGSV Y P G VA+K+L+ + R+F+ E+EI+ + H ++V
Sbjct: 36 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 430 GYCISDDRR--LLIYDYVPNNTLYFHLH 455
G C S RR LI +Y+P +L +L
Sbjct: 96 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ 123
>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3LPB|B Chain B, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3KRR|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
Quinoxaline Atp Site Inhibitor
Length = 295
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 32/88 (36%), Positives = 48/88 (54%), Gaps = 7/88 (7%)
Query: 375 LGEGGFGSVYKG-YLP----DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LG+G FGSV Y P G VA+K+L+ + R+F+ E+EI+ + H ++V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 430 GYCISDDRR--LLIYDYVPNNTLYFHLH 455
G C S RR LI +Y+P +L +L
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ 105
>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A
1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor
Length = 303
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 32/88 (36%), Positives = 48/88 (54%), Gaps = 7/88 (7%)
Query: 375 LGEGGFGSVYKG-YLP----DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LG+G FGSV Y P G VA+K+L+ + R+F+ E+EI+ + H ++V
Sbjct: 22 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 430 GYCISDDRR--LLIYDYVPNNTLYFHLH 455
G C S RR LI +Y+P +L +L
Sbjct: 82 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ 109
>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|2B7A|B Chain B, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|3FUP|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3FUP|B Chain B, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 293
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 32/88 (36%), Positives = 48/88 (54%), Gaps = 7/88 (7%)
Query: 375 LGEGGFGSVYKG-YLP----DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LG+G FGSV Y P G VA+K+L+ + R+F+ E+EI+ + H ++V
Sbjct: 16 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 430 GYCISDDRR--LLIYDYVPNNTLYFHLH 455
G C S RR LI +Y+P +L +L
Sbjct: 76 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ 103
>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
pdb|4AQC|B Chain B, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
Length = 301
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 32/88 (36%), Positives = 48/88 (54%), Gaps = 7/88 (7%)
Query: 375 LGEGGFGSVYKG-YLP----DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LG+G FGSV Y P G VA+K+L+ + R+F+ E+EI+ + H ++V
Sbjct: 24 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 430 GYCISDDRR--LLIYDYVPNNTLYFHLH 455
G C S RR LI +Y+P +L +L
Sbjct: 84 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ 111
>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
pdb|3Q32|B Chain B, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
Length = 301
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 32/88 (36%), Positives = 48/88 (54%), Gaps = 7/88 (7%)
Query: 375 LGEGGFGSVYKG-YLP----DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LG+G FGSV Y P G VA+K+L+ + R+F+ E+EI+ + H ++V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 430 GYCISDDRR--LLIYDYVPNNTLYFHLH 455
G C S RR LI +Y+P +L +L
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ 105
>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors
Length = 311
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 32/88 (36%), Positives = 48/88 (54%), Gaps = 7/88 (7%)
Query: 375 LGEGGFGSVYKG-YLP----DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LG+G FGSV Y P G VA+K+L+ + R+F+ E+EI+ + H ++V
Sbjct: 36 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 430 GYCISDDRR--LLIYDYVPNNTLYFHLH 455
G C S RR LI +Y+P +L +L
Sbjct: 96 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ 123
>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E63|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E64|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
Length = 293
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 32/88 (36%), Positives = 48/88 (54%), Gaps = 7/88 (7%)
Query: 375 LGEGGFGSVYKG-YLP----DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LG+G FGSV Y P G VA+K+L+ + R+F+ E+EI+ + H ++V
Sbjct: 17 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 430 GYCISDDRR--LLIYDYVPNNTLYFHLH 455
G C S RR LI +Y+P +L +L
Sbjct: 77 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ 104
>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
Length = 298
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 32/88 (36%), Positives = 48/88 (54%), Gaps = 7/88 (7%)
Query: 375 LGEGGFGSVYKG-YLP----DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LG+G FGSV Y P G VA+K+L+ + R+F+ E+EI+ + H ++V
Sbjct: 19 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 430 GYCISDDRR--LLIYDYVPNNTLYFHLH 455
G C S RR LI +Y+P +L +L
Sbjct: 79 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ 106
>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With
Its Activating Protein Tab1
pdb|2YIY|A Chain A, Crystal Structure Of Compound 8 Bound To Tak1-Tab
Length = 307
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 31/97 (31%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSLVG 430
+ ++G G FG V K ++VAIKQ++ + ER+ F E+ +SR++H ++V L G
Sbjct: 13 EEVVGRGAFGVVCKAKW-RAKDVAIKQIE---SESERKAFIVELRQLSRVNHPNIVKLYG 68
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGKWQLGFDIRNH 467
C+ + L+ +Y +LY LHG L + H
Sbjct: 69 ACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAH 103
>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
pdb|3IKA|B Chain B, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
Length = 331
Score = 45.8 bits (107), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 28/101 (27%), Positives = 57/101 (56%), Gaps = 10/101 (9%)
Query: 347 PGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKG-YLPDGRE----VAIKQLKI 401
P G ++++ ++K T+ F +LG G FG+VYKG ++P+G + VAIK+L+
Sbjct: 3 PSGEAPNQALL---RILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 58
Query: 402 GGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441
+ +E E +++ + + H+ L+G C++ +L++
Sbjct: 59 ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM 99
>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
pdb|4G5P|B Chain B, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
Length = 330
Score = 45.4 bits (106), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 26/86 (30%), Positives = 51/86 (59%), Gaps = 7/86 (8%)
Query: 362 LVKATDGFADQNLLGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGG-QGEREFKAEVE 415
++K T+ F +LG G FG+VYKG ++P+G + VAIK+L+ + +E E
Sbjct: 14 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 416 IISRIHHRHLVSLVGYCISDDRRLLI 441
+++ + + H+ L+G C++ +L++
Sbjct: 73 VMASVDNPHVCRLLGICLTSTVQLIM 98
>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
pdb|2JIU|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
Length = 328
Score = 45.4 bits (106), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 26/86 (30%), Positives = 51/86 (59%), Gaps = 7/86 (8%)
Query: 362 LVKATDGFADQNLLGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGG-QGEREFKAEVE 415
++K T+ F +LG G FG+VYKG ++P+G + VAIK+L+ + +E E
Sbjct: 12 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 416 IISRIHHRHLVSLVGYCISDDRRLLI 441
+++ + + H+ L+G C++ +L++
Sbjct: 71 VMASVDNPHVCRLLGICLTSTVQLIM 96
>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
pdb|2JIV|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
Length = 328
Score = 45.4 bits (106), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 26/86 (30%), Positives = 51/86 (59%), Gaps = 7/86 (8%)
Query: 362 LVKATDGFADQNLLGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGG-QGEREFKAEVE 415
++K T+ F +LG G FG+VYKG ++P+G + VAIK+L+ + +E E
Sbjct: 12 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 416 IISRIHHRHLVSLVGYCISDDRRLLI 441
+++ + + H+ L+G C++ +L++
Sbjct: 71 VMASVDNPHVCRLLGICLTSTVQLIM 96
>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation
pdb|2JIT|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation
Length = 327
Score = 45.4 bits (106), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 26/86 (30%), Positives = 51/86 (59%), Gaps = 7/86 (8%)
Query: 362 LVKATDGFADQNLLGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGG-QGEREFKAEVE 415
++K T+ F +LG G FG+VYKG ++P+G + VAIK+L+ + +E E
Sbjct: 11 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 416 IISRIHHRHLVSLVGYCISDDRRLLI 441
+++ + + H+ L+G C++ +L++
Sbjct: 70 VMASVDNPHVCRLLGICLTSTVQLIM 95
>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
pdb|4I24|B Chain B, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
Length = 329
Score = 45.4 bits (106), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 26/86 (30%), Positives = 51/86 (59%), Gaps = 7/86 (8%)
Query: 362 LVKATDGFADQNLLGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGG-QGEREFKAEVE 415
++K T+ F +LG G FG+VYKG ++P+G + VAIK+L+ + +E E
Sbjct: 13 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 416 IISRIHHRHLVSLVGYCISDDRRLLI 441
+++ + + H+ L+G C++ +L++
Sbjct: 72 VMASVDNPHVCRLLGICLTSTVQLIM 97
>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285
pdb|3W2P|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 2
pdb|3W2Q|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Hki-272
pdb|3W2R|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 4
Length = 331
Score = 45.4 bits (106), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 26/86 (30%), Positives = 51/86 (59%), Gaps = 7/86 (8%)
Query: 362 LVKATDGFADQNLLGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGG-QGEREFKAEVE 415
++K T+ F +LG G FG+VYKG ++P+G + VAIK+L+ + +E E
Sbjct: 15 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 73
Query: 416 IISRIHHRHLVSLVGYCISDDRRLLI 441
+++ + + H+ L+G C++ +L++
Sbjct: 74 VMASVDNPHVCRLLGICLTSTVQLIM 99
>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
pdb|4I21|B Chain B, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
Length = 329
Score = 45.1 bits (105), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 26/86 (30%), Positives = 51/86 (59%), Gaps = 7/86 (8%)
Query: 362 LVKATDGFADQNLLGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGG-QGEREFKAEVE 415
++K T+ F +LG G FG+VYKG ++P+G + VAIK+L+ + +E E
Sbjct: 13 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 416 IISRIHHRHLVSLVGYCISDDRRLLI 441
+++ + + H+ L+G C++ +L++
Sbjct: 72 VMASVDNPHVCRLLGICLTSTVQLIM 97
>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The
Gefitinib/erlotinib Resistant Egfr Kinase Domain
L858r+t790m
pdb|4I22|A Chain A, Structure Of The Monomeric (v948r)gefitinib/erlotinib
Resistant Double Mutant (l858r+t790m) Egfr Kinase Domain
Co-crystallized With Gefitinib
Length = 329
Score = 45.1 bits (105), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 26/86 (30%), Positives = 51/86 (59%), Gaps = 7/86 (8%)
Query: 362 LVKATDGFADQNLLGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGG-QGEREFKAEVE 415
++K T+ F +LG G FG+VYKG ++P+G + VAIK+L+ + +E E
Sbjct: 13 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 416 IISRIHHRHLVSLVGYCISDDRRLLI 441
+++ + + H+ L+G C++ +L++
Sbjct: 72 VMASVDNPHVCRLLGICLTSTVQLIM 97
>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase
Domain With Erlotinib
Length = 337
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 50/85 (58%), Gaps = 7/85 (8%)
Query: 362 LVKATDGFADQNLLGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGG-QGEREFKAEVE 415
++K T+ F +LG G FG+VYKG ++P+G + VAIK+L+ + +E E
Sbjct: 21 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 79
Query: 416 IISRIHHRHLVSLVGYCISDDRRLL 440
+++ + + H+ L+G C++ +L+
Sbjct: 80 VMASVDNPHVCRLLGICLTSTVQLI 104
>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992
Length = 330
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 50/85 (58%), Gaps = 7/85 (8%)
Query: 362 LVKATDGFADQNLLGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGG-QGEREFKAEVE 415
++K T+ F +LG G FG+VYKG ++P+G + VAIK+L+ + +E E
Sbjct: 14 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 416 IISRIHHRHLVSLVGYCISDDRRLL 440
+++ + + H+ L+G C++ +L+
Sbjct: 73 VMASVDNPHVCRLLGICLTSTVQLI 97
>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 34-Jab
pdb|2ITW|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Afn941
pdb|2ITX|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Amp- Pnp
pdb|2ITY|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Iressa
pdb|2J6M|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Aee788
pdb|3POZ|A Chain A, Egfr Kinase Domain Complexed With Tak-285
Length = 327
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 50/85 (58%), Gaps = 7/85 (8%)
Query: 362 LVKATDGFADQNLLGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGG-QGEREFKAEVE 415
++K T+ F +LG G FG+VYKG ++P+G + VAIK+L+ + +E E
Sbjct: 11 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 416 IISRIHHRHLVSLVGYCISDDRRLL 440
+++ + + H+ L+G C++ +L+
Sbjct: 70 VMASVDNPHVCRLLGICLTSTVQLI 94
>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain
pdb|2GS6|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain In
Complex With An Atp Analog-Peptide Conjugate
pdb|2RF9|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RF9|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|3W2S|A Chain A, Egfr Kinase Domain With Compound4
Length = 330
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 50/85 (58%), Gaps = 7/85 (8%)
Query: 362 LVKATDGFADQNLLGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGG-QGEREFKAEVE 415
++K T+ F +LG G FG+VYKG ++P+G + VAIK+L+ + +E E
Sbjct: 14 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 416 IISRIHHRHLVSLVGYCISDDRRLL 440
+++ + + H+ L+G C++ +L+
Sbjct: 73 VMASVDNPHVCRLLGICLTSTVQLI 97
>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 13-Jab
Length = 327
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 50/85 (58%), Gaps = 7/85 (8%)
Query: 362 LVKATDGFADQNLLGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGG-QGEREFKAEVE 415
++K T+ F +LG G FG+VYKG ++P+G + VAIK+L+ + +E E
Sbjct: 11 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 416 IISRIHHRHLVSLVGYCISDDRRLL 440
+++ + + H+ L+G C++ +L+
Sbjct: 70 VMASVDNPHVCRLLGICLTSTVQLI 94
>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor
Receptor
pdb|1M17|A Chain A, Epidermal Growth Factor Receptor Tyrosine Kinase Domain
With 4-Anilinoquinazoline Inhibitor Erlotinib
Length = 333
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 50/85 (58%), Gaps = 7/85 (8%)
Query: 362 LVKATDGFADQNLLGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGG-QGEREFKAEVE 415
++K T+ F +LG G FG+VYKG ++P+G + VAIK+L+ + +E E
Sbjct: 17 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 75
Query: 416 IISRIHHRHLVSLVGYCISDDRRLL 440
+++ + + H+ L+G C++ +L+
Sbjct: 76 VMASVDNPHVCRLLGICLTSTVQLI 100
>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFD|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|C Chain C, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|D Chain D, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
Length = 324
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 50/85 (58%), Gaps = 7/85 (8%)
Query: 362 LVKATDGFADQNLLGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGG-QGEREFKAEVE 415
++K T+ F +LG G FG+VYKG ++P+G + VAIK+L+ + +E E
Sbjct: 8 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 66
Query: 416 IISRIHHRHLVSLVGYCISDDRRLL 440
+++ + + H+ L+G C++ +L+
Sbjct: 67 VMASVDNPHVCRLLGICLTSTVQLI 91
>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In
Complex With Amppnp
Length = 334
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 50/85 (58%), Gaps = 7/85 (8%)
Query: 362 LVKATDGFADQNLLGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGG-QGEREFKAEVE 415
++K T+ F +LG G FG+VYKG ++P+G + VAIK+L+ + +E E
Sbjct: 18 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 416 IISRIHHRHLVSLVGYCISDDRRLL 440
+++ + + H+ L+G C++ +L+
Sbjct: 77 VMASVDNPHVCRLLGICLTSTVQLI 101
>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|B Chain B, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|C Chain C, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|D Chain D, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|E Chain E, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|F Chain F, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|G Chain G, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|H Chain H, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
Length = 327
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 50/85 (58%), Gaps = 7/85 (8%)
Query: 362 LVKATDGFADQNLLGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGG-QGEREFKAEVE 415
++K T+ F +LG G FG+VYKG ++P+G + VAIK+L+ + +E E
Sbjct: 11 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 416 IISRIHHRHLVSLVGYCISDDRRLL 440
+++ + + H+ L+G C++ +L+
Sbjct: 70 VMASVDNPHVCRLLGICLTSTVQLI 94
>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Aee788
pdb|2ITU|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Afn941
pdb|2ITV|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Amp-pnp
pdb|2ITZ|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Iressa
Length = 327
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 50/85 (58%), Gaps = 7/85 (8%)
Query: 362 LVKATDGFADQNLLGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGG-QGEREFKAEVE 415
++K T+ F +LG G FG+VYKG ++P+G + VAIK+L+ + +E E
Sbjct: 11 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 416 IISRIHHRHLVSLVGYCISDDRRLL 440
+++ + + H+ L+G C++ +L+
Sbjct: 70 VMASVDNPHVCRLLGICLTSTVQLI 94
>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor-
Gw572016
Length = 352
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 50/85 (58%), Gaps = 7/85 (8%)
Query: 362 LVKATDGFADQNLLGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGG-QGEREFKAEVE 415
++K T+ F +LG G FG+VYKG ++P+G + VAIK+L+ + +E E
Sbjct: 36 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 94
Query: 416 IISRIHHRHLVSLVGYCISDDRRLL 440
+++ + + H+ L+G C++ +L+
Sbjct: 95 VMASVDNPHVCRLLGICLTSTVQLI 119
>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In
Complex With Dacomitinib (soaked)
Length = 329
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 50/85 (58%), Gaps = 7/85 (8%)
Query: 362 LVKATDGFADQNLLGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGG-QGEREFKAEVE 415
++K T+ F +LG G FG+VYKG ++P+G + VAIK+L+ + +E E
Sbjct: 13 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 416 IISRIHHRHLVSLVGYCISDDRRLL 440
+++ + + H+ L+G C++ +L+
Sbjct: 72 VMASVDNPHVCRLLGICLTSTVQLI 96
>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor
pdb|2RGP|A Chain A, Structure Of Egfr In Complex With Hydrazone, A Potent Dual
Inhibitor
Length = 315
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 50/85 (58%), Gaps = 7/85 (8%)
Query: 362 LVKATDGFADQNLLGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGG-QGEREFKAEVE 415
++K T+ F +LG G FG+VYKG ++P+G + VAIK+L+ + +E E
Sbjct: 5 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 416 IISRIHHRHLVSLVGYCISDDRRLL 440
+++ + + H+ L+G C++ +L+
Sbjct: 64 VMASVDNPHVCRLLGICLTSTVQLI 88
>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|2GS7|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|C Chain C, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|D Chain D, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
Length = 330
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 50/85 (58%), Gaps = 7/85 (8%)
Query: 362 LVKATDGFADQNLLGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGG-QGEREFKAEVE 415
++K T+ F +LG G FG+VYKG ++P+G + VAIK+L+ + +E E
Sbjct: 14 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 416 IISRIHHRHLVSLVGYCISDDRRLL 440
+++ + + H+ L+G C++ +L+
Sbjct: 73 VMASVDNPHVCRLLGICLTSTVQLI 97
>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6D|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6Q|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
pdb|4E6Q|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
Length = 298
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 31/88 (35%), Positives = 48/88 (54%), Gaps = 7/88 (7%)
Query: 375 LGEGGFGSVYKG-YLP----DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LG+G FGSV Y P G VA+K+L+ + R+F+ E+EI+ + H ++V
Sbjct: 21 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 430 GYCISDDRR--LLIYDYVPNNTLYFHLH 455
G C S RR LI +++P +L +L
Sbjct: 81 GVCYSAGRRNLKLIMEFLPYGSLREYLQ 108
>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In
Complex With Amppnp
Length = 334
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 50/85 (58%), Gaps = 7/85 (8%)
Query: 362 LVKATDGFADQNLLGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGG-QGEREFKAEVE 415
++K T+ F +LG G FG+VYKG ++P+G + VAIK+L+ + +E E
Sbjct: 18 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 416 IISRIHHRHLVSLVGYCISDDRRLL 440
+++ + + H+ L+G C++ +L+
Sbjct: 77 VMASVDNPHVCRLLGICLTSTVQLI 101
>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic
Mutant L858r Egfr Kinase Domain
Length = 329
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 50/85 (58%), Gaps = 7/85 (8%)
Query: 362 LVKATDGFADQNLLGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGG-QGEREFKAEVE 415
++K T+ F +LG G FG+VYKG ++P+G + VAIK+L+ + +E E
Sbjct: 13 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 416 IISRIHHRHLVSLVGYCISDDRRLL 440
+++ + + H+ L+G C++ +L+
Sbjct: 72 VMASVDNPHVCRLLGICLTSTVQLI 96
>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And
Kinase Domains
Length = 361
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 28/104 (26%), Positives = 56/104 (53%), Gaps = 10/104 (9%)
Query: 343 SPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKG-YLPDGRE----VAIK 397
P P G ++++ ++K T+ F +LG G FG+VYKG ++P+G + VAI
Sbjct: 29 EPLTPSGEAPNQALL---RILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIM 84
Query: 398 QLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440
+L+ + +E E +++ + + H+ L+G C++ +L+
Sbjct: 85 ELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 128
>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine
Kinase Bound To A Pyrrolopyrimidine-Containing Compound
Length = 283
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 28/80 (35%), Positives = 38/80 (47%), Gaps = 1/80 (1%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V G +VAIK +K G E EF E +++ + H LV L G C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 435 DDRRLLIYDYVPNNTLYFHL 454
+I +Y+ N L +L
Sbjct: 91 QRPIFIITEYMANGCLLNYL 110
>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And
Inactive Conformations Suggests A Mechanism Of
Activation For Tec Family Kinases
Length = 283
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 28/80 (35%), Positives = 38/80 (47%), Gaps = 1/80 (1%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V G +VAIK +K G E EF E +++ + H LV L G C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 435 DDRRLLIYDYVPNNTLYFHL 454
+I +Y+ N L +L
Sbjct: 91 QRPIFIITEYMANGCLLNYL 110
>pdb|1FVR|A Chain A, Tie2 Kinase Domain
pdb|1FVR|B Chain B, Tie2 Kinase Domain
Length = 327
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 27/84 (32%), Positives = 49/84 (58%), Gaps = 5/84 (5%)
Query: 372 QNLLGEGGFGSVYKGYLP-DG--REVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRHLV 426
Q+++GEG FG V K + DG + AIK++K + + R+F E+E++ ++ HH +++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 427 SLVGYCISDDRRLLIYDYVPNNTL 450
+L+G C L +Y P+ L
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNL 113
>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A
Thiazolopyrimidine Inhibitor
Length = 324
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 27/84 (32%), Positives = 49/84 (58%), Gaps = 5/84 (5%)
Query: 372 QNLLGEGGFGSVYKGYLP-DG--REVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRHLV 426
Q+++GEG FG V K + DG + AIK++K + + R+F E+E++ ++ HH +++
Sbjct: 27 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 427 SLVGYCISDDRRLLIYDYVPNNTL 450
+L+G C L +Y P+ L
Sbjct: 87 NLLGACEHRGYLYLAIEYAPHGNL 110
>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2OSC|A Chain A, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2P4I|A Chain A, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|2P4I|B Chain B, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|3L8P|A Chain A, Crystal Structure Of Cytoplasmic Kinase Domain Of Tie2
Complexed With Inhibitor Cep11207
Length = 317
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 27/84 (32%), Positives = 49/84 (58%), Gaps = 5/84 (5%)
Query: 372 QNLLGEGGFGSVYKGYLP-DG--REVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRHLV 426
Q+++GEG FG V K + DG + AIK++K + + R+F E+E++ ++ HH +++
Sbjct: 20 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 427 SLVGYCISDDRRLLIYDYVPNNTL 450
+L+G C L +Y P+ L
Sbjct: 80 NLLGACEHRGYLYLAIEYAPHGNL 103
>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Isopropyl-7-
(4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3-
Ylamino)-2h- Phthalazin-1-One
pdb|3PIY|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With R406
pdb|3PIZ|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
(5-Amino-1-O-
Tolyl-1h-Pyrazol-4-Yl)-[3-(1-Methanesulfonyl-Piperidin-
4-Yl)-Phenyl]- Methanone
pdb|3PJ1|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
3-(2,6-Dichloro-
Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-Phenylamino]-1-
Methyl-3,4- Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3PJ2|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-[4-(2-
Diethylamino-Ethoxy)-Phenylamino]-6-(4-Fluoro-Phenoxy)-
8-Methyl-8h- Pyrido[2,3-D]pyrimidin-7-One
pdb|3PJ3|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Methyl-5-[(E)-
(3-Phenyl-Acryloyl)amino]-N-(2-Phenyl-3h-Imidazo[4,
5-B]pyridin-6-Yl)- Benzamide
Length = 274
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 28/80 (35%), Positives = 38/80 (47%), Gaps = 1/80 (1%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V G +VAIK +K G E EF E +++ + H LV L G C
Sbjct: 23 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 435 DDRRLLIYDYVPNNTLYFHL 454
+I +Y+ N L +L
Sbjct: 82 QRPIFIITEYMANGCLLNYL 101
>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain
pdb|4GT4|B Chain B, Structure Of Unliganded, Inactive Ror2 Kinase Domain
Length = 308
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/84 (34%), Positives = 42/84 (50%), Gaps = 7/84 (8%)
Query: 375 LGEGGFGSVYKGYL------PDGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVS 427
LGE FG VYKG+L + VAIK LK G EF+ E + +R+ H ++V
Sbjct: 34 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 428 LVGYCISDDRRLLIYDYVPNNTLY 451
L+G D +I+ Y + L+
Sbjct: 94 LLGVVTKDQPLSMIFSYCSHGDLH 117
>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain
pdb|3P08|B Chain B, Crystal Structure Of The Human Btk Kinase Domain
Length = 267
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 28/80 (35%), Positives = 38/80 (47%), Gaps = 1/80 (1%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V G +VAIK +K G E EF E +++ + H LV L G C
Sbjct: 16 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 435 DDRRLLIYDYVPNNTLYFHL 454
+I +Y+ N L +L
Sbjct: 75 QRPIFIITEYMANGCLLNYL 94
>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain
pdb|1K2P|B Chain B, Crystal Structure Of Bruton's Tyrosine Kinase Domain
Length = 263
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 28/80 (35%), Positives = 38/80 (47%), Gaps = 1/80 (1%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V G +VAIK +K G E EF E +++ + H LV L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 435 DDRRLLIYDYVPNNTLYFHL 454
+I +Y+ N L +L
Sbjct: 71 QRPIFIITEYMANGCLLNYL 90
>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r
In Complex With Dasatinib
Length = 265
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 28/80 (35%), Positives = 38/80 (47%), Gaps = 1/80 (1%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V G +VAIK +K G E EF E +++ + H LV L G C
Sbjct: 17 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 435 DDRRLLIYDYVPNNTLYFHL 454
+I +Y+ N L +L
Sbjct: 76 QRPIFIITEYMANGCLLNYL 95
>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex
With Inhibitor Cgi1746
Length = 271
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 28/80 (35%), Positives = 38/80 (47%), Gaps = 1/80 (1%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V G +VAIK +K G E EF E +++ + H LV L G C
Sbjct: 17 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 435 DDRRLLIYDYVPNNTLYFHL 454
+I +Y+ N L +L
Sbjct: 76 QRPIFIITEYMANGCLLNYL 95
>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2
pdb|3ZZW|B Chain B, Crystal Structure Of The Kinase Domain Of Ror2
Length = 289
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/84 (34%), Positives = 42/84 (50%), Gaps = 7/84 (8%)
Query: 375 LGEGGFGSVYKGYL------PDGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVS 427
LGE FG VYKG+L + VAIK LK G EF+ E + +R+ H ++V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 428 LVGYCISDDRRLLIYDYVPNNTLY 451
L+G D +I+ Y + L+
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLH 100
>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1)
pdb|3OMV|B Chain B, Crystal Structure Of C-Raf (Raf-1)
Length = 307
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 47/83 (56%), Gaps = 5/83 (6%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGE--REFKAEVEIISRIHHRHLVSLVGYC 432
+G G FG+VYKG +VA+K LK+ E + F+ EV ++ + H +++ +GY
Sbjct: 44 IGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY- 100
Query: 433 ISDDRRLLIYDYVPNNTLYFHLH 455
++ D ++ + ++LY HLH
Sbjct: 101 MTKDNLAIVTQWCEGSSLYKHLH 123
>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN The Apo Form
pdb|3UG2|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Gefitinib
pdb|3VJN|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Amppnp
Length = 334
Score = 43.5 bits (101), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 50/86 (58%), Gaps = 7/86 (8%)
Query: 362 LVKATDGFADQNLLGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGG-QGEREFKAEVE 415
++K T+ F +L G FG+VYKG ++P+G + VAIK+L+ + +E E
Sbjct: 18 ILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 416 IISRIHHRHLVSLVGYCISDDRRLLI 441
+++ + + H+ L+G C++ +L++
Sbjct: 77 VMASVDNPHVCRLLGICLTSTVQLIM 102
>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Pp1
Length = 314
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 29/83 (34%), Positives = 42/83 (50%), Gaps = 7/83 (8%)
Query: 375 LGEGGFGSVYKG--YLPDGRE----VAIKQLKIGGGQGE-REFKAEVEIISRIHHRHLVS 427
LGEG FG V K + GR VA+K LK E R+ +E ++ +++H H++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 428 LVGYCISDDRRLLIYDYVPNNTL 450
L G C D LLI +Y +L
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSL 113
>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain
pdb|2IVU|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Zd6474
pdb|2X2K|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2L|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|B Chain B, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
Length = 314
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 29/83 (34%), Positives = 42/83 (50%), Gaps = 7/83 (8%)
Query: 375 LGEGGFGSVYKG--YLPDGRE----VAIKQLKIGGGQGE-REFKAEVEIISRIHHRHLVS 427
LGEG FG V K + GR VA+K LK E R+ +E ++ +++H H++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 428 LVGYCISDDRRLLIYDYVPNNTL 450
L G C D LLI +Y +L
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSL 113
>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
pdb|2IVS|B Chain B, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
Length = 314
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 29/83 (34%), Positives = 42/83 (50%), Gaps = 7/83 (8%)
Query: 375 LGEGGFGSVYKG--YLPDGRE----VAIKQLKIGGGQGE-REFKAEVEIISRIHHRHLVS 427
LGEG FG V K + GR VA+K LK E R+ +E ++ +++H H++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 428 LVGYCISDDRRLLIYDYVPNNTL 450
L G C D LLI +Y +L
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSL 113
>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Amp-Pnp
pdb|2ITO|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Iressa
pdb|2ITP|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Aee788
pdb|2ITQ|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Afn941
Length = 327
Score = 43.1 bits (100), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 362 LVKATDGFADQNLLGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGG-QGEREFKAEVE 415
++K T+ F +L G FG+VYKG ++P+G + VAIK+L+ + +E E
Sbjct: 11 ILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 416 IISRIHHRHLVSLVGYCISDDRRLL 440
+++ + + H+ L+G C++ +L+
Sbjct: 70 VMASVDNPHVCRLLGICLTSTVQLI 94
>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
pdb|1MQB|B Chain B, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
Length = 333
Score = 43.1 bits (100), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 31/92 (33%), Positives = 47/92 (51%), Gaps = 6/92 (6%)
Query: 372 QNLLGEGGFGSVYKGYL--PDGRE---VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHL 425
Q ++G G FG VYKG L G++ VAIK LK G + +R +F E I+ + H ++
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 426 VSLVGYCISDDRRLLIYDYVPNNTLYFHLHGK 457
+ L G ++I +Y+ N L L K
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREK 140
>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s)
Length = 334
Score = 42.7 bits (99), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 362 LVKATDGFADQNLLGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGG-QGEREFKAEVE 415
++K T+ F +L G FG+VYKG ++P+G + VAIK+L+ + +E E
Sbjct: 18 ILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 416 IISRIHHRHLVSLVGYCISDDRRLL 440
+++ + + H+ L+G C++ +L+
Sbjct: 77 VMASVDNPHVCRLLGICLTSTVQLI 101
>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXR|B Chain B, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXS|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complexed With Pp2
Length = 268
Score = 42.7 bits (99), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 28/85 (32%), Positives = 40/85 (47%), Gaps = 3/85 (3%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V G +VA+K +K G E EF E + + ++ H LV G C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 435 DDRRLLIYDYVPNNTL--YFHLHGK 457
+ ++ +Y+ N L Y HGK
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRSHGK 99
>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma
Kinase Catalytic Domain
Length = 327
Score = 42.7 bits (99), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 24/76 (31%), Positives = 42/76 (55%), Gaps = 7/76 (9%)
Query: 375 LGEGGFGSVYKGYL------PDGREVAIKQL-KIGGGQGEREFKAEVEIISRIHHRHLVS 427
LG G FG VY+G + P +VA+K L ++ Q E +F E IIS+++H+++V
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 428 LVGYCISDDRRLLIYD 443
+G + R ++ +
Sbjct: 99 CIGVSLQSLPRFILLE 114
>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 42.7 bits (99), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 24/76 (31%), Positives = 42/76 (55%), Gaps = 7/76 (9%)
Query: 375 LGEGGFGSVYKGYL------PDGREVAIKQL-KIGGGQGEREFKAEVEIISRIHHRHLVS 427
LG G FG VY+G + P +VA+K L ++ Q E +F E IIS+++H+++V
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 428 LVGYCISDDRRLLIYD 443
+G + R ++ +
Sbjct: 113 CIGVSLQSLPRFILLE 128
>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|E Chain E, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|D Chain D, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4N|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E4N|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E5W|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4E5W|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4EHZ|A Chain A, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|B Chain B, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|C Chain C, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|D Chain D, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EI4|A Chain A, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4EI4|B Chain B, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4FK6|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
pdb|4FK6|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
Length = 302
Score = 42.4 bits (98), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 31/88 (35%), Positives = 48/88 (54%), Gaps = 8/88 (9%)
Query: 375 LGEGGFGSV-YKGYLPDG----REVAIKQLK-IGGGQGEREFKAEVEIISRIHHRHLVSL 428
LGEG FG V Y P+G +VA+K LK GG + K E+EI+ ++H ++V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 429 VGYCISD--DRRLLIYDYVPNNTLYFHL 454
G C D + LI +++P+ +L +L
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYL 116
>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In
Complex With Crizotinib
Length = 327
Score = 42.0 bits (97), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 24/76 (31%), Positives = 41/76 (53%), Gaps = 7/76 (9%)
Query: 375 LGEGGFGSVYKGYL------PDGREVAIKQL-KIGGGQGEREFKAEVEIISRIHHRHLVS 427
LG G FG VY+G + P +VA+K L ++ Q E +F E IIS+ +H+++V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 428 LVGYCISDDRRLLIYD 443
+G + R ++ +
Sbjct: 98 CIGVSLQSLPRFILME 113
>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 42.0 bits (97), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 24/76 (31%), Positives = 41/76 (53%), Gaps = 7/76 (9%)
Query: 375 LGEGGFGSVYKGYL------PDGREVAIKQL-KIGGGQGEREFKAEVEIISRIHHRHLVS 427
LG G FG VY+G + P +VA+K L ++ Q E +F E IIS+ +H+++V
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 428 LVGYCISDDRRLLIYD 443
+G + R ++ +
Sbjct: 113 CIGVSLQSLPRFILME 128
>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3EYH|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 290
Score = 42.0 bits (97), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 31/88 (35%), Positives = 48/88 (54%), Gaps = 8/88 (9%)
Query: 375 LGEGGFGSV-YKGYLPDG----REVAIKQLK-IGGGQGEREFKAEVEIISRIHHRHLVSL 428
LGEG FG V Y P+G +VA+K LK GG + K E+EI+ ++H ++V
Sbjct: 17 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 429 VGYCISD--DRRLLIYDYVPNNTLYFHL 454
G C D + LI +++P+ +L +L
Sbjct: 77 KGICTEDGGNGIKLIMEFLPSGSLKEYL 104
>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma
Kinase Catalytic Domain
pdb|4FNY|A Chain A, Crystal Structure Of The R1275q Anaplastic Lymphoma Kinase
Catalytic Domain In Complex With A Benzoxazole Inhibitor
Length = 327
Score = 42.0 bits (97), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 24/76 (31%), Positives = 41/76 (53%), Gaps = 7/76 (9%)
Query: 375 LGEGGFGSVYKGYL------PDGREVAIKQL-KIGGGQGEREFKAEVEIISRIHHRHLVS 427
LG G FG VY+G + P +VA+K L ++ Q E +F E IIS+ +H+++V
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 428 LVGYCISDDRRLLIYD 443
+G + R ++ +
Sbjct: 99 CIGVSLQSLPRFILLE 114
>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 367
Score = 42.0 bits (97), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 24/76 (31%), Positives = 41/76 (53%), Gaps = 7/76 (9%)
Query: 375 LGEGGFGSVYKGYL------PDGREVAIKQL-KIGGGQGEREFKAEVEIISRIHHRHLVS 427
LG G FG VY+G + P +VA+K L ++ Q E +F E IIS+ +H+++V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 428 LVGYCISDDRRLLIYD 443
+G + R ++ +
Sbjct: 139 CIGVSLQSLPRFILLE 154
>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma
Kinase In Complex With Ch5424802
Length = 344
Score = 42.0 bits (97), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 24/76 (31%), Positives = 41/76 (53%), Gaps = 7/76 (9%)
Query: 375 LGEGGFGSVYKGYL------PDGREVAIKQL-KIGGGQGEREFKAEVEIISRIHHRHLVS 427
LG G FG VY+G + P +VA+K L ++ Q E +F E IIS+ +H+++V
Sbjct: 55 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 428 LVGYCISDDRRLLIYD 443
+G + R ++ +
Sbjct: 115 CIGVSLQSLPRFILLE 130
>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In
Complex With Crizotinib (Pf-02341066)
Length = 327
Score = 42.0 bits (97), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 24/76 (31%), Positives = 41/76 (53%), Gaps = 7/76 (9%)
Query: 375 LGEGGFGSVYKGYL------PDGREVAIKQL-KIGGGQGEREFKAEVEIISRIHHRHLVS 427
LG G FG VY+G + P +VA+K L ++ Q E +F E IIS+ +H+++V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 428 LVGYCISDDRRLLIYD 443
+G + R ++ +
Sbjct: 98 CIGVSLQSLPRFILLE 113
>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4DCE|B Chain B, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4FOD|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 36
Length = 333
Score = 42.0 bits (97), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 24/76 (31%), Positives = 41/76 (53%), Gaps = 7/76 (9%)
Query: 375 LGEGGFGSVYKGYL------PDGREVAIKQL-KIGGGQGEREFKAEVEIISRIHHRHLVS 427
LG G FG VY+G + P +VA+K L ++ Q E +F E IIS+ +H+++V
Sbjct: 45 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 428 LVGYCISDDRRLLIYD 443
+G + R ++ +
Sbjct: 105 CIGVSLQSLPRFILLE 120
>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Piperidine-Carboxamide Inhibitor 2
Length = 327
Score = 42.0 bits (97), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 24/76 (31%), Positives = 41/76 (53%), Gaps = 7/76 (9%)
Query: 375 LGEGGFGSVYKGYL------PDGREVAIKQL-KIGGGQGEREFKAEVEIISRIHHRHLVS 427
LG G FG VY+G + P +VA+K L ++ Q E +F E IIS+ +H+++V
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 428 LVGYCISDDRRLLIYD 443
+G + R ++ +
Sbjct: 99 CIGVSLQSLPRFILLE 114
>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Nvp- Tae684
pdb|2XBA|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Pha-E429
Length = 315
Score = 42.0 bits (97), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 24/76 (31%), Positives = 41/76 (53%), Gaps = 7/76 (9%)
Query: 375 LGEGGFGSVYKGYL------PDGREVAIKQL-KIGGGQGEREFKAEVEIISRIHHRHLVS 427
LG G FG VY+G + P +VA+K L ++ Q E +F E IIS+ +H+++V
Sbjct: 30 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 428 LVGYCISDDRRLLIYD 443
+G + R ++ +
Sbjct: 90 CIGVSLQSLPRFILLE 105
>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 1
pdb|4FOC|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 2
Length = 353
Score = 42.0 bits (97), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 24/76 (31%), Positives = 41/76 (53%), Gaps = 7/76 (9%)
Query: 375 LGEGGFGSVYKGYL------PDGREVAIKQL-KIGGGQGEREFKAEVEIISRIHHRHLVS 427
LG G FG VY+G + P +VA+K L ++ Q E +F E IIS+ +H+++V
Sbjct: 65 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 428 LVGYCISDDRRLLIYD 443
+G + R ++ +
Sbjct: 125 CIGVSLQSLPRFILLE 140
>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
pdb|3LCS|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 344
Score = 42.0 bits (97), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 24/76 (31%), Positives = 41/76 (53%), Gaps = 7/76 (9%)
Query: 375 LGEGGFGSVYKGYL------PDGREVAIKQL-KIGGGQGEREFKAEVEIISRIHHRHLVS 427
LG G FG VY+G + P +VA+K L ++ Q E +F E IIS+ +H+++V
Sbjct: 56 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 428 LVGYCISDDRRLLIYD 443
+G + R ++ +
Sbjct: 116 CIGVSLQSLPRFILLE 131
>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule
Inhibitor
Length = 288
Score = 41.6 bits (96), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 2/76 (2%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V+ GY +VA+K LK G F AE ++ ++ H+ LV L ++
Sbjct: 30 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 87
Query: 435 DDRRLLIYDYVPNNTL 450
+ +I +Y+ N +L
Sbjct: 88 QEPIYIITEYMENGSL 103
>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OEZ|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OF0|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3OF0|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3QLF|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLF|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLG|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
pdb|3QLG|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
Length = 286
Score = 41.6 bits (96), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 27/83 (32%), Positives = 42/83 (50%), Gaps = 2/83 (2%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG+G FG V+ G VAIK LK G E F E +++ +I H LV L +S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKIRHEKLVQLYA-VVS 83
Query: 435 DDRRLLIYDYVPNNTLYFHLHGK 457
++ ++ +Y+ +L L G+
Sbjct: 84 EEPIYIVTEYMSKGSLLDFLKGE 106
>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule
W259
Length = 287
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 2/76 (2%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V+ GY +VA+K LK G F AE ++ ++ H+ LV L ++
Sbjct: 29 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 86
Query: 435 DDRRLLIYDYVPNNTL 450
+ +I +Y+ N +L
Sbjct: 87 QEPIYIITEYMENGSL 102
>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck
pdb|2OF4|A Chain A, Crystal Structure Of Furanopyrimidine 1 Bound To Lck
Length = 271
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 2/76 (2%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V+ GY +VA+K LK G F AE ++ ++ H+ LV L ++
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 78
Query: 435 DDRRLLIYDYVPNNTL 450
+ +I +Y+ N +L
Sbjct: 79 QEPIYIITEYMENGSL 94
>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase
Domain Of Human Lck, (Auto-Phosphorylated On Tyr394)
pdb|2ZM4|A Chain A, Crystal Structure Of Imidazo Quinoxaline 1 Bound To The
Kinase Domain Of Human Lck, Activated Form (Auto-
Phosphorylated On Tyr394)
pdb|2ZYB|A Chain A, Crystal Structure Of Phenylimidazo Pyrazin 2 Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC1|A Chain A, Crystal Structure Of Pyrazin Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC2|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC3|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC4|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC5|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC8|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACJ|A Chain A, Crystal Structure Of Imidazo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACK|A Chain A, Crystal Structure Of Pyrrolo Pyrazine Derivative Bound To
The Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD4|A Chain A, Crystal Structure Of Methoxy Benzofuran Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AD5|A Chain A, Crystal Structure Of Triazolone Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD6|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
Length = 285
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 2/76 (2%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V+ GY +VA+K LK G F AE ++ ++ H+ LV L ++
Sbjct: 27 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 84
Query: 435 DDRRLLIYDYVPNNTL 450
+ +I +Y+ N +L
Sbjct: 85 QEPIYIITEYMENGSL 100
>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43
Bound To Lck
Length = 273
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 2/76 (2%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V+ GY +VA+K LK G F AE ++ ++ H+ LV L ++
Sbjct: 23 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 80
Query: 435 DDRRLLIYDYVPNNTL 450
+ +I +Y+ N +L
Sbjct: 81 QEPIYIITEYMENGSL 96
>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck),
Activated Form (Auto-Phosphorylated On Tyr394)
pdb|3BYO|A Chain A, X-Ray Co-Crystal Structure Of 2-Amino-6-Phenylpyrimido[5',
4':5,6]pyrimido[1,2-A]benzimidazol-5(6h)-One 25 Bound To
Lck
Length = 271
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 2/76 (2%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V+ GY +VA+K LK G F AE ++ ++ H+ LV L ++
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 78
Query: 435 DDRRLLIYDYVPNNTL 450
+ +I +Y+ N +L
Sbjct: 79 QEPIYIITEYMENGSL 94
>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b
pdb|3BYU|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Reverse
Amide 23
Length = 277
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 2/76 (2%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V+ GY +VA+K LK G F AE ++ ++ H+ LV L ++
Sbjct: 27 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 84
Query: 435 DDRRLLIYDYVPNNTL 450
+ +I +Y+ N +L
Sbjct: 85 QEPIYIITEYMENGSL 100
>pdb|2PL0|A Chain A, Lck Bound To Imatinib
Length = 289
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 2/76 (2%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V+ GY +VA+K LK G F AE ++ ++ H+ LV L ++
Sbjct: 31 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 88
Query: 435 DDRRLLIYDYVPNNTL 450
+ +I +Y+ N +L
Sbjct: 89 QEPIYIITEYMENGSL 104
>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1
Bound To Lck
Length = 272
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 2/76 (2%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V+ GY +VA+K LK G F AE ++ ++ H+ LV L ++
Sbjct: 22 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 79
Query: 435 DDRRLLIYDYVPNNTL 450
+ +I +Y+ N +L
Sbjct: 80 QEPIYIITEYMENGSL 95
>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|2OFV|B Chain B, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|3B2W|A Chain A, Crystal Structure Of Pyrimidine Amide 11 Bound To Lck
Length = 277
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 2/76 (2%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V+ GY +VA+K LK G F AE ++ ++ H+ LV L ++
Sbjct: 26 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 83
Query: 435 DDRRLLIYDYVPNNTL 450
+ +I +Y+ N +L
Sbjct: 84 QEPIYIITEYMENGSL 99
>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
pdb|1QPJ|A Chain A, Crystal Structure Of The Lymphocyte-Specific Kinase Lck In
Complex With Staurosporine.
pdb|1QPC|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 2/76 (2%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V+ GY +VA+K LK G F AE ++ ++ H+ LV L ++
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 78
Query: 435 DDRRLLIYDYVPNNTL 450
+ +I +Y+ N +L
Sbjct: 79 QEPIYIITEYMENGSL 94
>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine
Length = 267
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 2/76 (2%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V+ GY +VA+K LK G F AE ++ ++ H+ LV L ++
Sbjct: 17 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 74
Query: 435 DDRRLLIYDYVPNNTL 450
+ +I +Y+ N +L
Sbjct: 75 QEPIYIITEYMENGSL 90
>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720
pdb|3C4C|B Chain B, B-Raf Kinase In Complex With Plx4720
Length = 280
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/84 (29%), Positives = 45/84 (53%), Gaps = 5/84 (5%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYC 432
+G G FG+VYKG +VA+K L + Q + FK EV ++ + H +++ +GY
Sbjct: 20 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHG 456
+ + ++ + ++LY HLH
Sbjct: 78 -TKPQLAIVTQWCEGSSLYHHLHA 100
>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
pdb|2OG8|B Chain B, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
Length = 265
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 2/76 (2%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V+ GY +VA+K LK G F AE ++ ++ H+ LV L ++
Sbjct: 16 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 73
Query: 435 DDRRLLIYDYVPNNTL 450
+ +I +Y+ N +L
Sbjct: 74 QEPIYIITEYMENGSL 89
>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
pdb|4FK3|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
Length = 292
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/84 (29%), Positives = 45/84 (53%), Gaps = 5/84 (5%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYC 432
+G G FG+VYKG +VA+K L + Q + FK EV ++ + H +++ +GY
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHG 456
+ + ++ + ++LY HLH
Sbjct: 90 -TKPQLAIVTQWCEGSSLYHHLHA 112
>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
pdb|3OG7|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
Length = 289
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/84 (29%), Positives = 45/84 (53%), Gaps = 5/84 (5%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYC 432
+G G FG+VYKG +VA+K L + Q + FK EV ++ + H +++ +GY
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHG 456
+ + ++ + ++LY HLH
Sbjct: 90 TA-PQLAIVTQWCEGSSLYHHLHA 112
>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
pdb|2FB8|B Chain B, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
Length = 281
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/83 (30%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYC 432
+G G FG+VYKG +VA+K L + Q + FK EV ++ + H +++ +GY
Sbjct: 21 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 433 ISDDRRLLIYDYVPNNTLYFHLH 455
+ + ++ + ++LY HLH
Sbjct: 79 -TKPQLAIVTQWCEGSSLYHHLH 100
>pdb|4H58|A Chain A, Braf In Complex With Compound 3
pdb|4H58|B Chain B, Braf In Complex With Compound 3
pdb|4H58|C Chain C, Braf In Complex With Compound 3
Length = 275
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/83 (30%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYC 432
+G G FG+VYKG +VA+K L + Q + FK EV ++ + H +++ +GY
Sbjct: 16 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 433 ISDDRRLLIYDYVPNNTLYFHLH 455
+ + ++ + ++LY HLH
Sbjct: 74 -TKPQLAIVTQWCEGSSLYHHLH 95
>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
pdb|3Q96|B Chain B, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
Length = 282
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/83 (30%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYC 432
+G G FG+VYKG +VA+K L + Q + FK EV ++ + H +++ +GY
Sbjct: 18 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 433 ISDDRRLLIYDYVPNNTLYFHLH 455
+ + ++ + ++LY HLH
Sbjct: 76 -TKPQLAIVTQWCEGSSLYHHLH 97
>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
pdb|3COH|B Chain B, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
Length = 268
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 4/95 (4%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREV-AIKQL---KIGGGQGEREFKAEVEIISRI 420
A + F LG+G FG+VY + + + A+K L ++ E + + EVEI S +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLH 455
H +++ L GY R LI +Y P T+Y L
Sbjct: 66 RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQ 100
>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006
pdb|1UWJ|B Chain B, The Complex Of Mutant V599e B-raf And Bay439006
Length = 276
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/83 (30%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYC 432
+G G FG+VYKG +VA+K L + Q + FK EV ++ + H +++ +GY
Sbjct: 16 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 433 ISDDRRLLIYDYVPNNTLYFHLH 455
+ + ++ + ++LY HLH
Sbjct: 74 -TKPQLAIVTQWCEGSSLYHHLH 95
>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006
pdb|1UWH|B Chain B, The Complex Of Wild Type B-Raf And Bay439006
Length = 276
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/83 (30%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYC 432
+G G FG+VYKG +VA+K L + Q + FK EV ++ + H +++ +GY
Sbjct: 16 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 433 ISDDRRLLIYDYVPNNTLYFHLH 455
+ + ++ + ++LY HLH
Sbjct: 74 TA-PQLAIVTQWCEGSSLYHHLH 95
>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 24/76 (31%), Positives = 41/76 (53%), Gaps = 7/76 (9%)
Query: 375 LGEGGFGSVYKGYL------PDGREVAIKQL-KIGGGQGEREFKAEVEIISRIHHRHLVS 427
LG G FG VY+G + P +VA+K L ++ Q E +F E IIS+ +H+++V
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 428 LVGYCISDDRRLLIYD 443
+G + R ++ +
Sbjct: 113 CIGVSLQSLPRFILLE 128
>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
pdb|4DBN|B Chain B, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 284
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/83 (30%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYC 432
+G G FG+VYKG +VA+K L + Q + FK EV ++ + H +++ +GY
Sbjct: 21 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 433 ISDDRRLLIYDYVPNNTLYFHLH 455
+ + ++ + ++LY HLH
Sbjct: 79 -TKPQLAIVTQWCEGSSLYHHLH 100
>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
pdb|1YI6|B Chain B, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
Length = 276
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 42/83 (50%), Gaps = 2/83 (2%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG+G FG V+ G VAIK LK G E F E +++ ++ H LV L +S
Sbjct: 16 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA-VVS 73
Query: 435 DDRRLLIYDYVPNNTLYFHLHGK 457
++ ++ +Y+ +L L G+
Sbjct: 74 EEPIXIVTEYMSKGSLLDFLKGE 96
>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3D4Q|B Chain B, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3PSB|A Chain A, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PSB|B Chain B, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PPJ|A Chain A, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPJ|B Chain B, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPK|A Chain A, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PPK|B Chain B, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PRF|A Chain A, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRF|B Chain B, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRI|A Chain A, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3PRI|B Chain B, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3Q4C|A Chain A, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3Q4C|B Chain B, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3PSD|A Chain A, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3PSD|B Chain B, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3SKC|A Chain A, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3SKC|B Chain B, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3TV4|A Chain A, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV4|B Chain B, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV6|A Chain A, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|3TV6|B Chain B, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|4E26|A Chain A, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E26|B Chain B, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E4X|A Chain A, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4E4X|B Chain B, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4G9C|A Chain A, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
pdb|4G9C|B Chain B, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
Length = 307
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/83 (30%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYC 432
+G G FG+VYKG +VA+K L + Q + FK EV ++ + H +++ +GY
Sbjct: 44 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 433 ISDDRRLLIYDYVPNNTLYFHLH 455
+ + ++ + ++LY HLH
Sbjct: 102 -TKPQLAIVTQWCEGSSLYHHLH 123
>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
pdb|3IDP|B Chain B, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
Length = 300
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/83 (30%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYC 432
+G G FG+VYKG +VA+K L + Q + FK EV ++ + H +++ +GY
Sbjct: 36 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 433 ISDDRRLLIYDYVPNNTLYFHLH 455
+ + ++ + ++LY HLH
Sbjct: 94 -TKPQLAIVTQWCEGSSLYHHLH 115
>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
pdb|4G9R|B Chain B, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
Length = 307
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/83 (30%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYC 432
+G G FG+VYKG +VA+K L + Q + FK EV ++ + H +++ +GY
Sbjct: 44 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 433 ISDDRRLLIYDYVPNNTLYFHLH 455
+ + ++ + ++LY HLH
Sbjct: 102 -TKPQLAIVTQWCEGSSLYHHLH 123
>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
pdb|3II5|B Chain B, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
Length = 306
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 25/83 (30%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYC 432
+G G FG+VYKG +VA+K L + Q + FK EV ++ + H +++ +GY
Sbjct: 43 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 433 ISDDRRLLIYDYVPNNTLYFHLH 455
+ + ++ + ++LY HLH
Sbjct: 101 -TKPQLAIVTQWCEGSSLYHHLH 122
>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase
Length = 453
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 42/83 (50%), Gaps = 2/83 (2%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG+G FG V+ G VAIK LK G E F E +++ ++ H LV L +S
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPE-AFLQEAQVMKKLRHEKLVQLYA-VVS 250
Query: 435 DDRRLLIYDYVPNNTLYFHLHGK 457
++ ++ +Y+ +L L G+
Sbjct: 251 EEPIYIVTEYMSKGSLLDFLKGE 273
>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
pdb|3GEQ|B Chain B, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
Length = 286
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 42/83 (50%), Gaps = 2/83 (2%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG+G FG V+ G VAIK LK G E F E +++ ++ H LV L +S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 435 DDRRLLIYDYVPNNTLYFHLHGK 457
++ ++ +Y+ +L L G+
Sbjct: 84 EEPIYIVTEYMSKGSLLDFLKGE 106
>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc4b
pdb|3U51|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
pdb|3U51|B Chain B, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
Length = 275
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 42/83 (50%), Gaps = 2/83 (2%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG+G FG V+ G VAIK LK G E F E +++ ++ H LV L +S
Sbjct: 15 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA-VVS 72
Query: 435 DDRRLLIYDYVPNNTLYFHLHGK 457
++ ++ +Y+ +L L G+
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKGE 95
>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|2OIQ|B Chain B, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|3D7T|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3DQX|A Chain A, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3DQX|B Chain B, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3EN4|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN4|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN5|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN5|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN6|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN6|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN7|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EN7|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EL7|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 3
pdb|3EL8|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3EL8|B Chain B, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3F6X|A Chain A, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|B Chain B, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|C Chain C, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|D Chain D, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3G6G|A Chain A, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|3G6G|B Chain B, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|4AGW|A Chain A, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|4AGW|B Chain B, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|3UQF|A Chain A, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQF|B Chain B, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQG|A Chain A, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|3UQG|B Chain B, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|4DGG|A Chain A, C-Src Kinase Domain In Complex With Rm-1-176
pdb|4DGG|B Chain B, C-Src Kinase Domain In Complex With Rm-1-176
Length = 286
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 42/83 (50%), Gaps = 2/83 (2%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG+G FG V+ G VAIK LK G E F E +++ ++ H LV L +S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 435 DDRRLLIYDYVPNNTLYFHLHGK 457
++ ++ +Y+ +L L G+
Sbjct: 84 EEPIYIVTEYMSKGSLLDFLKGE 106
>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDF|B Chain B, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDJ|A Chain A, Src Kinase In Complex With Inhibitor Ap23464
Length = 279
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 42/83 (50%), Gaps = 2/83 (2%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG+G FG V+ G VAIK LK G E F E +++ ++ H LV L +S
Sbjct: 19 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA-VVS 76
Query: 435 DDRRLLIYDYVPNNTLYFHLHGK 457
++ ++ +Y+ +L L G+
Sbjct: 77 EEPIYIVTEYMSKGSLLDFLKGE 99
>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|D Chain D, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 277
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 42/83 (50%), Gaps = 2/83 (2%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG+G FG V+ G VAIK LK G E F E +++ ++ H LV L +S
Sbjct: 17 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA-VVS 74
Query: 435 DDRRLLIYDYVPNNTLYFHLHGK 457
++ ++ +Y+ +L L G+
Sbjct: 75 EEPIYIVTEYMSKGSLLDFLKGE 97
>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
pdb|3G6H|B Chain B, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
Length = 286
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 42/83 (50%), Gaps = 2/83 (2%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG+G FG V+ G VAIK LK G E F E +++ ++ H LV L +S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 435 DDRRLLIYDYVPNNTLYFHLHGK 457
++ ++ +Y+ +L L G+
Sbjct: 84 EEPIYIVIEYMSKGSLLDFLKGE 106
>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|B Chain B, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|C Chain C, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|D Chain D, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
Length = 286
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 42/83 (50%), Gaps = 2/83 (2%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG+G FG V+ G VAIK LK G E F E +++ ++ H LV L +S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 435 DDRRLLIYDYVPNNTLYFHLHGK 457
++ ++ +Y+ +L L G+
Sbjct: 84 EEPIYIVIEYMSKGSLLDFLKGE 106
>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
pdb|3SVV|B Chain B, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
Length = 286
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 42/83 (50%), Gaps = 2/83 (2%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG+G FG V+ G VAIK LK G E F E +++ ++ H LV L +S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 435 DDRRLLIYDYVPNNTLYFHLHGK 457
++ ++ +Y+ +L L G+
Sbjct: 84 EEPIYIVCEYMSKGSLLDFLKGE 106
>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src
pdb|2SRC|A Chain A, Crystal Structure Of Human Tyrosine-protein Kinase C-src,
In Complex With Amp-pnp
Length = 452
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 42/83 (50%), Gaps = 2/83 (2%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG+G FG V+ G VAIK LK G E F E +++ ++ H LV L +S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA-VVS 249
Query: 435 DDRRLLIYDYVPNNTLYFHLHGK 457
++ ++ +Y+ +L L G+
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLKGE 272
>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An
Inhibitor
Length = 452
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 42/83 (50%), Gaps = 2/83 (2%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG+G FG V+ G VAIK LK G E F E +++ ++ H LV L +S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA-VVS 249
Query: 435 DDRRLLIYDYVPNNTLYFHLHGK 457
++ ++ +Y+ +L L G+
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLKGE 272
>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 291
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 31/84 (36%), Positives = 43/84 (51%), Gaps = 8/84 (9%)
Query: 375 LGEGGFGSV-YKGYLPD----GREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSL 428
LGEG FG V Y P G VA+K LK G G R ++ E+EI+ ++H H+V
Sbjct: 17 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 429 VGYCISDDRR--LLIYDYVPNNTL 450
G C + L+ +YVP +L
Sbjct: 77 KGCCEDQGEKSVQLVMEYVPLGSL 100
>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 290
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 31/84 (36%), Positives = 43/84 (51%), Gaps = 8/84 (9%)
Query: 375 LGEGGFGSV-YKGYLPD----GREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSL 428
LGEG FG V Y P G VA+K LK G G R ++ E+EI+ ++H H+V
Sbjct: 16 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 429 VGYCISDDRR--LLIYDYVPNNTL 450
G C + L+ +YVP +L
Sbjct: 76 KGCCEDQGEKSVQLVMEYVPLGSL 99
>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor
Length = 535
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 42/83 (50%), Gaps = 2/83 (2%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG+G FG V+ G VAIK LK G E F E +++ ++ H LV L +S
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA-VVS 332
Query: 435 DDRRLLIYDYVPNNTLYFHLHGK 457
++ ++ +Y+ +L L G+
Sbjct: 333 EEPIYIVTEYMSKGSLLDFLKGE 355
>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain
pdb|1YOJ|B Chain B, Crystal Structure Of Src Kinase Domain
pdb|1YOM|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
pdb|1YOM|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
Length = 283
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 42/83 (50%), Gaps = 2/83 (2%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG+G FG V+ G VAIK LK G E F E +++ ++ H LV L +S
Sbjct: 23 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA-VVS 80
Query: 435 DDRRLLIYDYVPNNTLYFHLHGK 457
++ ++ +Y+ +L L G+
Sbjct: 81 EEPIYIVTEYMNKGSLLDFLKGE 103
>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QQ7|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QI8|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|2QI8|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|3F3W|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3F3W|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3LOK|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
pdb|3LOK|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
Length = 286
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 41/83 (49%), Gaps = 2/83 (2%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG+G FG V+ G VAIK LK G E F E +++ ++ H LV L +S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 435 DDRRLLIYDYVPNNTLYFHLHGK 457
++ ++ +Y+ L L G+
Sbjct: 84 EEPIYIVMEYMSKGCLLDFLKGE 106
>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine
Inhibitor
Length = 272
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 4/95 (4%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREV-AIKQL---KIGGGQGEREFKAEVEIISRI 420
A + F LG+G FG+VY + + A+K L ++ E + + EVEI S +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLH 455
H +++ L GY R LI +Y P T+Y L
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 103
>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
pdb|1YOL|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
Length = 283
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 42/83 (50%), Gaps = 2/83 (2%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG+G FG V+ G VAIK LK G E F E +++ ++ H LV L +S
Sbjct: 23 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA-VVS 80
Query: 435 DDRRLLIYDYVPNNTLYFHLHGK 457
++ ++ +Y+ +L L G+
Sbjct: 81 EEPIYIVTEYMNKGSLLDFLKGE 103
>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase
pdb|2NP8|A Chain A, Structural Basis For The Inhibition Of Aurora A Kinase By
A Novel Class Of High Affinity Disubstituted Pyrimidine
Inhibitors
pdb|2X81|A Chain A, Structure Of Aurora A In Complex With Mln8054
pdb|3MYG|A Chain A, Aurora A Kinase Complexed With Sch 1473759
pdb|3VAP|A Chain A, Synthesis And Sar Studies Of Imidazo-[1,2-A]-Pyrazine
Aurora Kinase Inhibitors With Improved Off Target Kinase
Selectivity
Length = 272
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 4/95 (4%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREV-AIKQL---KIGGGQGEREFKAEVEIISRI 420
A + F LG+G FG+VY + + A+K L ++ E + + EVEI S +
Sbjct: 10 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLH 455
H +++ L GY R LI +Y P T+Y L
Sbjct: 70 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 104
>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O50|B Chain B, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O51|A Chain A, Crystal Structure Of Anthranilamide 10 Bound To Auroraa
pdb|3EFW|A Chain A, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
pdb|3EFW|B Chain B, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
Length = 267
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 4/95 (4%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREV-AIKQL---KIGGGQGEREFKAEVEIISRI 420
A + F LG+G FG+VY + + A+K L ++ E + + EVEI S +
Sbjct: 5 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLH 455
H +++ L GY R LI +Y P T+Y L
Sbjct: 65 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 99
>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680
Length = 292
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 30/93 (32%), Positives = 43/93 (46%), Gaps = 4/93 (4%)
Query: 367 DGFADQNLLGEGGFGSVYKGYLPDGRE-VAIKQL---KIGGGQGEREFKAEVEIISRIHH 422
D F LG+G FG+VY VA+K L +I E + + E+EI + +HH
Sbjct: 23 DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 423 RHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLH 455
+++ L Y R LI +Y P LY L
Sbjct: 83 PNILRLYNYFYDRRRIYLILEYAPRGELYKELQ 115
>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358
pdb|2J50|B Chain B, Structure Of Aurora-2 In Complex With Pha-739358
Length = 280
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 4/95 (4%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREV-AIKQL---KIGGGQGEREFKAEVEIISRI 420
A + F LG+G FG+VY + + A+K L ++ E + + EVEI S +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLH 455
H +++ L GY R LI +Y P T+Y L
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 100
>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A
Gsk3beta Inhibitor
Length = 287
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 4/95 (4%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREV-AIKQL---KIGGGQGEREFKAEVEIISRI 420
A + F LG+G FG+VY + + A+K L ++ E + + EVEI S +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLH 455
H +++ L GY R LI +Y P T+Y L
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 100
>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626
pdb|2J4Z|B Chain B, Structure Of Aurora-2 In Complex With Pha-680626
Length = 306
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 4/95 (4%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREV-AIKQL---KIGGGQGEREFKAEVEIISRI 420
A + F LG+G FG+VY + + A+K L ++ E + + EVEI S +
Sbjct: 32 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLH 455
H +++ L GY R LI +Y P T+Y L
Sbjct: 92 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 126
>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1E|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1F|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 4/95 (4%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREV-AIKQL---KIGGGQGEREFKAEVEIISRI 420
A + F LG+G FG+VY + + A+K L ++ E + + EVEI S +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLH 455
H +++ L GY R LI +Y P T+Y L
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 103
>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And
Tpx2
Length = 268
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 4/95 (4%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREV-AIKQL---KIGGGQGEREFKAEVEIISRI 420
A + F LG+G FG+VY + + A+K L ++ E + + EVEI S +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLH 455
H +++ L GY R LI +Y P T+Y L
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 100
>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And
Compound 10
Length = 268
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 4/95 (4%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREV-AIKQL---KIGGGQGEREFKAEVEIISRI 420
A + F LG+G FG+VY + + A+K L ++ E + + EVEI S +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLH 455
H +++ L GY R LI +Y P T+Y L
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 100
>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a
Length = 282
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 4/95 (4%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREV-AIKQL---KIGGGQGEREFKAEVEIISRI 420
A + F LG+G FG+VY + + A+K L ++ E + + EVEI S +
Sbjct: 8 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLH 455
H +++ L GY R LI +Y P T+Y L
Sbjct: 68 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 102
>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A
Diaminopyrimidine
Length = 281
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 4/95 (4%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREV-AIKQL---KIGGGQGEREFKAEVEIISRI 420
A + F LG+G FG+VY + + A+K L ++ E + + EVEI S +
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLH 455
H +++ L GY R LI +Y P T+Y L
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 101
>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|3R22|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|4DHF|A Chain A, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
pdb|4DHF|B Chain B, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
Length = 271
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 4/95 (4%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREV-AIKQL---KIGGGQGEREFKAEVEIISRI 420
A + F LG+G FG+VY + + A+K L ++ E + + EVEI S +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLH 455
H +++ L GY R LI +Y P T+Y L
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 103
>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine
Inhibitor
Length = 283
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 4/95 (4%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREV-AIKQL---KIGGGQGEREFKAEVEIISRI 420
A + F LG+G FG+VY + + A+K L ++ E + + EVEI S +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLH 455
H +++ L GY R LI +Y P T+Y L
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 103
>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|B Chain B, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|C Chain C, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H10|A Chain A, Aurora A Inhibitor Complex
pdb|3H10|B Chain B, Aurora A Inhibitor Complex
pdb|3H10|D Chain D, Aurora A Inhibitor Complex
pdb|3P9J|A Chain A, Aurora A Kinase Domain With Phthalazinone Pyrazole
Inhibitor
Length = 268
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 4/95 (4%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREV-AIKQL---KIGGGQGEREFKAEVEIISRI 420
A + F LG+G FG+VY + + A+K L ++ E + + EVEI S +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLH 455
H +++ L GY R LI +Y P T+Y L
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 100
>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With
Adpnp
Length = 275
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 4/95 (4%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREV-AIKQL---KIGGGQGEREFKAEVEIISRI 420
A + F LG+G FG+VY + + A+K L ++ E + + EVEI S +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLH 455
H +++ L GY R LI +Y P T+Y L
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 100
>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors
Length = 283
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 4/95 (4%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREV-AIKQL---KIGGGQGEREFKAEVEIISRI 420
A + F LG+G FG+VY + + A+K L ++ E + + EVEI S +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLH 455
H +++ L GY R LI +Y P T+Y L
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 103
>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor
pdb|2X6E|A Chain A, Aurora-A Bound To An Inhibitor
Length = 285
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 4/95 (4%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREV-AIKQL---KIGGGQGEREFKAEVEIISRI 420
A + F LG+G FG+VY + + A+K L ++ E + + EVEI S +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLH 455
H +++ L GY R LI +Y P T+Y L
Sbjct: 71 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 105
>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With
N-(4-chlorophenyl)-2-
((pyridin-4-ylmethyl)amino)benzamide
Length = 360
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 46/97 (47%), Gaps = 9/97 (9%)
Query: 375 LGEGGFGSVYKGYL------PDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRHLV 426
LG G FG V + P R VA+K LK G E + E++I++ I HH ++V
Sbjct: 35 LGRGAFGKVVQASAFGIKKSPTCRTVAVKMLKEGATASEYKALMTELKILTHIGHHLNVV 94
Query: 427 SLVGYCISDDRRLL-IYDYVPNNTLYFHLHGKWQLGF 462
+L+G C L+ I +Y L +L K L F
Sbjct: 95 NLLGACTKQGGPLMVIVEYCKYGNLSNYLKSKRDLFF 131
>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWO|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWP|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2HWP|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2QLQ|A Chain A, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|2QLQ|B Chain B, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|3F3T|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3T|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3U|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3U|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3V|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3F3V|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3G5D|A Chain A, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3G5D|B Chain B, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3TZ7|A Chain A, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ7|B Chain B, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ8|A Chain A, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ8|B Chain B, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ9|A Chain A, Kinase Domain Of Csrc In Complex With Rl130
pdb|3TZ9|B Chain B, Kinase Domain Of Csrc In Complex With Rl130
Length = 286
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 41/83 (49%), Gaps = 2/83 (2%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG+G FG V+ G VAIK LK G E F E +++ ++ H LV L +S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 435 DDRRLLIYDYVPNNTLYFHLHGK 457
++ ++ +Y+ L L G+
Sbjct: 84 EEPIYIVTEYMSKGCLLDFLKGE 106
>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300
Length = 280
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 4/95 (4%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREV-AIKQL---KIGGGQGEREFKAEVEIISRI 420
A + F LG+G FG+VY + + A+K L ++ E + + EVEI S +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLH 455
H +++ L GY R LI +Y P T+Y L
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 100
>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679
pdb|3UNZ|B Chain B, Aurora A In Complex With Rpm1679
pdb|3UO4|A Chain A, Aurora A In Complex With Rpm1680
pdb|3UO5|A Chain A, Aurora A In Complex With Yl1-038-31
pdb|3UO6|A Chain A, Aurora A In Complex With Yl5-083
pdb|3UO6|B Chain B, Aurora A In Complex With Yl5-083
pdb|3UOD|A Chain A, Aurora A In Complex With Rpm1693
pdb|3UOH|A Chain A, Aurora A In Complex With Rpm1722
pdb|3UOH|B Chain B, Aurora A In Complex With Rpm1722
pdb|3UOJ|A Chain A, Aurora A In Complex With Rpm1715
pdb|3UOJ|B Chain B, Aurora A In Complex With Rpm1715
pdb|3UOK|A Chain A, Aurora A In Complex With Yl5-81-1
pdb|3UOK|B Chain B, Aurora A In Complex With Yl5-81-1
pdb|3UOL|A Chain A, Aurora A In Complex With So2-162
pdb|3UOL|B Chain B, Aurora A In Complex With So2-162
pdb|3UP2|A Chain A, Aurora A In Complex With Rpm1686
pdb|3UP7|A Chain A, Aurora A In Complex With Yl1-038-09
pdb|4DEA|A Chain A, Aurora A In Complex With Yl1-038-18
pdb|4DEB|A Chain A, Aurora A In Complex With Rk2-17-01
pdb|4DED|A Chain A, Aurora A In Complex With Yl1-038-21
pdb|4DEE|A Chain A, Aurora A In Complex With Adp
Length = 279
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 4/95 (4%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREV-AIKQL---KIGGGQGEREFKAEVEIISRI 420
A + F LG+G FG+VY + + A+K L ++ E + + EVEI S +
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLH 455
H +++ L GY R LI +Y P T+Y L
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 101
>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A
Inhibitors: Structure Basis For Potency And Specificity
pdb|3K5U|A Chain A, Identification, Sar Studies And X-Ray Cocrystal Analysis
Of A Novel Furano-Pyrimidine Aurora Kinase A Inhibitor
pdb|3M11|A Chain A, Crystal Structure Of Aurora A Kinase Complexed With
Inhibitor
Length = 279
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 4/95 (4%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREV-AIKQL---KIGGGQGEREFKAEVEIISRI 420
A + F LG+G FG+VY + + A+K L ++ E + + EVEI S +
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLH 455
H +++ L GY R LI +Y P T+Y L
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 101
>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1G|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 4/95 (4%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREV-AIKQL---KIGGGQGEREFKAEVEIISRI 420
A + F LG+G FG+VY + + A+K L ++ E + + EVEI S +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLH 455
H +++ L GY R LI +Y P T+Y L
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 103
>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287,
Thr288 And Bound To Tpx2 1-43
pdb|1OL7|A Chain A, Structure Of Human Aurora-A 122-403 Phosphorylated On
Thr287, Thr288
Length = 282
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 4/95 (4%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREV-AIKQL---KIGGGQGEREFKAEVEIISRI 420
A + F LG+G FG+VY + + A+K L ++ E + + EVEI S +
Sbjct: 8 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLH 455
H +++ L GY R LI +Y P T+Y L
Sbjct: 68 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 102
>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine-
Threonine Kinase
Length = 297
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 4/95 (4%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREV-AIKQL---KIGGGQGEREFKAEVEIISRI 420
A + F LG+G FG+VY + + A+K L ++ E + + EVEI S +
Sbjct: 23 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLH 455
H +++ L GY R LI +Y P T+Y L
Sbjct: 83 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 117
>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|B Chain B, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|C Chain C, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|D Chain D, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|E Chain E, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|F Chain F, Aurora-2 T287d T288d Complexed With Pha-680632
Length = 306
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 4/95 (4%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREV-AIKQL---KIGGGQGEREFKAEVEIISRI 420
A + F LG+G FG+VY + + A+K L ++ E + + EVEI S +
Sbjct: 32 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLH 455
H +++ L GY R LI +Y P T+Y L
Sbjct: 92 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 126
>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
pdb|2C6E|B Chain B, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
Length = 283
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 4/95 (4%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREV-AIKQL---KIGGGQGEREFKAEVEIISRI 420
A + F LG+G FG+VY + + A+K L ++ E + + EVEI S +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLH 455
H +++ L GY R LI +Y P T+Y L
Sbjct: 71 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 105
>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site
Inhibitor Showing High Selectivity Within The Janus
Kinase Family
Length = 315
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 28/83 (33%), Positives = 44/83 (53%), Gaps = 7/83 (8%)
Query: 375 LGEGGFGSV-YKGYLP----DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LG+G FGSV Y P G VA+KQL+ G +R+F+ E++I+ +H +V
Sbjct: 19 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 430 GYCISDDRR--LLIYDYVPNNTL 450
G R+ L+ +Y+P+ L
Sbjct: 79 GVSYGPGRQSLRLVMEYLPSGCL 101
>pdb|3A4O|X Chain X, Lyn Kinase Domain
Length = 286
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 23/76 (30%), Positives = 37/76 (48%), Gaps = 1/76 (1%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V+ GY + +VA+K LK G + F E ++ + H LV L
Sbjct: 21 LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 435 DDRRLLIYDYVPNNTL 450
++ +I +Y+ +L
Sbjct: 80 EEPIYIITEYMAKGSL 95
>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With
Quinoline-Thiadiazole- Thiophene Inhibitor
Length = 302
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 29/84 (34%), Positives = 42/84 (50%), Gaps = 8/84 (9%)
Query: 375 LGEGGFGSV-YKGYLPD----GREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSL 428
LGEG FG V Y P G VA+K LK G R +K E++I+ ++H H++
Sbjct: 22 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 429 VGYCISDDRR--LLIYDYVPNNTL 450
G C + L+ +YVP +L
Sbjct: 82 KGCCEDQGEKSLQLVMEYVPLGSL 105
>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-1,2,2-trimethyl-propyl)-amide
pdb|4HVG|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-2-hydroxy-1,2-dimethyl-propyl)- Amide
pdb|4HVH|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-2-hydroxy-1,2-dimethyl-propyl
pdb|4HVI|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-1-methyl-2-oxo-2-piperidin-1-yl- Ethyl)-amide
Length = 314
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 28/83 (33%), Positives = 44/83 (53%), Gaps = 7/83 (8%)
Query: 375 LGEGGFGSV-YKGYLP----DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LG+G FGSV Y P G VA+KQL+ G +R+F+ E++I+ +H +V
Sbjct: 18 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 430 GYCISDDRR--LLIYDYVPNNTL 450
G R+ L+ +Y+P+ L
Sbjct: 78 GVSYGPGRQSLRLVMEYLPSGCL 100
>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6
Length = 302
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 29/84 (34%), Positives = 42/84 (50%), Gaps = 8/84 (9%)
Query: 375 LGEGGFGSV-YKGYLPD----GREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSL 428
LGEG FG V Y P G VA+K LK G R +K E++I+ ++H H++
Sbjct: 22 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 429 VGYCISDDRR--LLIYDYVPNNTL 450
G C + L+ +YVP +L
Sbjct: 82 KGCCEDQGEKSLQLVMEYVPLGSL 105
>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXL|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 327
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 28/83 (33%), Positives = 44/83 (53%), Gaps = 7/83 (8%)
Query: 375 LGEGGFGSV-YKGYLP----DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LG+G FGSV Y P G VA+KQL+ G +R+F+ E++I+ +H +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 430 GYCISDDRR--LLIYDYVPNNTL 450
G R+ L+ +Y+P+ L
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCL 113
>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp
Length = 285
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 4/95 (4%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREV-AIKQL---KIGGGQGEREFKAEVEIISRI 420
A + F LG+G FG+VY + + A+K L ++ E + + EVEI S +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLH 455
H +++ L GY R LI +Y P T+Y L
Sbjct: 71 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 105
>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a
pdb|4H1M|A Chain A, Crystal Structure Of Pyk2 With The Indole 10c
Length = 293
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 33/118 (27%), Positives = 56/118 (47%), Gaps = 16/118 (13%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLPDGR----EVAIKQLKIGGGQGERE-FKAEVEIISR 419
A + +LGEG FG VY+G + + VA+K K +E F +E I+
Sbjct: 22 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 81
Query: 420 IHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGKWQLGFDIRNHNNGLLILTVL 477
+ H H+V L+G I ++ +I + P +G +LG + + N L +LT++
Sbjct: 82 LDHPHIVKLIGI-IEEEPTWIIMELYP--------YG--ELGHYLERNKNSLKVLTLV 128
>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine
Kinase
pdb|3FZP|A Chain A, Crystal Structure Of Pyk2 Complexed With Atpgs
pdb|3FZR|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-431396
pdb|3FZS|A Chain A, Crystal Structure Of Pyk2 Complexed With Birb796
pdb|3FZT|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-4618433
pdb|3H3C|A Chain A, Crystal Structure Of Pyk2 In Complex With Sulfoximine-
Substituted Trifluoromethylpyrimidine Analog
pdb|3ET7|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-2318841
Length = 277
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 33/118 (27%), Positives = 56/118 (47%), Gaps = 16/118 (13%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLPDGR----EVAIKQLKIGGGQGERE-FKAEVEIISR 419
A + +LGEG FG VY+G + + VA+K K +E F +E I+
Sbjct: 6 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 65
Query: 420 IHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGKWQLGFDIRNHNNGLLILTVL 477
+ H H+V L+G I ++ +I + P +G +LG + + N L +LT++
Sbjct: 66 LDHPHIVKLIGI-IEEEPTWIIMELYP--------YG--ELGHYLERNKNSLKVLTLV 112
>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine
Kinase 2 Beta (ptk2b)
Length = 281
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 33/118 (27%), Positives = 56/118 (47%), Gaps = 16/118 (13%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLPDGR----EVAIKQLKIGGGQGERE-FKAEVEIISR 419
A + +LGEG FG VY+G + + VA+K K +E F +E I+
Sbjct: 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 69
Query: 420 IHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGKWQLGFDIRNHNNGLLILTVL 477
+ H H+V L+G I ++ +I + P +G +LG + + N L +LT++
Sbjct: 70 LDHPHIVKLIGI-IEEEPTWIIMELYP--------YG--ELGHYLERNKNSLKVLTLV 116
>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|2P0C|B Chain B, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|3BRB|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BRB|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BPR|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|C Chain C, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|D Chain D, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3TCP|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
pdb|3TCP|B Chain B, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
Length = 313
Score = 39.7 bits (91), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 31/83 (37%), Positives = 43/83 (51%), Gaps = 12/83 (14%)
Query: 364 KATDGFADQNLL------GEGGFGSVYKGYLP--DGR--EVAIKQLKI-GGGQGE-REFK 411
K D D+NLL GEG FGSV +G L DG +VA+K +K+ Q E EF
Sbjct: 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFL 84
Query: 412 AEVEIISRIHHRHLVSLVGYCIS 434
+E + H +++ L+G CI
Sbjct: 85 SEAACMKDFSHPNVIRLLGVCIE 107
>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|B Chain B, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|C Chain C, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|D Chain D, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|E Chain E, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
Length = 326
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 25/81 (30%), Positives = 44/81 (54%), Gaps = 9/81 (11%)
Query: 373 NLLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVG 430
L+G G +G VYKG ++ G+ AIK + + G + E E K E+ ++ + HHR++ + G
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYG 88
Query: 431 YCIS------DDRRLLIYDYV 445
I DD+ L+ ++
Sbjct: 89 AFIKKNPPGMDDQLWLVMEFC 109
>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant
Length = 262
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 4/95 (4%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREV-AIKQL---KIGGGQGEREFKAEVEIISRI 420
A + F LG+G FG+VY + + A+K L ++ E + + EVEI S +
Sbjct: 3 ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLH 455
H +++ L GY R LI +Y P T+Y L
Sbjct: 63 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 97
>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly
Mutant) In Complex With N6-Benzyl Adp
Length = 452
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 42/83 (50%), Gaps = 2/83 (2%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG+G FG V+ G VAIK LK G E F E +++ ++ H LV L +S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA-VVS 249
Query: 435 DDRRLLIYDYVPNNTLYFHLHGK 457
++ ++ +Y+ +L L G+
Sbjct: 250 EEPIYIVGEYMSKGSLLDFLKGE 272
>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain
pdb|3UIU|B Chain B, Crystal Structure Of Apo-Pkr Kinase Domain
Length = 306
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 30/91 (32%), Positives = 46/91 (50%), Gaps = 16/91 (17%)
Query: 369 FADQNLLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVS 427
F + L+G GGFG V+K + DG+ I+++K + ERE KA ++++ H ++V
Sbjct: 14 FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKA----LAKLDHVNIVH 69
Query: 428 LVGYC---------ISDDRRLLIYDYVPNNT 449
G C SDD L DY P N+
Sbjct: 70 YNG-CWDGFDYDPETSDD-SLESSDYDPENS 98
>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly,
Lys240->arg, Met302- >leu) In Complex With
1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]-
Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea
pdb|3DJ5|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 290.
pdb|3DJ6|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 823.
pdb|3DJ7|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 130.
pdb|3D15|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
1-(3-Chloro-Phenyl)-3-
{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)-
Ethyl]-Thiazol-2- Yl}-Urea [sns-314]
pdb|3D2I|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With 1-{5-[2-(1-Methyl-1h-
Pyrazolo[4,
3-D]pyrimidin-7-Ylamino)-Ethyl]-Thiazol-2-Yl}-3-
(3-Trifluoromethyl-Phenyl)-Urea
pdb|3D2K|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
[7-(2-{2-[3-(3-Chloro-
Phenyl)-Ureido]-Thiazol-5-Yl}-Ethylamino)-Pyrazolo[4,3-
D]pyrimidin-1-Yl]-Acetic Acid
Length = 272
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 28/85 (32%), Positives = 43/85 (50%), Gaps = 4/85 (4%)
Query: 375 LGEGGFGSVYKGYLPDGREV-AIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLVG 430
LG+G FG+VY + + A+K L ++ E + + EVEI S + H +++ L G
Sbjct: 20 LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLH 455
Y R LI +Y P T+Y L
Sbjct: 80 YFHDATRVYLILEYAPLGTVYRELQ 104
>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form)
Length = 285
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 29/95 (30%), Positives = 45/95 (47%), Gaps = 4/95 (4%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREV-AIKQL---KIGGGQGEREFKAEVEIISRI 420
A + F LG+G FG+VY + + A+K L ++ E + + EVEI S +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLH 455
H +++ L GY R LI +Y P +Y L
Sbjct: 71 RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQ 105
>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Indirubin 3'-Monoxime Bound
Length = 313
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 21/76 (27%), Positives = 42/76 (55%), Gaps = 2/76 (2%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKA--EVEIISRIHHRHLVSLVGYC 432
+GEG +G VYK GR VA+K++++ A E+ ++ +HH ++VSL+
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 433 ISDDRRLLIYDYVPNN 448
S+ L+++++ +
Sbjct: 89 HSERCLTLVFEFMEKD 104
>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Adp Bound
Length = 311
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 21/76 (27%), Positives = 42/76 (55%), Gaps = 2/76 (2%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKA--EVEIISRIHHRHLVSLVGYC 432
+GEG +G VYK GR VA+K++++ A E+ ++ +HH ++VSL+
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 433 ISDDRRLLIYDYVPNN 448
S+ L+++++ +
Sbjct: 89 HSERCLTLVFEFMEKD 104
>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor
Discovered Through Site-Directed Dynamic Tethering
Length = 272
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 28/85 (32%), Positives = 43/85 (50%), Gaps = 4/85 (4%)
Query: 375 LGEGGFGSVYKGYLPDGREV-AIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLVG 430
LG+G FG+VY + + A+K L ++ E + + EVEI S + H +++ L G
Sbjct: 20 LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLH 455
Y R LI +Y P T+Y L
Sbjct: 80 YFHDATRVYLILEYAPLGTVYRELQ 104
>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form
pdb|2ZV8|A Chain A, Lyn Tyrosine Kinase Domain-Amp-Pnp Complex
pdb|2ZV9|A Chain A, Lyn Tyrosine Kinase Domain-Pp2 Complex
pdb|2ZVA|A Chain A, Lyn Tyrosine Kinase Domain-dasatinib Complex
Length = 279
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 22/76 (28%), Positives = 37/76 (48%), Gaps = 1/76 (1%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V+ GY + +VA+K LK G + F E ++ + H LV L
Sbjct: 20 LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 435 DDRRLLIYDYVPNNTL 450
++ +I +++ +L
Sbjct: 79 EEPIYIITEFMAKGSL 94
>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure
pdb|2WTV|B Chain B, Aurora-A Inhibitor Structure
pdb|2WTV|C Chain C, Aurora-A Inhibitor Structure
pdb|2WTV|D Chain D, Aurora-A Inhibitor Structure
Length = 285
Score = 38.9 bits (89), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 29/95 (30%), Positives = 45/95 (47%), Gaps = 4/95 (4%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREV-AIKQL---KIGGGQGEREFKAEVEIISRI 420
A + F LG+G FG+VY + + A+K L ++ E + + EVEI S +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLH 455
H +++ L GY R LI +Y P +Y L
Sbjct: 71 RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQ 105
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 38.9 bits (89), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 23/90 (25%), Positives = 44/90 (48%), Gaps = 5/90 (5%)
Query: 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGG----GQGEREFKAEVEIISRIHHRHLVS 427
+ ++G GGFG VY+ + G EVA+K + Q + E ++ + + H ++++
Sbjct: 12 EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGK 457
L G C+ + L+ ++ L L GK
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVLSGK 100
>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta.
pdb|1H8F|B Chain B, Glycogen Synthase Kinase 3 Beta
Length = 352
Score = 38.9 bits (89), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 28/95 (29%), Positives = 44/95 (46%), Gaps = 11/95 (11%)
Query: 368 GFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLV 426
+ D ++G G FG VY+ L D G VAIK++ G R E++I+ ++ H ++V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR----ELQIMRKLDHCNIV 76
Query: 427 SLVGYCISDDRRL------LIYDYVPNNTLYFHLH 455
L + S + L+ DYVP H
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH 111
>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With
6-Bromoindirubin-3'-Oxime
Length = 350
Score = 38.9 bits (89), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 28/95 (29%), Positives = 44/95 (46%), Gaps = 11/95 (11%)
Query: 368 GFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLV 426
+ D ++G G FG VY+ L D G VAIK++ G R E++I+ ++ H ++V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR----ELQIMRKLDHCNIV 76
Query: 427 SLVGYCISDDRRL------LIYDYVPNNTLYFHLH 455
L + S + L+ DYVP H
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH 111
>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
Gleevec
pdb|3HMI|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
5-Amino-3-{[4-
(Aminosulfonyl)phenyl]amino}-N-(2,
6-Difluorophenyl)-1h-1,2,4- Triazole-1-Carbothioamide
pdb|2XYN|A Chain A, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|B Chain B, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|C Chain C, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
Length = 292
Score = 38.9 bits (89), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 27/81 (33%), Positives = 41/81 (50%), Gaps = 2/81 (2%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG G +G VY G + VA+K LK + E EF E ++ I H +LV L+G C
Sbjct: 40 LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 434 SDDRRLLIYDYVPNNTLYFHL 454
+ ++ +Y+P L +L
Sbjct: 99 LEPPFYIVTEYMPYGNLLDYL 119
>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3D|B Chain B, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3W|A Chain A, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q3W|B Chain B, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q41|A Chain A, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q41|B Chain B, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q4L|A Chain A, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|1Q4L|B Chain B, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|3Q3B|A Chain A, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
pdb|3Q3B|B Chain B, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
Length = 424
Score = 38.9 bits (89), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 28/95 (29%), Positives = 45/95 (47%), Gaps = 11/95 (11%)
Query: 368 GFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLV 426
+ D ++G G FG VY+ L D G VAIK++ Q +R E++I+ ++ H ++V
Sbjct: 59 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 114
Query: 427 SLVGYCISDDRRL------LIYDYVPNNTLYFHLH 455
L + S + L+ DYVP H
Sbjct: 115 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH 149
>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1I09|B Chain B, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1J1B|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1B|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1C|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|1J1C|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|2JLD|A Chain A, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|2JLD|B Chain B, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|3M1S|A Chain A, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3M1S|B Chain B, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3PUP|A Chain A, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
pdb|3PUP|B Chain B, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
Length = 420
Score = 38.9 bits (89), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 28/95 (29%), Positives = 45/95 (47%), Gaps = 11/95 (11%)
Query: 368 GFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLV 426
+ D ++G G FG VY+ L D G VAIK++ Q +R E++I+ ++ H ++V
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 110
Query: 427 SLVGYCISDDRRL------LIYDYVPNNTLYFHLH 455
L + S + L+ DYVP H
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH 145
>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
pdb|3SAY|B Chain B, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
Length = 430
Score = 38.9 bits (89), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 28/95 (29%), Positives = 45/95 (47%), Gaps = 11/95 (11%)
Query: 368 GFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLV 426
+ D ++G G FG VY+ L D G VAIK++ Q +R E++I+ ++ H ++V
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 110
Query: 427 SLVGYCISDDRRL------LIYDYVPNNTLYFHLH 455
L + S + L+ DYVP H
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH 145
>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACC|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACD|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACD|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACG|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACG|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACH|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACH|B Chain B, Gsk3b In Complex With Inhibitor
Length = 465
Score = 38.9 bits (89), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 28/95 (29%), Positives = 45/95 (47%), Gaps = 11/95 (11%)
Query: 368 GFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLV 426
+ D ++G G FG VY+ L D G VAIK++ Q +R E++I+ ++ H ++V
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 155
Query: 427 SLVGYCISDDRRL------LIYDYVPNNTLYFHLH 455
L + S + L+ DYVP H
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH 190
>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex
With A Staurosporine Analogue
Length = 290
Score = 38.9 bits (89), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 28/83 (33%), Positives = 43/83 (51%), Gaps = 7/83 (8%)
Query: 375 LGEGGFGSV-YKGYLP----DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSL- 428
LG+G FGSV Y P G VA+KQL+ G +R+F+ E++I+ +H +V
Sbjct: 15 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 429 -VGYCISDDRRLLIYDYVPNNTL 450
V Y L+ +Y+P+ L
Sbjct: 75 GVSYGPGRPELRLVMEYLPSGCL 97
>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp
pdb|1PYX|B Chain B, Gsk-3 Beta Complexed With Amp-Pnp
pdb|3DU8|A Chain A, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
pdb|3DU8|B Chain B, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
Length = 422
Score = 38.9 bits (89), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 28/95 (29%), Positives = 45/95 (47%), Gaps = 11/95 (11%)
Query: 368 GFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLV 426
+ D ++G G FG VY+ L D G VAIK++ Q +R E++I+ ++ H ++V
Sbjct: 57 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 112
Query: 427 SLVGYCISDDRRL------LIYDYVPNNTLYFHLH 455
L + S + L+ DYVP H
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH 147
>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|1Q5K|B Chain B, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|3I4B|A Chain A, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3I4B|B Chain B, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3L1S|A Chain A, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
pdb|3L1S|B Chain B, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
Length = 414
Score = 38.9 bits (89), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 28/95 (29%), Positives = 45/95 (47%), Gaps = 11/95 (11%)
Query: 368 GFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLV 426
+ D ++G G FG VY+ L D G VAIK++ Q +R E++I+ ++ H ++V
Sbjct: 49 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 104
Query: 427 SLVGYCISDDRRL------LIYDYVPNNTLYFHLH 455
L + S + L+ DYVP H
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH 139
>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A19|C Chain C, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A1A|B Chain B, Pkr Kinase Domain-Eif2alpha Complex
Length = 284
Score = 38.5 bits (88), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 22/63 (34%), Positives = 36/63 (57%), Gaps = 5/63 (7%)
Query: 369 FADQNLLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVS 427
F + L+G GGFG V+K + DG+ IK++K + ERE KA ++++ H ++V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKA----LAKLDHVNIVH 68
Query: 428 LVG 430
G
Sbjct: 69 YNG 71
>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
pdb|1R0E|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
Length = 391
Score = 38.5 bits (88), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 28/95 (29%), Positives = 45/95 (47%), Gaps = 11/95 (11%)
Query: 368 GFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLV 426
+ D ++G G FG VY+ L D G VAIK++ Q +R E++I+ ++ H ++V
Sbjct: 26 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 81
Query: 427 SLVGYCISDDRRL------LIYDYVPNNTLYFHLH 455
L + S + L+ DYVP H
Sbjct: 82 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH 116
>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXP|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 318
Score = 38.5 bits (88), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 29/84 (34%), Positives = 41/84 (48%), Gaps = 8/84 (9%)
Query: 375 LGEGGFGSV-YKGYLPD----GREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSL 428
LGEG FG V Y P G VA+K LK G R +K E++I+ ++H H++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 429 VGYC--ISDDRRLLIYDYVPNNTL 450
G C L+ +YVP +L
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSL 122
>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Imidazopyridine Inhibitor
Length = 382
Score = 38.5 bits (88), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 28/95 (29%), Positives = 45/95 (47%), Gaps = 11/95 (11%)
Query: 368 GFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLV 426
+ D ++G G FG VY+ L D G VAIK++ Q +R E++I+ ++ H ++V
Sbjct: 33 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 88
Query: 427 SLVGYCISDDRRL------LIYDYVPNNTLYFHLH 455
L + S + L+ DYVP H
Sbjct: 89 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH 123
>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide
Length = 350
Score = 38.5 bits (88), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 27/86 (31%), Positives = 43/86 (50%), Gaps = 11/86 (12%)
Query: 368 GFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLV 426
+ D ++G G FG VY+ L D G VAIK++ G R E++I+ ++ H ++V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR----ELQIMRKLDHCNIV 76
Query: 427 SLVGYCISDDRRL------LIYDYVP 446
L + S + L+ DYVP
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVP 102
>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
pdb|3KEX|B Chain B, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
Length = 325
Score = 38.5 bits (88), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 27/88 (30%), Positives = 45/88 (51%), Gaps = 7/88 (7%)
Query: 373 NLLGEGGFGSVYKG-YLPDGREVAIKQL--KIGGGQGEREFKAEVE---IISRIHHRHLV 426
+LG G FG+V+KG ++P+G + I I G + F+A + I + H H+V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHL 454
L+G C + L+ Y+P +L H+
Sbjct: 79 RLLGLCPGSSLQ-LVTQYLPLGSLLDHV 105
>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRK|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRM|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
pdb|3ZRM|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
Length = 371
Score = 38.5 bits (88), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 28/95 (29%), Positives = 45/95 (47%), Gaps = 11/95 (11%)
Query: 368 GFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLV 426
+ D ++G G FG VY+ L D G VAIK++ Q +R E++I+ ++ H ++V
Sbjct: 33 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 88
Query: 427 SLVGYCISDDRRL------LIYDYVPNNTLYFHLH 455
L + S + L+ DYVP H
Sbjct: 89 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH 123
>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
pdb|1GNG|B Chain B, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
Length = 378
Score = 38.5 bits (88), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 28/95 (29%), Positives = 45/95 (47%), Gaps = 11/95 (11%)
Query: 368 GFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLV 426
+ D ++G G FG VY+ L D G VAIK++ Q +R E++I+ ++ H ++V
Sbjct: 40 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 95
Query: 427 SLVGYCISDDRRL------LIYDYVPNNTLYFHLH 455
L + S + L+ DYVP H
Sbjct: 96 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH 130
>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
pdb|3LMG|B Chain B, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
Length = 344
Score = 38.5 bits (88), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 27/88 (30%), Positives = 45/88 (51%), Gaps = 7/88 (7%)
Query: 373 NLLGEGGFGSVYKG-YLPDGREVAIKQL--KIGGGQGEREFKAEVE---IISRIHHRHLV 426
+LG G FG+V+KG ++P+G + I I G + F+A + I + H H+V
Sbjct: 37 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHL 454
L+G C + L+ Y+P +L H+
Sbjct: 97 RLLGLCPGSSLQ-LVTQYLPLGSLLDHV 123
>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
pdb|4AFJ|B Chain B, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
Length = 367
Score = 38.5 bits (88), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 28/95 (29%), Positives = 45/95 (47%), Gaps = 11/95 (11%)
Query: 368 GFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLV 426
+ D ++G G FG VY+ L D G VAIK++ Q +R E++I+ ++ H ++V
Sbjct: 29 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 84
Query: 427 SLVGYCISDDRRL------LIYDYVPNNTLYFHLH 455
L + S + L+ DYVP H
Sbjct: 85 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH 119
>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex
Length = 353
Score = 38.5 bits (88), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 28/95 (29%), Positives = 45/95 (47%), Gaps = 11/95 (11%)
Query: 368 GFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLV 426
+ D ++G G FG VY+ L D G VAIK++ Q +R E++I+ ++ H ++V
Sbjct: 25 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 80
Query: 427 SLVGYCISDDRRL------LIYDYVPNNTLYFHLH 455
L + S + L+ DYVP H
Sbjct: 81 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH 115
>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex
pdb|3F88|B Chain B, Glycogen Synthase Kinase 3beta Inhibitor Complex
Length = 349
Score = 38.5 bits (88), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 28/95 (29%), Positives = 45/95 (47%), Gaps = 11/95 (11%)
Query: 368 GFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLV 426
+ D ++G G FG VY+ L D G VAIK++ Q +R E++I+ ++ H ++V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 76
Query: 427 SLVGYCISDDRRL------LIYDYVPNNTLYFHLH 455
L + S + L+ DYVP H
Sbjct: 77 RLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARH 111
>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
pdb|2OW3|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
Length = 352
Score = 38.5 bits (88), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 28/95 (29%), Positives = 45/95 (47%), Gaps = 11/95 (11%)
Query: 368 GFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLV 426
+ D ++G G FG VY+ L D G VAIK++ Q +R E++I+ ++ H ++V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 76
Query: 427 SLVGYCISDDRRL------LIYDYVPNNTLYFHLH 455
L + S + L+ DYVP H
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH 111
>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Benzoimidazol Inhibitor
Length = 372
Score = 38.5 bits (88), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 28/95 (29%), Positives = 45/95 (47%), Gaps = 11/95 (11%)
Query: 368 GFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLV 426
+ D ++G G FG VY+ L D G VAIK++ Q +R E++I+ ++ H ++V
Sbjct: 34 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 89
Query: 427 SLVGYCISDDRRL------LIYDYVPNNTLYFHLH 455
L + S + L+ DYVP H
Sbjct: 90 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH 124
>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Inhibitor 7d
Length = 350
Score = 38.5 bits (88), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 28/95 (29%), Positives = 45/95 (47%), Gaps = 11/95 (11%)
Query: 368 GFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLV 426
+ D ++G G FG VY+ L D G VAIK++ Q +R E++I+ ++ H ++V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 76
Query: 427 SLVGYCISDDRRL------LIYDYVPNNTLYFHLH 455
L + S + L+ DYVP H
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH 111
>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|3SD0|B Chain B, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|4B7T|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Leucettine L4
Length = 350
Score = 38.5 bits (88), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 28/95 (29%), Positives = 45/95 (47%), Gaps = 11/95 (11%)
Query: 368 GFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLV 426
+ D ++G G FG VY+ L D G VAIK++ Q +R E++I+ ++ H ++V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 76
Query: 427 SLVGYCISDDRRL------LIYDYVPNNTLYFHLH 455
L + S + L+ DYVP H
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH 111
>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck
In Complex With Non-selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 38.5 bits (88), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 24/76 (31%), Positives = 39/76 (51%), Gaps = 2/76 (2%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G G V+ GY +VA+K LK G F AE ++ ++ H+ LV L ++
Sbjct: 21 LGAGQAGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 78
Query: 435 DDRRLLIYDYVPNNTL 450
+ +I +Y+ N +L
Sbjct: 79 QEPIYIITEYMENGSL 94
>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
pdb|3F7Z|B Chain B, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
Length = 350
Score = 38.5 bits (88), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 28/95 (29%), Positives = 45/95 (47%), Gaps = 11/95 (11%)
Query: 368 GFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLV 426
+ D ++G G FG VY+ L D G VAIK++ Q +R E++I+ ++ H ++V
Sbjct: 22 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 77
Query: 427 SLVGYCISDDRRL------LIYDYVPNNTLYFHLH 455
L + S + L+ DYVP H
Sbjct: 78 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH 112
>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With
Staurosporine
Length = 283
Score = 38.1 bits (87), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 39/76 (51%), Gaps = 2/76 (2%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V+ G +VAIK LK G E F E +I+ ++ H LV L +S
Sbjct: 17 LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPE-SFLEEAQIMKKLKHDKLVQLYA-VVS 74
Query: 435 DDRRLLIYDYVPNNTL 450
++ ++ +Y+ +L
Sbjct: 75 EEPIYIVTEYMNKGSL 90
>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK6|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 38.1 bits (87), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 27/81 (33%), Positives = 41/81 (50%), Gaps = 2/81 (2%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG G FG VY+G + VA+K LK + E EF E ++ I H +LV L+G C
Sbjct: 19 LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 434 SDDRRLLIYDYVPNNTLYFHL 454
+ +I +++ L +L
Sbjct: 78 REPPFYIITEFMTYGNLLDYL 98
>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo
Form)
pdb|4FVQ|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain
(Mg-Atp-Bound Form)
Length = 289
Score = 37.7 bits (86), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 21/79 (26%), Positives = 36/79 (45%), Gaps = 8/79 (10%)
Query: 375 LGEGGFGSVYKGYLPD--------GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLV 426
LG+G F ++KG + EV +K L F ++S++ H+HLV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 427 SLVGYCISDDRRLLIYDYV 445
G C+ D +L+ ++V
Sbjct: 76 LNYGVCVCGDENILVQEFV 94
>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Novel Bosutinib Isoform 1, Previously Thought
To Be Bosutinib
Length = 293
Score = 37.7 bits (86), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 20/73 (27%), Positives = 38/73 (52%), Gaps = 1/73 (1%)
Query: 375 LGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG+G FG VYK + G A K ++ + ++ E+EI++ H ++V L+G
Sbjct: 19 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 434 SDDRRLLIYDYVP 446
D + ++ ++ P
Sbjct: 79 HDGKLWIMIEFCP 91
>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PK9|C Chain C, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PMI|A Chain A, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
pdb|2PMI|C Chain C, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
Length = 317
Score = 37.4 bits (85), Expect = 0.018, Method: Compositional matrix adjust.
Identities = 20/88 (22%), Positives = 46/88 (52%), Gaps = 2/88 (2%)
Query: 363 VKATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFK-AEVEIISRI 420
+ ++ F LG G + +VYKG G VA+K++K+ +G E+ ++ +
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNN 448
H ++V L ++++ L+++++ N+
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDND 88
>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3PP0|B Chain B, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3RCD|A Chain A, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|B Chain B, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|C Chain C, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|D Chain D, Her2 Kinase Domain Complexed With Tak-285
Length = 338
Score = 37.4 bits (85), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 26/89 (29%), Positives = 46/89 (51%), Gaps = 7/89 (7%)
Query: 373 NLLGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLV 426
+LG G FG+VYKG ++PDG VAIK L+ + +E E +++ + ++
Sbjct: 23 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLH 455
L+G C++ + L+ +P L H+
Sbjct: 83 RLLGICLTSTVQ-LVTQLMPYGCLLDHVR 110
>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Su11274
pdb|4AOT|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4AOT|B Chain B, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4EQU|A Chain A, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
pdb|4EQU|B Chain B, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
Length = 302
Score = 37.4 bits (85), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 20/73 (27%), Positives = 38/73 (52%), Gaps = 1/73 (1%)
Query: 375 LGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG+G FG VYK + G A K ++ + ++ E+EI++ H ++V L+G
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 434 SDDRRLLIYDYVP 446
D + ++ ++ P
Sbjct: 87 HDGKLWIMIEFCP 99
>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis
Length = 394
Score = 37.0 bits (84), Expect = 0.021, Method: Compositional matrix adjust.
Identities = 26/90 (28%), Positives = 49/90 (54%), Gaps = 11/90 (12%)
Query: 368 GFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVS 427
+ + ++G G FG V++ L + EVAIK++ Q +R E++I+ + H ++V
Sbjct: 41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVL----QDKRFKNRELQIMRIVKHPNVVD 96
Query: 428 LVGYCISD-DRR-----LLIYDYVPNNTLY 451
L + S+ D++ L+ +YVP T+Y
Sbjct: 97 LKAFFYSNGDKKDEVFLNLVLEYVP-ETVY 125
>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer
Length = 319
Score = 37.0 bits (84), Expect = 0.023, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 38/81 (46%), Gaps = 4/81 (4%)
Query: 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGE--REFKAEVEIISRIHHRHLVSLVG 430
L+G+G FG VY G EVAI+ + I + + FK EV + H ++V +G
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 431 YCISDDRRLLIYDYVPNNTLY 451
C+S +I TLY
Sbjct: 97 ACMSPPHLAIITSLCKGRTLY 117
>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant
V617f (Mg- Atp-Bound Form)
Length = 289
Score = 37.0 bits (84), Expect = 0.025, Method: Compositional matrix adjust.
Identities = 21/79 (26%), Positives = 35/79 (44%), Gaps = 8/79 (10%)
Query: 375 LGEGGFGSVYKGYLPD--------GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLV 426
LG+G F ++KG + EV +K L F ++S++ H+HLV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 427 SLVGYCISDDRRLLIYDYV 445
G C D +L+ ++V
Sbjct: 76 LNYGVCFCGDENILVQEFV 94
>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRI|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRK|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dp- 987
Length = 277
Score = 37.0 bits (84), Expect = 0.026, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 38/72 (52%), Gaps = 2/72 (2%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG G +G VY+G + VA+K LK + E EF E ++ I H +LV L+G C
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 434 SDDRRLLIYDYV 445
+ +I +++
Sbjct: 85 REPPFYIITEFM 96
>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
pdb|2GQG|B Chain B, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
Length = 278
Score = 37.0 bits (84), Expect = 0.026, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 38/72 (52%), Gaps = 2/72 (2%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG G +G VY+G + VA+K LK + E EF E ++ I H +LV L+G C
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 434 SDDRRLLIYDYV 445
+ +I +++
Sbjct: 85 REPPFYIITEFM 96
>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZ5|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 37.0 bits (84), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 25/93 (26%), Positives = 44/93 (47%), Gaps = 10/93 (10%)
Query: 375 LGEGGFGSVY--------KGYLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRH 424
LGEG FG V K + VA+K LK + + + +E+E++ I H++
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGK 457
+++L+G C D +I +Y L +L +
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRAR 135
>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
pdb|3QRJ|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
Length = 277
Score = 36.6 bits (83), Expect = 0.028, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 38/72 (52%), Gaps = 2/72 (2%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG G +G VY+G + VA+K LK + E EF E ++ I H +LV L+G C
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 434 SDDRRLLIYDYV 445
+ +I +++
Sbjct: 85 REPPFYIIIEFM 96
>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant
Abl Mutant In Complex With The Aurora Kinase Inhibitor
Vx-680
Length = 287
Score = 36.6 bits (83), Expect = 0.028, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG G +G VY+G + VA+K LK + E EF E ++ I H +LV L+G C
Sbjct: 22 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 434 SDDRRLLIYDYVPNNTLYFHLH 455
+ +I +++ L +L
Sbjct: 81 REPPFYIITEFMTYGNLLDYLR 102
>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 495
Score = 36.6 bits (83), Expect = 0.028, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 38/72 (52%), Gaps = 2/72 (2%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG G +G VY+G + VA+K LK + E EF E ++ I H +LV L+G C
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 434 SDDRRLLIYDYV 445
+ +I +++
Sbjct: 287 REPPFYIITEFM 298
>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|B Chain B, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|C Chain C, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|D Chain D, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HZ4|A Chain A, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|B Chain B, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|C Chain C, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
Length = 273
Score = 36.6 bits (83), Expect = 0.029, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 38/72 (52%), Gaps = 2/72 (2%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG G +G VY+G + VA+K LK + E EF E ++ I H +LV L+G C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 434 SDDRRLLIYDYV 445
+ +I +++
Sbjct: 80 REPPFYIITEFM 91
>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf
Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp
Analog And Substrate Peptide
Length = 334
Score = 36.6 bits (83), Expect = 0.029, Method: Compositional matrix adjust.
Identities = 25/93 (26%), Positives = 44/93 (47%), Gaps = 10/93 (10%)
Query: 375 LGEGGFGSVY--------KGYLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRH 424
LGEG FG V K + VA+K LK + + + +E+E++ I H++
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGK 457
+++L+G C D +I +Y L +L +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRAR 135
>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970
pdb|2HZI|B Chain B, Abl Kinase Domain In Complex With Pd180970
pdb|3CS9|A Chain A, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|B Chain B, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|C Chain C, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|D Chain D, Human Abl Kinase In Complex With Nilotinib
Length = 277
Score = 36.6 bits (83), Expect = 0.029, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 38/72 (52%), Gaps = 2/72 (2%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG G +G VY+G + VA+K LK + E EF E ++ I H +LV L+G C
Sbjct: 25 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 434 SDDRRLLIYDYV 445
+ +I +++
Sbjct: 84 REPPFYIITEFM 95
>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082
pdb|2HZ0|B Chain B, Abl Kinase Domain In Complex With Nvp-Aeg082
Length = 270
Score = 36.6 bits (83), Expect = 0.030, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 38/72 (52%), Gaps = 2/72 (2%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG G +G VY+G + VA+K LK + E EF E ++ I H +LV L+G C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 434 SDDRRLLIYDYV 445
+ +I +++
Sbjct: 80 REPPFYIITEFM 91
>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK7|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 277
Score = 36.6 bits (83), Expect = 0.030, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 41/81 (50%), Gaps = 2/81 (2%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG G +G VY+G + VA+K LK + E EF E ++ I H +LV L+G C
Sbjct: 19 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 434 SDDRRLLIYDYVPNNTLYFHL 454
+ +I +++ L +L
Sbjct: 78 REPPFYIIIEFMTYGNLLDYL 98
>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
pdb|2V7A|B Chain B, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
Length = 286
Score = 36.6 bits (83), Expect = 0.030, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 41/81 (50%), Gaps = 2/81 (2%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG G +G VY+G + VA+K LK + E EF E ++ I H +LV L+G C
Sbjct: 22 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 434 SDDRRLLIYDYVPNNTLYFHL 454
+ +I +++ L +L
Sbjct: 81 REPPFYIIIEFMTYGNLLDYL 101
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
Length = 293
Score = 36.6 bits (83), Expect = 0.030, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 41/81 (50%), Gaps = 2/81 (2%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG G +G VY+G + VA+K LK + E EF E ++ I H +LV L+G C
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 434 SDDRRLLIYDYVPNNTLYFHL 454
+ +I +++ L +L
Sbjct: 85 REPPFYIITEFMTYGNLLDYL 105
>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK3|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 36.6 bits (83), Expect = 0.030, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 41/81 (50%), Gaps = 2/81 (2%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG G +G VY+G + VA+K LK + E EF E ++ I H +LV L+G C
Sbjct: 19 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 434 SDDRRLLIYDYVPNNTLYFHL 454
+ +I +++ L +L
Sbjct: 78 REPPFYIITEFMTYGNLLDYL 98
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
Length = 293
Score = 36.6 bits (83), Expect = 0.030, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 41/81 (50%), Gaps = 2/81 (2%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG G +G VY+G + VA+K LK + E EF E ++ I H +LV L+G C
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 434 SDDRRLLIYDYVPNNTLYFHL 454
+ +I +++ L +L
Sbjct: 85 REPPFYIITEFMTYGNLLDYL 105
>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains
Trapped In Trans-Phosphorylation Reaction
Length = 334
Score = 36.6 bits (83), Expect = 0.031, Method: Compositional matrix adjust.
Identities = 25/93 (26%), Positives = 44/93 (47%), Gaps = 10/93 (10%)
Query: 375 LGEGGFGSVY--------KGYLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRH 424
LGEG FG V K + VA+K LK + + + +E+E++ I H++
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGK 457
+++L+G C D +I +Y L +L +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRAR 135
>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2F|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
Length = 287
Score = 36.6 bits (83), Expect = 0.031, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 41/81 (50%), Gaps = 2/81 (2%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG G +G VY+G + VA+K LK + E EF E ++ I H +LV L+G C
Sbjct: 23 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 434 SDDRRLLIYDYVPNNTLYFHL 454
+ +I +++ L +L
Sbjct: 82 REPPFYIITEFMTYGNLLDYL 102
>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPL|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 537
Score = 36.6 bits (83), Expect = 0.032, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 38/72 (52%), Gaps = 2/72 (2%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG G +G VY+G + VA+K LK + E EF E ++ I H +LV L+G C
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 434 SDDRRLLIYDYV 445
+ +I +++
Sbjct: 326 REPPFYIITEFM 337
>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
pdb|2HIW|B Chain B, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
Length = 287
Score = 36.6 bits (83), Expect = 0.033, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 41/81 (50%), Gaps = 2/81 (2%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG G +G VY+G + VA+K LK + E EF E ++ I H +LV L+G C
Sbjct: 23 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 434 SDDRRLLIYDYVPNNTLYFHL 454
+ +I +++ L +L
Sbjct: 82 REPPFYIITEFMTYGNLLDYL 102
>pdb|2FO0|A Chain A, Organization Of The Sh3-Sh2 Unit In Active And Inactive
Forms Of The C-Abl Tyrosine Kinase
Length = 495
Score = 36.6 bits (83), Expect = 0.033, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 38/72 (52%), Gaps = 2/72 (2%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG G +G VY+G + VA+K LK + E EF E ++ I H +LV L+G C
Sbjct: 225 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 283
Query: 434 SDDRRLLIYDYV 445
+ +I +++
Sbjct: 284 REPPFYIITEFM 295
>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
pdb|3OY3|B Chain B, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
Length = 284
Score = 36.6 bits (83), Expect = 0.034, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 41/81 (50%), Gaps = 2/81 (2%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG G +G VY+G + VA+K LK + E EF E ++ I H +LV L+G C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 434 SDDRRLLIYDYVPNNTLYFHL 454
+ +I +++ L +L
Sbjct: 80 REPPFYIIIEFMTYGNLLDYL 100
>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A
Dfg-Out Inhibitor Ap24534
Length = 284
Score = 36.6 bits (83), Expect = 0.034, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 41/81 (50%), Gaps = 2/81 (2%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG G +G VY+G + VA+K LK + E EF E ++ I H +LV L+G C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 434 SDDRRLLIYDYVPNNTLYFHL 454
+ +I +++ L +L
Sbjct: 80 REPPFYIITEFMTYGNLLDYL 100
>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
pdb|3PYY|B Chain B, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
Length = 298
Score = 36.6 bits (83), Expect = 0.034, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 38/72 (52%), Gaps = 2/72 (2%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG G +G VY+G + VA+K LK + E EF E ++ I H +LV L+G C
Sbjct: 34 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 434 SDDRRLLIYDYV 445
+ +I +++
Sbjct: 93 REPPFYIITEFM 104
>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|C Chain C, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|D Chain D, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome
Length = 324
Score = 36.6 bits (83), Expect = 0.034, Method: Compositional matrix adjust.
Identities = 25/93 (26%), Positives = 44/93 (47%), Gaps = 10/93 (10%)
Query: 375 LGEGGFGSVY--------KGYLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRH 424
LGEG FG V K + VA+K LK + + + +E+E++ I H++
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGK 457
+++L+G C D +I +Y L +L +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRAR 135
>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|C Chain C, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|D Chain D, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|3UE4|A Chain A, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
pdb|3UE4|B Chain B, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
Length = 287
Score = 36.6 bits (83), Expect = 0.034, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 41/81 (50%), Gaps = 2/81 (2%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG G +G VY+G + VA+K LK + E EF E ++ I H +LV L+G C
Sbjct: 23 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 434 SDDRRLLIYDYVPNNTLYFHL 454
+ +I +++ L +L
Sbjct: 82 REPPFYIITEFMTYGNLLDYL 102
>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|2QOH|B Chain B, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|3KF4|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KF4|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
Length = 288
Score = 36.6 bits (83), Expect = 0.035, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 41/81 (50%), Gaps = 2/81 (2%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG G +G VY+G + VA+K LK + E EF E ++ I H +LV L+G C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 434 SDDRRLLIYDYVPNNTLYFHL 454
+ +I +++ L +L
Sbjct: 80 REPPFYIITEFMTYGNLLDYL 100
>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound
With Ppy-A
pdb|3IK3|A Chain A, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
pdb|3IK3|B Chain B, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
Length = 288
Score = 36.6 bits (83), Expect = 0.035, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 41/81 (50%), Gaps = 2/81 (2%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG G +G VY+G + VA+K LK + E EF E ++ I H +LV L+G C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 434 SDDRRLLIYDYVPNNTLYFHL 454
+ +I +++ L +L
Sbjct: 80 REPPFYIIIEFMTYGNLLDYL 100
>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZR|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 36.2 bits (82), Expect = 0.036, Method: Compositional matrix adjust.
Identities = 25/93 (26%), Positives = 44/93 (47%), Gaps = 10/93 (10%)
Query: 375 LGEGGFGSVY--------KGYLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRH 424
LGEG FG V K + VA+K LK + + + +E+E++ I H++
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGK 457
+++L+G C D +I +Y L +L +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRAR 135
>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia
pdb|3GC0|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia In
Complex With Amp
Length = 329
Score = 36.2 bits (82), Expect = 0.038, Method: Compositional matrix adjust.
Identities = 25/87 (28%), Positives = 43/87 (49%), Gaps = 3/87 (3%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLPDGRE-VAIKQLKIGGGQGEREFKA--EVEIISRIH 421
+ D + LGEG +G VYK E VAIK++++ + A EV ++ +
Sbjct: 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ 91
Query: 422 HRHLVSLVGYCISDDRRLLIYDYVPNN 448
HR+++ L + R LI++Y N+
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEYAEND 118
>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
pdb|2PZP|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 36.2 bits (82), Expect = 0.041, Method: Compositional matrix adjust.
Identities = 25/93 (26%), Positives = 44/93 (47%), Gaps = 10/93 (10%)
Query: 375 LGEGGFGSVY--------KGYLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRH 424
LGEG FG V K + VA+K LK + + + +E+E++ I H++
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGK 457
+++L+G C D +I +Y L +L +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRAR 135
>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
pdb|2PSQ|B Chain B, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
Length = 370
Score = 36.2 bits (82), Expect = 0.045, Method: Compositional matrix adjust.
Identities = 26/99 (26%), Positives = 46/99 (46%), Gaps = 10/99 (10%)
Query: 375 LGEGGFGSVY--------KGYLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRH 424
LGEG FG V K + VA+K LK + + + +E+E++ I H++
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGKWQLGFD 463
+++L+G C D +I +Y L +L + G +
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGME 187
>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex
With An Hydantoin Inhibitor
Length = 305
Score = 35.8 bits (81), Expect = 0.047, Method: Compositional matrix adjust.
Identities = 30/112 (26%), Positives = 47/112 (41%), Gaps = 9/112 (8%)
Query: 353 SRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYL-------PDGREVAIKQLKIGGGQ 405
+ +F +E A + LG+G FG VY+G P+ R VAIK +
Sbjct: 2 AADVFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASM 60
Query: 406 GER-EFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHG 456
ER EF E ++ + H+V L+G L+I + + L +L
Sbjct: 61 RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS 112
>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|D Chain D, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|F Chain F, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|H Chain H, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1IAS|A Chain A, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|B Chain B, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|C Chain C, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|D Chain D, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|E Chain E, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|3FAA|A Chain A, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|B Chain B, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|C Chain C, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|D Chain D, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|E Chain E, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3KCF|A Chain A, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|B Chain B, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|C Chain C, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|D Chain D, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|E Chain E, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|2X7O|A Chain A, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|B Chain B, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|C Chain C, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|D Chain D, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|E Chain E, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
Length = 342
Score = 35.8 bits (81), Expect = 0.054, Method: Compositional matrix adjust.
Identities = 27/91 (29%), Positives = 48/91 (52%), Gaps = 12/91 (13%)
Query: 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
Q +G+G FG V++G G EVA+ KI + ER + E EI + RH +++G+
Sbjct: 47 QESIGKGRFGEVWRGKWR-GEEVAV---KIFSSREERSWFREAEIYQTVMLRH-ENILGF 101
Query: 432 CISDDRR-------LLIYDYVPNNTLYFHLH 455
+D++ L+ DY + +L+ +L+
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN 132
>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With
Inhibitor
Length = 326
Score = 35.8 bits (81), Expect = 0.059, Method: Compositional matrix adjust.
Identities = 27/91 (29%), Positives = 48/91 (52%), Gaps = 12/91 (13%)
Query: 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
Q +G+G FG V++G G EVA+ KI + ER + E EI + RH +++G+
Sbjct: 34 QESIGKGRFGEVWRGKWR-GEEVAV---KIFSSREERSWFREAEIYQTVMLRH-ENILGF 88
Query: 432 CISDDRR-------LLIYDYVPNNTLYFHLH 455
+D++ L+ DY + +L+ +L+
Sbjct: 89 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN 119
>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542
Length = 309
Score = 35.8 bits (81), Expect = 0.059, Method: Compositional matrix adjust.
Identities = 27/91 (29%), Positives = 48/91 (52%), Gaps = 12/91 (13%)
Query: 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
Q +G+G FG V++G G EVA+ KI + ER + E EI + RH +++G+
Sbjct: 14 QESIGKGRFGEVWRGKWR-GEEVAV---KIFSSREERSWFREAEIYQTVMLRH-ENILGF 68
Query: 432 CISDDRR-------LLIYDYVPNNTLYFHLH 455
+D++ L+ DY + +L+ +L+
Sbjct: 69 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN 99
>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3-
Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine
pdb|2WOU|A Chain A, Alk5 In Complex With
4-((4-((2,6-Dimethyl-3-Pyridyl)oxy)-2-
Pyridyl)amino)benzenesulfonamide
Length = 306
Score = 35.8 bits (81), Expect = 0.061, Method: Compositional matrix adjust.
Identities = 27/91 (29%), Positives = 48/91 (52%), Gaps = 12/91 (13%)
Query: 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
Q +G+G FG V++G G EVA+ KI + ER + E EI + RH +++G+
Sbjct: 11 QESIGKGRFGEVWRGKWR-GEEVAV---KIFSSREERSWFREAEIYQTVMLRH-ENILGF 65
Query: 432 CISDDRR-------LLIYDYVPNNTLYFHLH 455
+D++ L+ DY + +L+ +L+
Sbjct: 66 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN 96
>pdb|3B2T|A Chain A, Structure Of Phosphotransferase
pdb|3B2T|B Chain B, Structure Of Phosphotransferase
Length = 311
Score = 35.4 bits (80), Expect = 0.062, Method: Compositional matrix adjust.
Identities = 25/93 (26%), Positives = 44/93 (47%), Gaps = 10/93 (10%)
Query: 375 LGEGGFGSVY--------KGYLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRH 424
LGEG FG V K + VA+K LK + + + +E+E++ I H++
Sbjct: 30 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGK 457
+++L+G C D +I +Y L +L +
Sbjct: 90 IINLLGACTQDGPLYVIVEYASKGNLREYLRAR 122
>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp
Site Inhibitor
Length = 301
Score = 35.4 bits (80), Expect = 0.062, Method: Compositional matrix adjust.
Identities = 27/91 (29%), Positives = 48/91 (52%), Gaps = 12/91 (13%)
Query: 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
Q +G+G FG V++G G EVA+ KI + ER + E EI + RH +++G+
Sbjct: 9 QESIGKGRFGEVWRGKWR-GEEVAV---KIFSSREERSWFREAEIYQTVMLRH-ENILGF 63
Query: 432 CISDDRR-------LLIYDYVPNNTLYFHLH 455
+D++ L+ DY + +L+ +L+
Sbjct: 64 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN 94
>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human
Tgf- Beta Type I Receptor
pdb|3GXL|A Chain A, Alk-5 Kinase Complex With Gw857175
pdb|3HMM|A Chain A, Structure Of Alk5 + Gw855857
Length = 303
Score = 35.4 bits (80), Expect = 0.062, Method: Compositional matrix adjust.
Identities = 27/91 (29%), Positives = 48/91 (52%), Gaps = 12/91 (13%)
Query: 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
Q +G+G FG V++G G EVA+ KI + ER + E EI + RH +++G+
Sbjct: 8 QESIGKGRFGEVWRGKWR-GEEVAV---KIFSSREERSWFREAEIYQTVMLRH-ENILGF 62
Query: 432 CISDDRR-------LLIYDYVPNNTLYFHLH 455
+D++ L+ DY + +L+ +L+
Sbjct: 63 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN 93
>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain
pdb|1OEC|A Chain A, Fgfr2 Kinase Domain
Length = 316
Score = 35.4 bits (80), Expect = 0.063, Method: Compositional matrix adjust.
Identities = 25/93 (26%), Positives = 44/93 (47%), Gaps = 10/93 (10%)
Query: 375 LGEGGFGSVY--------KGYLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRH 424
LGEG FG V K + VA+K LK + + + +E+E++ I H++
Sbjct: 35 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGK 457
+++L+G C D +I +Y L +L +
Sbjct: 95 IINLLGACTQDGPLYVIVEYASKGNLREYLRAR 127
>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome.
pdb|2PWL|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 35.4 bits (80), Expect = 0.063, Method: Compositional matrix adjust.
Identities = 25/93 (26%), Positives = 43/93 (46%), Gaps = 10/93 (10%)
Query: 375 LGEGGFGSVY--------KGYLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRH 424
LGEG FG V K + VA+K LK + + + +E+E++ I H++
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGK 457
++ L+G C D +I +Y L +L +
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRAR 135
>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
pdb|3RI1|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
Length = 313
Score = 35.4 bits (80), Expect = 0.063, Method: Compositional matrix adjust.
Identities = 25/93 (26%), Positives = 44/93 (47%), Gaps = 10/93 (10%)
Query: 375 LGEGGFGSVY--------KGYLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRH 424
LGEG FG V K + VA+K LK + + + +E+E++ I H++
Sbjct: 32 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGK 457
+++L+G C D +I +Y L +L +
Sbjct: 92 IINLLGACTQDGPLYVIVEYASKGNLREYLRAR 124
>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor
Kinase
Length = 299
Score = 35.4 bits (80), Expect = 0.065, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 40/89 (44%), Gaps = 7/89 (7%)
Query: 375 LGEGGFGSVY----KGYLPDGRE--VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVS 427
LG+G FG VY KG + D E VAIK + ER EF E ++ + H+V
Sbjct: 18 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHG 456
L+G L+I + + L +L
Sbjct: 78 LLGVVSQGQPTLVIMELMTRGDLKSYLRS 106
>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|3F5P|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|E Chain E, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|F Chain F, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|G Chain G, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|H Chain H, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|I Chain I, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|J Chain J, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|K Chain K, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|M Chain M, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|L Chain L, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|R Chain R, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|S Chain S, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|T Chain T, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
Length = 308
Score = 35.4 bits (80), Expect = 0.068, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 40/89 (44%), Gaps = 7/89 (7%)
Query: 375 LGEGGFGSVY----KGYLPDGRE--VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVS 427
LG+G FG VY KG + D E VAIK + ER EF E ++ + H+V
Sbjct: 27 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHG 456
L+G L+I + + L +L
Sbjct: 87 LLGVVSQGQPTLVIMELMTRGDLKSYLRS 115
>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With Bms-754807
[1-(4-((5-Cyclopropyl-
1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2,
4]triazin-2-Yl)-N-
(6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide]
Length = 315
Score = 35.4 bits (80), Expect = 0.073, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 40/89 (44%), Gaps = 7/89 (7%)
Query: 375 LGEGGFGSVY----KGYLPDGRE--VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVS 427
LG+G FG VY KG + D E VAIK + ER EF E ++ + H+V
Sbjct: 26 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHG 456
L+G L+I + + L +L
Sbjct: 86 LLGVVSQGQPTLVIMELMTRGDLKSYLRS 114
>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
pdb|1M7N|B Chain B, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
Length = 322
Score = 35.4 bits (80), Expect = 0.077, Method: Compositional matrix adjust.
Identities = 27/90 (30%), Positives = 40/90 (44%), Gaps = 9/90 (10%)
Query: 375 LGEGGFGSVYKGYL-------PDGREVAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLV 426
LG+G FG VY+G P+ R VAIK + ER EF E ++ + H+V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLHG 456
L+G L+I + + L +L
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRS 121
>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution.
pdb|1P4O|B Chain B, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution
Length = 322
Score = 35.4 bits (80), Expect = 0.079, Method: Compositional matrix adjust.
Identities = 27/90 (30%), Positives = 40/90 (44%), Gaps = 9/90 (10%)
Query: 375 LGEGGFGSVYKGYL-------PDGREVAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLV 426
LG+G FG VY+G P+ R VAIK + ER EF E ++ + H+V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLHG 456
L+G L+I + + L +L
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRS 121
>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea
Inhibitor
Length = 316
Score = 35.4 bits (80), Expect = 0.079, Method: Compositional matrix adjust.
Identities = 24/66 (36%), Positives = 34/66 (51%), Gaps = 8/66 (12%)
Query: 375 LGEGGFGSVYKG------YLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRHLV 426
LG G FG V + R VA+K LK G E R +E++I+ I HH ++V
Sbjct: 36 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 427 SLVGYC 432
+L+G C
Sbjct: 96 NLLGAC 101
>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights
Into Receptor Autoregulation
Length = 343
Score = 35.0 bits (79), Expect = 0.081, Method: Compositional matrix adjust.
Identities = 20/78 (25%), Positives = 38/78 (48%), Gaps = 7/78 (8%)
Query: 375 LGEGGFGSVYKGYLP------DGREVAIKQLKI-GGGQGEREFKAEVEIISRIHHRHLVS 427
+GEG FG V++ P VA+K LK + +F+ E +++ + ++V
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 428 LVGYCISDDRRLLIYDYV 445
L+G C L+++Y+
Sbjct: 115 LLGVCAVGKPMCLLFEYM 132
>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel
4-amino-furo[2,3-d]pyrimidine
Length = 316
Score = 35.0 bits (79), Expect = 0.081, Method: Compositional matrix adjust.
Identities = 24/66 (36%), Positives = 34/66 (51%), Gaps = 8/66 (12%)
Query: 375 LGEGGFGSVYKG------YLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRHLV 426
LG G FG V + R VA+K LK G E R +E++I+ I HH ++V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 427 SLVGYC 432
+L+G C
Sbjct: 95 NLLGAC 100
>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1
Receptor Kinase In Complex With Pqip
Length = 301
Score = 35.0 bits (79), Expect = 0.081, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 40/89 (44%), Gaps = 7/89 (7%)
Query: 375 LGEGGFGSVY----KGYLPDGRE--VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVS 427
LG+G FG VY KG + D E VAIK + ER EF E ++ + H+V
Sbjct: 20 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHG 456
L+G L+I + + L +L
Sbjct: 80 LLGVVSQGQPTLVIMELMTRGDLKSYLRS 108
>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|B Chain B, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|C Chain C, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|D Chain D, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
Length = 301
Score = 35.0 bits (79), Expect = 0.083, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 40/89 (44%), Gaps = 7/89 (7%)
Query: 375 LGEGGFGSVY----KGYLPDGRE--VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVS 427
LG+G FG VY KG + D E VAIK + ER EF E ++ + H+V
Sbjct: 20 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHG 456
L+G L+I + + L +L
Sbjct: 80 LLGVVSQGQPTLVIMELMTRGDLKSYLRS 108
>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 35.0 bits (79), Expect = 0.084, Method: Compositional matrix adjust.
Identities = 24/66 (36%), Positives = 34/66 (51%), Gaps = 8/66 (12%)
Query: 375 LGEGGFGSVYKG------YLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRHLV 426
LG G FG V + R VA+K LK G E R +E++I+ I HH ++V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 427 SLVGYC 432
+L+G C
Sbjct: 95 NLLGAC 100
>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
pdb|2Q0B|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 35.0 bits (79), Expect = 0.085, Method: Compositional matrix adjust.
Identities = 25/93 (26%), Positives = 43/93 (46%), Gaps = 10/93 (10%)
Query: 375 LGEGGFGSVY--------KGYLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRH 424
LGEG FG V K + VA+K LK + + + +E+E++ I H++
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGK 457
+++L+G C D +I Y L +L +
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRAR 135
>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|B Chain B, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|C Chain C, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|D Chain D, Igf-1rk In Complex With Ligand Msc1609119a-1
Length = 304
Score = 35.0 bits (79), Expect = 0.086, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 40/89 (44%), Gaps = 7/89 (7%)
Query: 375 LGEGGFGSVY----KGYLPDGRE--VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVS 427
LG+G FG VY KG + D E VAIK + ER EF E ++ + H+V
Sbjct: 23 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHG 456
L+G L+I + + L +L
Sbjct: 83 LLGVVSQGQPTLVIMELMTRGDLKSYLRS 111
>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A
Benzimidazole Inhibitor
pdb|3NW5|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11b)
pdb|3NW6|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11a)
pdb|3NW7|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (34)
Length = 307
Score = 35.0 bits (79), Expect = 0.086, Method: Compositional matrix adjust.
Identities = 27/90 (30%), Positives = 40/90 (44%), Gaps = 9/90 (10%)
Query: 375 LGEGGFGSVYKGYL-------PDGREVAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLV 426
LG+G FG VY+G P+ R VAIK + ER EF E ++ + H+V
Sbjct: 26 LGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 84
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLHG 456
L+G L+I + + L +L
Sbjct: 85 RLLGVVSQGQPTLVIMELMTRGDLKSYLRS 114
>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120
Length = 316
Score = 35.0 bits (79), Expect = 0.086, Method: Compositional matrix adjust.
Identities = 24/66 (36%), Positives = 34/66 (51%), Gaps = 8/66 (12%)
Query: 375 LGEGGFGSVYKG------YLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRHLV 426
LG G FG V + R VA+K LK G E R +E++I+ I HH ++V
Sbjct: 37 LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 427 SLVGYC 432
+L+G C
Sbjct: 97 NLLGAC 102
>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr)
Kinase Domain
Length = 316
Score = 35.0 bits (79), Expect = 0.086, Method: Compositional matrix adjust.
Identities = 24/66 (36%), Positives = 34/66 (51%), Gaps = 8/66 (12%)
Query: 375 LGEGGFGSVYKG------YLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRHLV 426
LG G FG V + R VA+K LK G E R +E++I+ I HH ++V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 427 SLVGYC 432
+L+G C
Sbjct: 95 NLLGAC 100
>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain
pdb|1JQH|B Chain B, Igf-1 Receptor Kinase Domain
pdb|1JQH|C Chain C, Igf-1 Receptor Kinase Domain
Length = 308
Score = 35.0 bits (79), Expect = 0.088, Method: Compositional matrix adjust.
Identities = 27/90 (30%), Positives = 40/90 (44%), Gaps = 9/90 (10%)
Query: 375 LGEGGFGSVYKGYL-------PDGREVAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLV 426
LG+G FG VY+G P+ R VAIK + ER EF E ++ + H+V
Sbjct: 27 LGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 85
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLHG 456
L+G L+I + + L +L
Sbjct: 86 RLLGVVSQGQPTLVIMELMTRGDLKSYLRS 115
>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy)
Quinolin-4-Yloxy)benzofuran-3-Carboxamide)
pdb|4AG8|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Axitinib (Ag-013736)
(N-Methyl-2-(3-((E)-2-Pyridin-2-
Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-Benzamide)
Length = 316
Score = 35.0 bits (79), Expect = 0.089, Method: Compositional matrix adjust.
Identities = 24/66 (36%), Positives = 34/66 (51%), Gaps = 8/66 (12%)
Query: 375 LGEGGFGSVYKG------YLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRHLV 426
LG G FG V + R VA+K LK G E R +E++I+ I HH ++V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 427 SLVGYC 432
+L+G C
Sbjct: 95 NLLGAC 100
>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 35.0 bits (79), Expect = 0.089, Method: Compositional matrix adjust.
Identities = 24/66 (36%), Positives = 34/66 (51%), Gaps = 8/66 (12%)
Query: 375 LGEGGFGSVYKG------YLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRHLV 426
LG G FG V + R VA+K LK G E R +E++I+ I HH ++V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 427 SLVGYC 432
+L+G C
Sbjct: 95 NLLGAC 100
>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridinyl-Triazine Inhibitor
pdb|2QU5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzimidazole Inhibitor
pdb|2QU6|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|2QU6|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|3B8Q|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8Q|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|2RL5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A 2,3-Dihydro-1,4-Benzoxazine Inhibitor
pdb|3BE2|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzamide Inhibitor
pdb|3CP9|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CP9|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPB|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPB|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPC|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPC|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3DTW|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
pdb|3DTW|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
Length = 314
Score = 35.0 bits (79), Expect = 0.091, Method: Compositional matrix adjust.
Identities = 24/66 (36%), Positives = 34/66 (51%), Gaps = 8/66 (12%)
Query: 375 LGEGGFGSVYKG------YLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRHLV 426
LG G FG V + R VA+K LK G E R +E++I+ I HH ++V
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 427 SLVGYC 432
+L+G C
Sbjct: 86 NLLGAC 91
>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridyl-Pyrimidine Benzimidazole Inhibitor
Length = 314
Score = 35.0 bits (79), Expect = 0.092, Method: Compositional matrix adjust.
Identities = 24/66 (36%), Positives = 34/66 (51%), Gaps = 8/66 (12%)
Query: 375 LGEGGFGSVYKG------YLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRHLV 426
LG G FG V + R VA+K LK G E R +E++I+ I HH ++V
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 427 SLVGYC 432
+L+G C
Sbjct: 86 NLLGAC 91
>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Axitinib (Ag-013736)
(N-Methyl-2-(
3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-
Benzamide)
pdb|4AGD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sunitinib (Su11248) (N-2-
Diethylaminoethyl)-5-((Z)-(5-Fluoro-2-Oxo-1h-Indol-3-
Ylidene)methyl)-2,4-Dimethyl-1h-Pyrrole-3-Carboxamide)
pdb|4ASD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sorafenib (Bay 43-9006)
pdb|4ASE|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Tivozanib (Av-951)
Length = 353
Score = 35.0 bits (79), Expect = 0.093, Method: Compositional matrix adjust.
Identities = 24/66 (36%), Positives = 34/66 (51%), Gaps = 8/66 (12%)
Query: 375 LGEGGFGSVYKG------YLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRHLV 426
LG G FG V + R VA+K LK G E R +E++I+ I HH ++V
Sbjct: 72 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 427 SLVGYC 432
+L+G C
Sbjct: 132 NLLGAC 137
>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|2P2I|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|3EFL|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
pdb|3EFL|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
Length = 314
Score = 35.0 bits (79), Expect = 0.095, Method: Compositional matrix adjust.
Identities = 24/66 (36%), Positives = 34/66 (51%), Gaps = 8/66 (12%)
Query: 375 LGEGGFGSVYKG------YLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRHLV 426
LG G FG V + R VA+K LK G E R +E++I+ I HH ++V
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 427 SLVGYC 432
+L+G C
Sbjct: 86 NLLGAC 91
>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyrazolone Inhibitor
Length = 314
Score = 35.0 bits (79), Expect = 0.100, Method: Compositional matrix adjust.
Identities = 24/66 (36%), Positives = 34/66 (51%), Gaps = 8/66 (12%)
Query: 375 LGEGGFGSVYKG------YLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRHLV 426
LG G FG V + R VA+K LK G E R +E++I+ I HH ++V
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 427 SLVGYC 432
+L+G C
Sbjct: 86 NLLGAC 91
>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2
With A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 318
Score = 35.0 bits (79), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 24/66 (36%), Positives = 34/66 (51%), Gaps = 8/66 (12%)
Query: 375 LGEGGFGSVYKG------YLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRHLV 426
LG G FG V + R VA+K LK G E R +E++I+ I HH ++V
Sbjct: 37 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 427 SLVGYC 432
+L+G C
Sbjct: 97 NLLGAC 102
>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|B Chain B, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|C Chain C, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|D Chain D, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
Length = 336
Score = 35.0 bits (79), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 40/89 (44%), Gaps = 7/89 (7%)
Query: 375 LGEGGFGSVY----KGYLPDGRE--VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVS 427
LG+G FG VY KG + D E VAIK + ER EF E ++ + H+V
Sbjct: 55 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHG 456
L+G L+I + + L +L
Sbjct: 115 LLGVVSQGQPTLVIMELMTRGDLKSYLRS 143
>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 34.7 bits (78), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 26/99 (26%), Positives = 46/99 (46%), Gaps = 10/99 (10%)
Query: 375 LGEGGFGSVY--------KGYLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRH 424
LGEG FG V K +VA+K LK + + + +E+E++ I H++
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGKWQLGFD 463
+++L+G C D +I +Y L +L + G +
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLE 134
>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
pdb|2PY3|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 34.7 bits (78), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 25/93 (26%), Positives = 43/93 (46%), Gaps = 10/93 (10%)
Query: 375 LGEGGFGSVY--------KGYLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRH 424
LGEG FG V K + VA+K LK + + + +E+E++ I H++
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGK 457
+++L+G C D +I Y L +L +
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRAR 135
>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A
Novel Pyrrolopyrimidine Inhibitor
Length = 359
Score = 34.7 bits (78), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 24/66 (36%), Positives = 34/66 (51%), Gaps = 8/66 (12%)
Query: 375 LGEGGFGSVYKG------YLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRHLV 426
LG G FG V + R VA+K LK G E R +E++I+ I HH ++V
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 427 SLVGYC 432
+L+G C
Sbjct: 90 NLLGAC 95
>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With
Compound A
Length = 356
Score = 34.7 bits (78), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 24/66 (36%), Positives = 34/66 (51%), Gaps = 8/66 (12%)
Query: 375 LGEGGFGSVYKG------YLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRHLV 426
LG G FG V + R VA+K LK G E R +E++I+ I HH ++V
Sbjct: 28 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 87
Query: 427 SLVGYC 432
+L+G C
Sbjct: 88 NLLGAC 93
>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
pdb|1Y6B|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
Length = 366
Score = 34.7 bits (78), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 24/66 (36%), Positives = 34/66 (51%), Gaps = 8/66 (12%)
Query: 375 LGEGGFGSVYKG------YLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRHLV 426
LG G FG V + R VA+K LK G E R +E++I+ I HH ++V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 427 SLVGYC 432
+L+G C
Sbjct: 95 NLLGAC 100
>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
pdb|3G2F|B Chain B, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
Length = 336
Score = 34.7 bits (78), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 30/92 (32%), Positives = 43/92 (46%), Gaps = 15/92 (16%)
Query: 374 LLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
L+G G +G+VYKG L D R VA+K Q F E I R+ ++ + +
Sbjct: 20 LIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN---FINEKNIY-RVPLMEHDNIARFIV 74
Query: 434 SDDR--------RLLIYDYVPNNTL--YFHLH 455
D+R LL+ +Y PN +L Y LH
Sbjct: 75 GDERVTADGRMEYLLVMEYYPNGSLXKYLSLH 106
>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Back Pocket Binder
Length = 368
Score = 34.7 bits (78), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 24/66 (36%), Positives = 34/66 (51%), Gaps = 8/66 (12%)
Query: 375 LGEGGFGSVYKG------YLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRHLV 426
LG G FG V + R VA+K LK G E R +E++I+ I HH ++V
Sbjct: 37 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 427 SLVGYC 432
+L+G C
Sbjct: 97 NLLGAC 102
>pdb|3ZGW|A Chain A, Crystal Structure Of Maternal Embryonic Leucine Zipper
Kinase (melk) In Complex With Amp-pnp
Length = 347
Score = 34.7 bits (78), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 44/95 (46%), Gaps = 5/95 (5%)
Query: 359 YEELVKATDGFADQNLLGEGGFGSV-YKGYLPDGREVAIKQL-KIGGGQGEREFKAEVEI 416
Y+EL+K + +G GGF V ++ G VAIK + K G K E+E
Sbjct: 5 YDELLKY---YELHETIGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEA 61
Query: 417 ISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLY 451
+ + H+H+ L + ++ ++ +Y P L+
Sbjct: 62 LKNLRHQHICQLYHVLETANKIFMVLEYCPGGELF 96
>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
pdb|3TT0|B Chain B, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
Length = 382
Score = 34.3 bits (77), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 26/99 (26%), Positives = 46/99 (46%), Gaps = 10/99 (10%)
Query: 375 LGEGGFGSVY--------KGYLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRH 424
LGEG FG V K +VA+K LK + + + +E+E++ I H++
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGKWQLGFD 463
+++L+G C D +I +Y L +L + G +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLE 175
>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|B Chain B, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|C Chain C, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|D Chain D, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|E Chain E, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|F Chain F, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
Length = 294
Score = 34.3 bits (77), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 33/107 (30%), Positives = 52/107 (48%), Gaps = 13/107 (12%)
Query: 375 LGEGGFGSVYKGYLPDGR----EVAIKQLKIGGGQGE---REFKAEVEIISRIHHRHLVS 427
LG GG +VY L + +VAIK + I + E + F+ EV S++ H+++VS
Sbjct: 19 LGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 428 LVGYCISDDRRLLIYDYVPNNTL--YFHLHGKWQLGFDIRNHNNGLL 472
++ DD L+ +Y+ TL Y HG + I N N +L
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAI-NFTNQIL 121
>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGK|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1AGW|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|1AGW|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|2FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
pdb|2FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
Length = 310
Score = 34.3 bits (77), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 26/99 (26%), Positives = 46/99 (46%), Gaps = 10/99 (10%)
Query: 375 LGEGGFGSVY--------KGYLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRH 424
LGEG FG V K +VA+K LK + + + +E+E++ I H++
Sbjct: 29 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGKWQLGFD 463
+++L+G C D +I +Y L +L + G +
Sbjct: 89 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLE 127
>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|B Chain B, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|C Chain C, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|D Chain D, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
Length = 317
Score = 34.3 bits (77), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 26/99 (26%), Positives = 46/99 (46%), Gaps = 10/99 (10%)
Query: 375 LGEGGFGSVY--------KGYLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRH 424
LGEG FG V K +VA+K LK + + + +E+E++ I H++
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGKWQLGFD 463
+++L+G C D +I +Y L +L + G +
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLE 134
>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|B Chain B, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|C Chain C, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 34.3 bits (77), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 26/99 (26%), Positives = 46/99 (46%), Gaps = 10/99 (10%)
Query: 375 LGEGGFGSVY--------KGYLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRH 424
LGEG FG V K +VA+K LK + + + +E+E++ I H++
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGKWQLGFD 463
+++L+G C D +I +Y L +L + G +
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLE 134
>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F63|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F64|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F64|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F65|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
pdb|4F65|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
Length = 309
Score = 34.3 bits (77), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 26/99 (26%), Positives = 46/99 (46%), Gaps = 10/99 (10%)
Query: 375 LGEGGFGSVY--------KGYLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRH 424
LGEG FG V K +VA+K LK + + + +E+E++ I H++
Sbjct: 28 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGKWQLGFD 463
+++L+G C D +I +Y L +L + G +
Sbjct: 88 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLE 126
>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
pdb|3RHX|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
Length = 306
Score = 34.3 bits (77), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 26/99 (26%), Positives = 46/99 (46%), Gaps = 10/99 (10%)
Query: 375 LGEGGFGSVY--------KGYLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRH 424
LGEG FG V K +VA+K LK + + + +E+E++ I H++
Sbjct: 25 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGKWQLGFD 463
+++L+G C D +I +Y L +L + G +
Sbjct: 85 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLE 123
>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3JS2|B Chain B, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3KY2|A Chain A, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
pdb|3KY2|B Chain B, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
Length = 317
Score = 34.3 bits (77), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 26/99 (26%), Positives = 46/99 (46%), Gaps = 10/99 (10%)
Query: 375 LGEGGFGSVY--------KGYLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRH 424
LGEG FG V K +VA+K LK + + + +E+E++ I H++
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGKWQLGFD 463
+++L+G C D +I +Y L +L + G +
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLE 134
>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
pdb|3VW6|B Chain B, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
Length = 269
Score = 34.3 bits (77), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 23/93 (24%), Positives = 44/93 (47%), Gaps = 1/93 (1%)
Query: 367 DGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHL 425
D D+ +LG+G +G VY G L + +AIK++ + + E+ + + H+++
Sbjct: 8 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNI 67
Query: 426 VSLVGYCISDDRRLLIYDYVPNNTLYFHLHGKW 458
V +G + + + VP +L L KW
Sbjct: 68 VQYLGSFSENGFIKIFMEQVPGGSLSALLRSKW 100
>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
pdb|3C4F|B Chain B, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
Length = 302
Score = 34.3 bits (77), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 26/99 (26%), Positives = 46/99 (46%), Gaps = 10/99 (10%)
Query: 375 LGEGGFGSVY--------KGYLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRH 424
LGEG FG V K +VA+K LK + + + +E+E++ I H++
Sbjct: 21 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGKWQLGFD 463
+++L+G C D +I +Y L +L + G +
Sbjct: 81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLE 119
>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
pdb|2CLQ|B Chain B, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
Length = 295
Score = 33.9 bits (76), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 23/93 (24%), Positives = 44/93 (47%), Gaps = 1/93 (1%)
Query: 367 DGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHL 425
D D+ +LG+G +G VY G L + +AIK++ + + E+ + + H+++
Sbjct: 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNI 81
Query: 426 VSLVGYCISDDRRLLIYDYVPNNTLYFHLHGKW 458
V +G + + + VP +L L KW
Sbjct: 82 VQYLGSFSENGFIKIFMEQVPGGSLSALLRSKW 114
>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5Q|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
Length = 348
Score = 33.9 bits (76), Expect = 0.19, Method: Compositional matrix adjust.
Identities = 20/81 (24%), Positives = 39/81 (48%), Gaps = 4/81 (4%)
Query: 369 FADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFK---AEVEIISRIHHRH 424
F+D +G G FG+VY + + VAIK++ G Q +++ EV + ++ H +
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 425 LVSLVGYCISDDRRLLIYDYV 445
+ G + + L+ +Y
Sbjct: 116 TIQYRGCYLREHTAWLVMEYC 136
>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase
pdb|3COM|B Chain B, Crystal Structure Of Mst1 Kinase
Length = 314
Score = 33.9 bits (76), Expect = 0.19, Method: Compositional matrix adjust.
Identities = 22/71 (30%), Positives = 36/71 (50%), Gaps = 3/71 (4%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LGEG +GSVYK + G+ VAIKQ+ + +E E+ I+ + H+V G
Sbjct: 37 LGEGSYGSVYKAIHKETGQIVAIKQVPVESDL--QEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 434 SDDRRLLIYDY 444
+ ++ +Y
Sbjct: 95 KNTDLWIVMEY 105
>pdb|1RJB|A Chain A, Crystal Structure Of Flt3
Length = 344
Score = 33.9 bits (76), Expect = 0.21, Method: Compositional matrix adjust.
Identities = 28/92 (30%), Positives = 46/92 (50%), Gaps = 8/92 (8%)
Query: 374 LLGEGGFGSVYK----GYLPDGR--EVAIKQLKIGGGQGERE-FKAEVEIISRI-HHRHL 425
+LG G FG V G G +VA+K LK ERE +E+++++++ H ++
Sbjct: 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 426 VSLVGYCISDDRRLLIYDYVPNNTLYFHLHGK 457
V+L+G C LI++Y L +L K
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSK 143
>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure
pdb|2GCD|B Chain B, Tao2 Kinase Domain-Staurosporine Structure
Length = 309
Score = 33.9 bits (76), Expect = 0.23, Method: Compositional matrix adjust.
Identities = 20/81 (24%), Positives = 39/81 (48%), Gaps = 4/81 (4%)
Query: 369 FADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFK---AEVEIISRIHHRH 424
F+D +G G FG+VY + + VAIK++ G Q +++ EV + ++ H +
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 425 LVSLVGYCISDDRRLLIYDYV 445
+ G + + L+ +Y
Sbjct: 77 TIQYRGCYLREHTAWLVMEYC 97
>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The
Murine Receptor Tyrosine Kinase Tyro3 (Sky)
Length = 323
Score = 33.5 bits (75), Expect = 0.25, Method: Compositional matrix adjust.
Identities = 26/77 (33%), Positives = 36/77 (46%), Gaps = 6/77 (7%)
Query: 360 EELVKATDGFADQNLLGEGGFGSVYKGYLP--DGR--EVAIKQLK--IGGGQGEREFKAE 413
E+++ F +LG+G FGSV + L DG +VA+K LK I EF E
Sbjct: 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75
Query: 414 VEIISRIHHRHLVSLVG 430
+ H H+ LVG
Sbjct: 76 AACMKEFDHPHVAKLVG 92
>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
pdb|2BUJ|B Chain B, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
Length = 317
Score = 33.1 bits (74), Expect = 0.32, Method: Compositional matrix adjust.
Identities = 21/63 (33%), Positives = 34/63 (53%), Gaps = 3/63 (4%)
Query: 375 LGEGGFGSV--YKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYC 432
LGEGGF V +G L DG A+K++ Q E + E ++ +H +++ LV YC
Sbjct: 37 LGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 433 ISD 435
+ +
Sbjct: 96 LRE 98
>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolotriazine Based Inhibitor
Length = 373
Score = 33.1 bits (74), Expect = 0.32, Method: Compositional matrix adjust.
Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 372 QNLLGEGGFGSVYKGYL--PDGREV--AIKQLKIGGGQGE-REFKAEVEIISRIHHRHLV 426
++G G FG VY G L DG+++ A+K L GE +F E I+ H +++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 427 SLVGYCI-SDDRRLLIYDYVPNNTL 450
SL+G C+ S+ L++ Y+ + L
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDL 178
>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase
pdb|3RHK|A Chain A, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
pdb|3RHK|B Chain B, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
Length = 318
Score = 33.1 bits (74), Expect = 0.33, Method: Compositional matrix adjust.
Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 372 QNLLGEGGFGSVYKGYL--PDGREV--AIKQLKIGGGQGE-REFKAEVEIISRIHHRHLV 426
++G G FG VY G L DG+++ A+K L GE +F E I+ H +++
Sbjct: 53 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 427 SLVGYCI-SDDRRLLIYDYVPNNTL 450
SL+G C+ S+ L++ Y+ + L
Sbjct: 113 SLLGICLRSEGSPLVVLPYMKHGDL 137
>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With
6-Benzyloxyquinoline Inhibitor
Length = 319
Score = 33.1 bits (74), Expect = 0.35, Method: Compositional matrix adjust.
Identities = 27/83 (32%), Positives = 45/83 (54%), Gaps = 6/83 (7%)
Query: 374 LLGEGGFGSVYKGYL--PDGREV--AIKQLKIGGGQGE-REFKAEVEIISRIHHRHLVSL 428
++G G FG VY G L DG+++ A+K L GE +F E I+ H +++SL
Sbjct: 42 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 429 VGYCI-SDDRRLLIYDYVPNNTL 450
+G C+ S+ L++ Y+ + L
Sbjct: 102 LGICLRSEGSPLVVLPYMKHGDL 124
>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972
pdb|3QTI|B Chain B, C-Met Kinase In Complex With Nvp-Bvu972
Length = 314
Score = 33.1 bits (74), Expect = 0.36, Method: Compositional matrix adjust.
Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 372 QNLLGEGGFGSVYKGYL--PDGREV--AIKQLKIGGGQGE-REFKAEVEIISRIHHRHLV 426
++G G FG VY G L DG+++ A+K L GE +F E I+ H +++
Sbjct: 35 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 427 SLVGYCI-SDDRRLLIYDYVPNNTL 450
SL+G C+ S+ L++ Y+ + L
Sbjct: 95 SLLGICLRSEGSPLVVLPYMKHGDL 119
>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In
Complex With An Mk-2461 Analog With Specificity For The
Activated Receptor
pdb|3R7O|A Chain A, Structure Of Dually Phosphorylated C-Met Receptor Kinase
In Complex With An Mk-2461 Analog
Length = 307
Score = 33.1 bits (74), Expect = 0.37, Method: Compositional matrix adjust.
Identities = 27/83 (32%), Positives = 45/83 (54%), Gaps = 6/83 (7%)
Query: 374 LLGEGGFGSVYKGYL--PDGREV--AIKQLKIGGGQGE-REFKAEVEIISRIHHRHLVSL 428
++G G FG VY G L DG+++ A+K L GE +F E I+ H +++SL
Sbjct: 36 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 429 VGYCI-SDDRRLLIYDYVPNNTL 450
+G C+ S+ L++ Y+ + L
Sbjct: 96 LGICLRSEGSPLVVLPYMKHGDL 118
>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
pdb|4GG7|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
Length = 319
Score = 33.1 bits (74), Expect = 0.37, Method: Compositional matrix adjust.
Identities = 27/83 (32%), Positives = 45/83 (54%), Gaps = 6/83 (7%)
Query: 374 LLGEGGFGSVYKGYL--PDGREV--AIKQLKIGGGQGE-REFKAEVEIISRIHHRHLVSL 428
++G G FG VY G L DG+++ A+K L GE +F E I+ H +++SL
Sbjct: 56 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 429 VGYCI-SDDRRLLIYDYVPNNTL 450
+G C+ S+ L++ Y+ + L
Sbjct: 116 LGICLRSEGSPLVVLPYMKHGDL 138
>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1
Length = 317
Score = 33.1 bits (74), Expect = 0.38, Method: Compositional matrix adjust.
Identities = 27/83 (32%), Positives = 45/83 (54%), Gaps = 6/83 (7%)
Query: 374 LLGEGGFGSVYKGYL--PDGREV--AIKQLKIGGGQGE-REFKAEVEIISRIHHRHLVSL 428
++G G FG VY G L DG+++ A+K L GE +F E I+ H +++SL
Sbjct: 38 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 429 VGYCI-SDDRRLLIYDYVPNNTL 450
+G C+ S+ L++ Y+ + L
Sbjct: 98 LGICLRSEGSPLVVLPYMKHGDL 120
>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CTJ|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CE3|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolopyridinepyridone Based Inhibitor
pdb|3F82|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
N-
(4-(2-Amino-3-Chloropyridin-4-Yloxy)-3-Fluorophenyl)-4-
Ethoxy-1-(4-Fluorophenyl)-2-Oxo-1,2-Dihydropyridine-3-
Carboxamide
pdb|3L8V|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepat Growth Factor Receptor C-Met In Complex With A
Biarylamine Inhibitor
Length = 314
Score = 33.1 bits (74), Expect = 0.38, Method: Compositional matrix adjust.
Identities = 27/83 (32%), Positives = 45/83 (54%), Gaps = 6/83 (7%)
Query: 374 LLGEGGFGSVYKGYL--PDGREV--AIKQLKIGGGQGE-REFKAEVEIISRIHHRHLVSL 428
++G G FG VY G L DG+++ A+K L GE +F E I+ H +++SL
Sbjct: 37 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 429 VGYCI-SDDRRLLIYDYVPNNTL 450
+G C+ S+ L++ Y+ + L
Sbjct: 97 LGICLRSEGSPLVVLPYMKHGDL 119
>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The
Dually-Phosphorylated, Activated State
Length = 308
Score = 33.1 bits (74), Expect = 0.39, Method: Compositional matrix adjust.
Identities = 27/83 (32%), Positives = 45/83 (54%), Gaps = 6/83 (7%)
Query: 374 LLGEGGFGSVYKGYL--PDGREV--AIKQLKIGGGQGE-REFKAEVEIISRIHHRHLVSL 428
++G G FG VY G L DG+++ A+K L GE +F E I+ H +++SL
Sbjct: 37 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 429 VGYCI-SDDRRLLIYDYVPNNTL 450
+G C+ S+ L++ Y+ + L
Sbjct: 97 LGICLRSEGSPLVVLPYMKHGDL 119
>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1
pdb|3DKF|A Chain A, Sgx Clone 5698a65kfg1h1
Length = 317
Score = 33.1 bits (74), Expect = 0.39, Method: Compositional matrix adjust.
Identities = 27/83 (32%), Positives = 45/83 (54%), Gaps = 6/83 (7%)
Query: 374 LLGEGGFGSVYKGYL--PDGREV--AIKQLKIGGGQGE-REFKAEVEIISRIHHRHLVSL 428
++G G FG VY G L DG+++ A+K L GE +F E I+ H +++SL
Sbjct: 38 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 429 VGYCI-SDDRRLLIYDYVPNNTL 450
+G C+ S+ L++ Y+ + L
Sbjct: 98 LGICLRSEGSPLVVLPYMKHGDL 120
>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor
Length = 292
Score = 33.1 bits (74), Expect = 0.39, Method: Compositional matrix adjust.
Identities = 27/84 (32%), Positives = 45/84 (53%), Gaps = 6/84 (7%)
Query: 373 NLLGEGGFGSVYKGYL--PDGREV--AIKQLKIGGGQGE-REFKAEVEIISRIHHRHLVS 427
++G G FG VY G L DG+++ A+K L GE +F E I+ H +++S
Sbjct: 28 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 87
Query: 428 LVGYCI-SDDRRLLIYDYVPNNTL 450
L+G C+ S+ L++ Y+ + L
Sbjct: 88 LLGICLRSEGSPLVVLPYMKHGDL 111
>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain
Of C-Met
pdb|2WKM|A Chain A, X-Ray Structure Of Pha-00665752 Bound To The Kinase Domain
Of C-Met
pdb|3ZXZ|A Chain A, X-Ray Structure Of Pf-04217903 Bound To The Kinase Domain
Of C-Met
pdb|3ZZE|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
N'-
((3z)-4-Chloro-7-Methyl-2-Oxo-1,2-Dihydro-3h-Indol-3-
Ylidene)-2-(4-Hydroxyphenyl)propanohydrazide
pdb|4AOI|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( 3-((1h-
Pyrrolo(2,3-B)pyridin-3-Yl)methyl)-(1,2,4)triazolo(
4,3-B)(1,2,4) Triazin-6-Yl)benzonitrile
pdb|4AP7|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( (6-(4-
Fluorophenyl)-(1,2,4)triazolo(4,3-B)(1,2,
4)triazin-3-Yl)methyl) Phenol
Length = 306
Score = 32.7 bits (73), Expect = 0.40, Method: Compositional matrix adjust.
Identities = 27/84 (32%), Positives = 45/84 (53%), Gaps = 6/84 (7%)
Query: 373 NLLGEGGFGSVYKGYL--PDGREV--AIKQLKIGGGQGE-REFKAEVEIISRIHHRHLVS 427
++G G FG VY G L DG+++ A+K L GE +F E I+ H +++S
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 428 LVGYCI-SDDRRLLIYDYVPNNTL 450
L+G C+ S+ L++ Y+ + L
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDL 116
>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
The Microbial Alkaloid K-252a
pdb|1R1W|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met
Length = 312
Score = 32.7 bits (73), Expect = 0.41, Method: Compositional matrix adjust.
Identities = 27/83 (32%), Positives = 45/83 (54%), Gaps = 6/83 (7%)
Query: 374 LLGEGGFGSVYKGYL--PDGREV--AIKQLKIGGGQGE-REFKAEVEIISRIHHRHLVSL 428
++G G FG VY G L DG+++ A+K L GE +F E I+ H +++SL
Sbjct: 35 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 429 VGYCI-SDDRRLLIYDYVPNNTL 450
+G C+ S+ L++ Y+ + L
Sbjct: 95 LGICLRSEGSPLVVLPYMKHGDL 117
>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor.
pdb|2RFN|B Chain B, X-ray Structure Of C-met With Inhibitor.
pdb|2RFS|A Chain A, X-Ray Structure Of Su11274 Bound To C-Met
pdb|3CCN|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3CD8|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3EFJ|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFJ|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFK|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 50
pdb|3EFK|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 50
Length = 310
Score = 32.7 bits (73), Expect = 0.41, Method: Compositional matrix adjust.
Identities = 27/83 (32%), Positives = 45/83 (54%), Gaps = 6/83 (7%)
Query: 374 LLGEGGFGSVYKGYL--PDGREV--AIKQLKIGGGQGE-REFKAEVEIISRIHHRHLVSL 428
++G G FG VY G L DG+++ A+K L GE +F E I+ H +++SL
Sbjct: 37 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 429 VGYCI-SDDRRLLIYDYVPNNTL 450
+G C+ S+ L++ Y+ + L
Sbjct: 97 LGICLRSEGSPLVVLPYMKHGDL 119
>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880
(Gsk1
Length = 302
Score = 32.7 bits (73), Expect = 0.43, Method: Compositional matrix adjust.
Identities = 27/84 (32%), Positives = 45/84 (53%), Gaps = 6/84 (7%)
Query: 373 NLLGEGGFGSVYKGYL--PDGREV--AIKQLKIGGGQGE-REFKAEVEIISRIHHRHLVS 427
++G G FG VY G L DG+++ A+K L GE +F E I+ H +++S
Sbjct: 34 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 428 LVGYCI-SDDRRLLIYDYVPNNTL 450
L+G C+ S+ L++ Y+ + L
Sbjct: 94 LLGICLRSEGSPLVVLPYMKHGDL 117
>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine
Inhibitor 13
pdb|3U6H|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 26
pdb|3U6I|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 58a
pdb|4DEG|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridazine Inhibitor 2
pdb|4DEH|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 3
pdb|4DEI|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 24
Length = 309
Score = 32.7 bits (73), Expect = 0.43, Method: Compositional matrix adjust.
Identities = 27/83 (32%), Positives = 45/83 (54%), Gaps = 6/83 (7%)
Query: 374 LLGEGGFGSVYKGYL--PDGREV--AIKQLKIGGGQGE-REFKAEVEIISRIHHRHLVSL 428
++G G FG VY G L DG+++ A+K L GE +F E I+ H +++SL
Sbjct: 36 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 429 VGYCI-SDDRRLLIYDYVPNNTL 450
+G C+ S+ L++ Y+ + L
Sbjct: 96 LGICLRSEGSPLVVLPYMKHGDL 118
>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
pdb|3F66|B Chain B, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
Length = 298
Score = 32.7 bits (73), Expect = 0.46, Method: Compositional matrix adjust.
Identities = 27/84 (32%), Positives = 45/84 (53%), Gaps = 6/84 (7%)
Query: 373 NLLGEGGFGSVYKGYL--PDGREV--AIKQLKIGGGQGE-REFKAEVEIISRIHHRHLVS 427
++G G FG VY G L DG+++ A+K L GE +F E I+ H +++S
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 428 LVGYCI-SDDRRLLIYDYVPNNTL 450
L+G C+ S+ L++ Y+ + L
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDL 114
>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg-
1009247
Length = 270
Score = 32.3 bits (72), Expect = 0.56, Method: Compositional matrix adjust.
Identities = 19/57 (33%), Positives = 27/57 (47%), Gaps = 1/57 (1%)
Query: 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSL 428
+ LG G FG V+ +VA+K +K G E F AE ++ + H LV L
Sbjct: 20 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKL 75
>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex
pdb|1AD5|B Chain B, Src Family Kinase Hck-Amp-Pnp Complex
pdb|2HCK|A Chain A, Src Family Kinase Hck-Quercetin Complex
pdb|2HCK|B Chain B, Src Family Kinase Hck-Quercetin Complex
Length = 438
Score = 32.3 bits (72), Expect = 0.60, Method: Compositional matrix adjust.
Identities = 19/57 (33%), Positives = 27/57 (47%), Gaps = 1/57 (1%)
Query: 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSL 428
+ LG G FG V+ +VA+K +K G E F AE ++ + H LV L
Sbjct: 187 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKL 242
>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family-
Selective Tyrosine Kinase Inhibitor
pdb|2C0I|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0I|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0O|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0O|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0T|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-641359
pdb|2C0T|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-641359
Length = 454
Score = 32.3 bits (72), Expect = 0.67, Method: Compositional matrix adjust.
Identities = 19/57 (33%), Positives = 27/57 (47%), Gaps = 1/57 (1%)
Query: 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSL 428
+ LG G FG V+ +VA+K +K G E F AE ++ + H LV L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKL 248
>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7
pdb|1UA2|B Chain B, Crystal Structure Of Human Cdk7
pdb|1UA2|C Chain C, Crystal Structure Of Human Cdk7
pdb|1UA2|D Chain D, Crystal Structure Of Human Cdk7
Length = 346
Score = 32.0 bits (71), Expect = 0.73, Method: Compositional matrix adjust.
Identities = 20/82 (24%), Positives = 41/82 (50%), Gaps = 6/82 (7%)
Query: 373 NLLGEGGFGSVYKGYLPDGRE-VAIKQLKIGGGQG-----EREFKAEVEIISRIHHRHLV 426
+ LGEG F +VYK + + VAIK++K+G R E++++ + H +++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 427 SLVGYCISDDRRLLIYDYVPNN 448
L+ L++D++ +
Sbjct: 76 GLLDAFGHKSNISLVFDFMETD 97
>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The
Kinase Domain Of Focal Adhesion Kinase With A
Phosphorylated Activation Loop
Length = 276
Score = 32.0 bits (71), Expect = 0.76, Method: Compositional matrix adjust.
Identities = 23/61 (37%), Positives = 32/61 (52%), Gaps = 5/61 (8%)
Query: 375 LGEGGFGSVYKG-YL-PD--GREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSLV 429
+GEG FG V++G Y+ P+ VAIK K RE F E + + H H+V L+
Sbjct: 18 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 430 G 430
G
Sbjct: 78 G 78
>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 32.0 bits (71), Expect = 0.80, Method: Compositional matrix adjust.
Identities = 23/61 (37%), Positives = 32/61 (52%), Gaps = 5/61 (8%)
Query: 375 LGEGGFGSVYKG-YL-PD--GREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSLV 429
+GEG FG V++G Y+ P+ VAIK K RE F E + + H H+V L+
Sbjct: 18 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 430 G 430
G
Sbjct: 78 G 78
>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
pdb|2JKO|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 32.0 bits (71), Expect = 0.82, Method: Compositional matrix adjust.
Identities = 23/61 (37%), Positives = 32/61 (52%), Gaps = 5/61 (8%)
Query: 375 LGEGGFGSVYKG-YL-PD--GREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSLV 429
+GEG FG V++G Y+ P+ VAIK K RE F E + + H H+V L+
Sbjct: 18 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 430 G 430
G
Sbjct: 78 G 78
>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major
pdb|3E3P|B Chain B, Glycogen Synthase Kinase From Leishmania Major
Length = 360
Score = 32.0 bits (71), Expect = 0.83, Method: Compositional matrix adjust.
Identities = 28/97 (28%), Positives = 47/97 (48%), Gaps = 9/97 (9%)
Query: 360 EELVKATDGFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIIS 418
E K D F + + G+G FG+V G G VAIK++ RE + ++ ++
Sbjct: 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQI-MQDLA 74
Query: 419 RIHHRHLVSLVGYCIS---DDRRLL----IYDYVPNN 448
+HH ++V L Y + DRR + + +YVP+
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDT 111
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 31.6 bits (70), Expect = 0.90, Method: Compositional matrix adjust.
Identities = 20/91 (21%), Positives = 46/91 (50%), Gaps = 3/91 (3%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIH 421
+ + F +GEG +G VYK G VA+K++++ A E+ ++ ++
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 422 HRHLVSLVGYCISDDRRLLIYDYVPNNTLYF 452
H ++V L+ ++++ L++++V + F
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEHVDQDLKKF 94
>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
pdb|4EBV|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
Length = 304
Score = 31.6 bits (70), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 23/61 (37%), Positives = 32/61 (52%), Gaps = 5/61 (8%)
Query: 375 LGEGGFGSVYKG-YL-PD--GREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSLV 429
+GEG FG V++G Y+ P+ VAIK K RE F E + + H H+V L+
Sbjct: 46 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 430 G 430
G
Sbjct: 106 G 106
>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 31.6 bits (70), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 23/61 (37%), Positives = 32/61 (52%), Gaps = 5/61 (8%)
Query: 375 LGEGGFGSVYKG-YL-PD--GREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSLV 429
+GEG FG V++G Y+ P+ VAIK K RE F E + + H H+V L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 430 G 430
G
Sbjct: 458 G 458
>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And
Kinase Domains Of Focal Adhesion Kinase.
pdb|2JKQ|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 31.6 bits (70), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 23/61 (37%), Positives = 32/61 (52%), Gaps = 5/61 (8%)
Query: 375 LGEGGFGSVYKG-YL-PD--GREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSLV 429
+GEG FG V++G Y+ P+ VAIK K RE F E + + H H+V L+
Sbjct: 18 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 430 G 430
G
Sbjct: 78 G 78
>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains.
pdb|2J0K|B Chain B, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 31.6 bits (70), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 23/61 (37%), Positives = 32/61 (52%), Gaps = 5/61 (8%)
Query: 375 LGEGGFGSVYKG-YL-PD--GREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSLV 429
+GEG FG V++G Y+ P+ VAIK K RE F E + + H H+V L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 430 G 430
G
Sbjct: 458 G 458
>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A
Methanesulfonamide Diaminopyrimidine Inhibitor
Length = 276
Score = 31.2 bits (69), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 23/61 (37%), Positives = 32/61 (52%), Gaps = 5/61 (8%)
Query: 375 LGEGGFGSVYKG-YL-PD--GREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSLV 429
+GEG FG V++G Y+ P+ VAIK K RE F E + + H H+V L+
Sbjct: 15 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 430 G 430
G
Sbjct: 75 G 75
>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native
pdb|3MFS|A Chain A, Cask-4m Cam Kinase Domain, Amppnp
pdb|3MFT|A Chain A, Cask-4m Cam Kinase Domain, Mn2+
pdb|3MFU|A Chain A, Cask-4m Cam Kinase Domain, Amppnp-Mn2+
Length = 351
Score = 31.2 bits (69), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 21/96 (21%), Positives = 43/96 (44%), Gaps = 6/96 (6%)
Query: 373 NLLGEGGFGSVYKGYLPD-GREVAIKQLKIGG-----GQGEREFKAEVEIISRIHHRHLV 426
++G+G F V + + G++ A+K + + G + K E I + H H+V
Sbjct: 30 EVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLHGKWQLGF 462
L+ SD ++++++ L F + + GF
Sbjct: 90 ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGF 125
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 31.2 bits (69), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 20/89 (22%), Positives = 45/89 (50%), Gaps = 3/89 (3%)
Query: 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIHHR 423
+ F +GEG +G VYK G VA+K++++ A E+ ++ ++H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 424 HLVSLVGYCISDDRRLLIYDYVPNNTLYF 452
++V L+ ++++ L++++V + F
Sbjct: 62 NIVKLLDVIHTENKLYLVFEHVHQDLKTF 90
>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii,
25.M01780 Or Tgme49_007820
Length = 458
Score = 31.2 bits (69), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 21/73 (28%), Positives = 41/73 (56%), Gaps = 3/73 (4%)
Query: 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQ-LKIGGGQGE-REFKAEVEIISRIHHR 423
D + ++L+G G +G V + Y + R VAIK+ L++ + + E+ I++R++H
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 424 HLVSLVGYCISDD 436
H+V ++ I D
Sbjct: 113 HVVKVLDIVIPKD 125
>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak)
pdb|4I4F|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With An Allosteric Binding Pyrazolobenzothiazine
Compound
Length = 281
Score = 31.2 bits (69), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 23/61 (37%), Positives = 32/61 (52%), Gaps = 5/61 (8%)
Query: 375 LGEGGFGSVYKG-YL-PD--GREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSLV 429
+GEG FG V++G Y+ P+ VAIK K RE F E + + H H+V L+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 430 G 430
G
Sbjct: 83 G 83
>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2ETM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2IJM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
pdb|2IJM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
Length = 281
Score = 31.2 bits (69), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 23/61 (37%), Positives = 32/61 (52%), Gaps = 5/61 (8%)
Query: 375 LGEGGFGSVYKG-YL-PD--GREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSLV 429
+GEG FG V++G Y+ P+ VAIK K RE F E + + H H+V L+
Sbjct: 20 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 430 G 430
G
Sbjct: 80 G 80
>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
pdb|3PXK|B Chain B, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
Length = 282
Score = 31.2 bits (69), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 23/61 (37%), Positives = 32/61 (52%), Gaps = 5/61 (8%)
Query: 375 LGEGGFGSVYKG-YL-PD--GREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSLV 429
+GEG FG V++G Y+ P+ VAIK K RE F E + + H H+V L+
Sbjct: 21 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 430 G 430
G
Sbjct: 81 G 81
>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
pdb|1V0O|B Chain B, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
Length = 288
Score = 31.2 bits (69), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 19/81 (23%), Positives = 41/81 (50%), Gaps = 12/81 (14%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKA-------EVEIISRIHHRHLVS 427
+GEG +G VYK G A+K++++ E+E + E+ I+ + H ++V
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRL-----EKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 428 LVGYCISDDRRLLIYDYVPNN 448
L + R +L+++++ +
Sbjct: 65 LYDVIHTKKRLVLVFEHLDQD 85
>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5
pdb|1V0B|B Chain B, Crystal Structure Of The T198a Mutant Of Pfpk5
Length = 288
Score = 31.2 bits (69), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 19/81 (23%), Positives = 41/81 (50%), Gaps = 12/81 (14%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKA-------EVEIISRIHHRHLVS 427
+GEG +G VYK G A+K++++ E+E + E+ I+ + H ++V
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRL-----EKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 428 LVGYCISDDRRLLIYDYVPNN 448
L + R +L+++++ +
Sbjct: 65 LYDVIHTKKRLVLVFEHLDQD 85
>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5
pdb|1OB3|B Chain B, Structure Of P. Falciparum Pfpk5
pdb|1V0P|A Chain A, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
pdb|1V0P|B Chain B, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
Length = 288
Score = 31.2 bits (69), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 19/81 (23%), Positives = 41/81 (50%), Gaps = 12/81 (14%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKA-------EVEIISRIHHRHLVS 427
+GEG +G VYK G A+K++++ E+E + E+ I+ + H ++V
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRL-----EKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 428 LVGYCISDDRRLLIYDYVPNN 448
L + R +L+++++ +
Sbjct: 65 LYDVIHTKKRLVLVFEHLDQD 85
>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase
pdb|3COK|B Chain B, Crystal Structure Of Plk4 Kinase
Length = 278
Score = 31.2 bits (69), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 23/70 (32%), Positives = 35/70 (50%), Gaps = 6/70 (8%)
Query: 367 DGFADQNLLGEGGFGSVYKG-YLPDGREVAIKQLK----IGGGQGEREFKAEVEIISRIH 421
+ F NLLG+G F VY+ + G EVAIK + G +R + EV+I ++
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLK 69
Query: 422 HRHLVSLVGY 431
H ++ L Y
Sbjct: 70 HPSILELYNY 79
>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With Peptide Substrate And Atp Analog
pdb|1GAG|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With A Bisubstrate Inhibitor
Length = 306
Score = 31.2 bits (69), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 27/109 (24%), Positives = 45/109 (41%), Gaps = 7/109 (6%)
Query: 355 SMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPD------GREVAIKQLKIGGGQGER 408
S+F +E + + LG+G FG VY+G D VA+K + ER
Sbjct: 5 SVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER 64
Query: 409 -EFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHG 456
EF E ++ H+V L+G L++ + + + L +L
Sbjct: 65 IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS 113
>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2-
Yl]amino}phenyl)acetic Acid
Length = 303
Score = 31.2 bits (69), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 27/109 (24%), Positives = 45/109 (41%), Gaps = 7/109 (6%)
Query: 355 SMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPD------GREVAIKQLKIGGGQGER 408
S+F +E + + LG+G FG VY+G D VA+K + ER
Sbjct: 2 SVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER 61
Query: 409 -EFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHG 456
EF E ++ H+V L+G L++ + + + L +L
Sbjct: 62 IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS 110
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 30.8 bits (68), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 19/91 (20%), Positives = 46/91 (50%), Gaps = 3/91 (3%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIH 421
+ + F +GEG +G VYK G VA+K++++ A E+ ++ ++
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 422 HRHLVSLVGYCISDDRRLLIYDYVPNNTLYF 452
H ++V L+ ++++ L+++++ + F
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFLHQDLKTF 94
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 30.8 bits (68), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 18/84 (21%), Positives = 44/84 (52%), Gaps = 3/84 (3%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIH 421
+ + F +GEG +G VYK G VA+K++++ A E+ ++ ++
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 422 HRHLVSLVGYCISDDRRLLIYDYV 445
H ++V L+ ++++ L+++++
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFL 87
>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|1RQQ|B Chain B, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|2AUH|A Chain A, Crystal Structure Of The Grb14 Bps Region In Complex With
The Insulin Receptor Tyrosine Kinase
pdb|2B4S|B Chain B, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|2B4S|D Chain D, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|3BU3|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide
pdb|3BU5|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide And Atp
pdb|3BU6|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Phosphopeptide
Length = 306
Score = 30.8 bits (68), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 24/89 (26%), Positives = 38/89 (42%), Gaps = 7/89 (7%)
Query: 375 LGEGGFGSVYKGYLPD------GREVAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVS 427
LG+G FG VY+G D VA+K + ER EF E ++ H+V
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHG 456
L+G L++ + + + L +L
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLRS 113
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 30.8 bits (68), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 18/84 (21%), Positives = 44/84 (52%), Gaps = 3/84 (3%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIH 421
+ + F +GEG +G VYK G VA+K++++ A E+ ++ ++
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 422 HRHLVSLVGYCISDDRRLLIYDYV 445
H ++V L+ ++++ L+++++
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFL 87
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 30.8 bits (68), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 19/91 (20%), Positives = 46/91 (50%), Gaps = 3/91 (3%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIH 421
+ + F +GEG +G VYK G VA+K++++ A E+ ++ ++
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 422 HRHLVSLVGYCISDDRRLLIYDYVPNNTLYF 452
H ++V L+ ++++ L+++++ + F
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKF 94
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 30.8 bits (68), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 19/91 (20%), Positives = 46/91 (50%), Gaps = 3/91 (3%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIH 421
+ + F +GEG +G VYK G VA+K++++ A E+ ++ ++
Sbjct: 5 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 422 HRHLVSLVGYCISDDRRLLIYDYVPNNTLYF 452
H ++V L+ ++++ L+++++ + F
Sbjct: 65 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKF 95
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 30.8 bits (68), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 19/91 (20%), Positives = 46/91 (50%), Gaps = 3/91 (3%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIH 421
+ + F +GEG +G VYK G VA+K++++ A E+ ++ ++
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 422 HRHLVSLVGYCISDDRRLLIYDYVPNNTLYF 452
H ++V L+ ++++ L+++++ + F
Sbjct: 63 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKF 93
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 30.8 bits (68), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 18/84 (21%), Positives = 44/84 (52%), Gaps = 3/84 (3%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIH 421
+ + F +GEG +G VYK G VA+K++++ A E+ ++ ++
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 422 HRHLVSLVGYCISDDRRLLIYDYV 445
H ++V L+ ++++ L+++++
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFL 84
>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of
The Insulin Receptor Tyrosine Kinase
Length = 306
Score = 30.8 bits (68), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 27/109 (24%), Positives = 45/109 (41%), Gaps = 7/109 (6%)
Query: 355 SMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPD------GREVAIKQLKIGGGQGER 408
S+F +E + + LG+G FG VY+G D VA+K + ER
Sbjct: 5 SVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER 64
Query: 409 -EFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHG 456
EF E ++ H+V L+G L++ + + + L +L
Sbjct: 65 IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS 113
>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With
Ind E804
Length = 324
Score = 30.8 bits (68), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 21/77 (27%), Positives = 42/77 (54%), Gaps = 4/77 (5%)
Query: 375 LGEGGFGSVYKG--YLPDGREVAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSLVGY 431
LGEG + +VYKG L D VA+K++++ +G EV ++ + H ++V+L
Sbjct: 10 LGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 432 CISDDRRLLIYDYVPNN 448
++ L+++Y+ +
Sbjct: 69 IHTEKSLTLVFEYLDKD 85
>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Human Insulin Receptor
Length = 306
Score = 30.8 bits (68), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 27/109 (24%), Positives = 45/109 (41%), Gaps = 7/109 (6%)
Query: 355 SMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPD------GREVAIKQLKIGGGQGER 408
S+F +E + + LG+G FG VY+G D VA+K + ER
Sbjct: 5 SVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER 64
Query: 409 -EFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHG 456
EF E ++ H+V L+G L++ + + + L +L
Sbjct: 65 IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS 113
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 30.8 bits (68), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 19/91 (20%), Positives = 46/91 (50%), Gaps = 3/91 (3%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIH 421
+ + F +GEG +G VYK G VA+K++++ A E+ ++ ++
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 422 HRHLVSLVGYCISDDRRLLIYDYVPNNTLYF 452
H ++V L+ ++++ L+++++ + F
Sbjct: 63 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKF 93
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 30.8 bits (68), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 18/84 (21%), Positives = 44/84 (52%), Gaps = 3/84 (3%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIH 421
+ + F +GEG +G VYK G VA+K++++ A E+ ++ ++
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 422 HRHLVSLVGYCISDDRRLLIYDYV 445
H ++V L+ ++++ L+++++
Sbjct: 62 HPNIVKLLDVIHTENKLYLVFEFL 85
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 30.8 bits (68), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 19/91 (20%), Positives = 46/91 (50%), Gaps = 3/91 (3%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIH 421
+ + F +GEG +G VYK G VA+K++++ A E+ ++ ++
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 422 HRHLVSLVGYCISDDRRLLIYDYVPNNTLYF 452
H ++V L+ ++++ L+++++ + F
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKF 91
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 30.8 bits (68), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 18/84 (21%), Positives = 44/84 (52%), Gaps = 3/84 (3%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIH 421
+ + F +GEG +G VYK G VA+K++++ A E+ ++ ++
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 422 HRHLVSLVGYCISDDRRLLIYDYV 445
H ++V L+ ++++ L+++++
Sbjct: 63 HPNIVKLLDVIHTENKLYLVFEFL 86
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 30.8 bits (68), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 19/91 (20%), Positives = 46/91 (50%), Gaps = 3/91 (3%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIH 421
+ + F +GEG +G VYK G VA+K++++ A E+ ++ ++
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 422 HRHLVSLVGYCISDDRRLLIYDYVPNNTLYF 452
H ++V L+ ++++ L+++++ + F
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKF 91
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 30.8 bits (68), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 18/84 (21%), Positives = 44/84 (52%), Gaps = 3/84 (3%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIH 421
+ + F +GEG +G VYK G VA+K++++ A E+ ++ ++
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 422 HRHLVSLVGYCISDDRRLLIYDYV 445
H ++V L+ ++++ L+++++
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFL 87
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 30.8 bits (68), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 18/84 (21%), Positives = 44/84 (52%), Gaps = 3/84 (3%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIH 421
+ + F +GEG +G VYK G VA+K++++ A E+ ++ ++
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 422 HRHLVSLVGYCISDDRRLLIYDYV 445
H ++V L+ ++++ L+++++
Sbjct: 63 HPNIVKLLDVIHTENKLYLVFEFL 86
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 30.8 bits (68), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 19/91 (20%), Positives = 46/91 (50%), Gaps = 3/91 (3%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIH 421
+ + F +GEG +G VYK G VA+K++++ A E+ ++ ++
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 422 HRHLVSLVGYCISDDRRLLIYDYVPNNTLYF 452
H ++V L+ ++++ L+++++ + F
Sbjct: 62 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKF 92
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 30.8 bits (68), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 18/84 (21%), Positives = 44/84 (52%), Gaps = 3/84 (3%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIH 421
+ + F +GEG +G VYK G VA+K++++ A E+ ++ ++
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 422 HRHLVSLVGYCISDDRRLLIYDYV 445
H ++V L+ ++++ L+++++
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFL 84
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 30.8 bits (68), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 18/82 (21%), Positives = 43/82 (52%), Gaps = 3/82 (3%)
Query: 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIHHR 423
+ F +GEG +G VYK G VA+K++++ A E+ ++ ++H
Sbjct: 10 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 424 HLVSLVGYCISDDRRLLIYDYV 445
++V L+ ++++ L+++++
Sbjct: 70 NIVKLLDVIHTENKLYLVFEFL 91
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 30.8 bits (68), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 19/91 (20%), Positives = 46/91 (50%), Gaps = 3/91 (3%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIH 421
+ + F +GEG +G VYK G VA+K++++ A E+ ++ ++
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 422 HRHLVSLVGYCISDDRRLLIYDYVPNNTLYF 452
H ++V L+ ++++ L+++++ + F
Sbjct: 62 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKF 92
>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The
Insulin Receptor Tyrosine Kinase
Length = 306
Score = 30.8 bits (68), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 24/89 (26%), Positives = 38/89 (42%), Gaps = 7/89 (7%)
Query: 375 LGEGGFGSVYKGYLPD------GREVAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVS 427
LG+G FG VY+G D VA+K + ER EF E ++ H+V
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHG 456
L+G L++ + + + L +L
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLRS 113
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 30.8 bits (68), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 19/91 (20%), Positives = 46/91 (50%), Gaps = 3/91 (3%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIH 421
+ + F +GEG +G VYK G VA+K++++ A E+ ++ ++
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 422 HRHLVSLVGYCISDDRRLLIYDYVPNNTLYF 452
H ++V L+ ++++ L+++++ + F
Sbjct: 62 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKF 92
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 30.8 bits (68), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 18/82 (21%), Positives = 43/82 (52%), Gaps = 3/82 (3%)
Query: 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIHHR 423
+ F +GEG +G VYK G VA+K++++ A E+ ++ ++H
Sbjct: 10 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 424 HLVSLVGYCISDDRRLLIYDYV 445
++V L+ ++++ L+++++
Sbjct: 70 NIVKLLDVIHTENKLYLVFEFL 91
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 30.4 bits (67), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 18/82 (21%), Positives = 43/82 (52%), Gaps = 3/82 (3%)
Query: 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIHHR 423
+ F +GEG +G VYK G VA+K++++ A E+ ++ ++H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 424 HLVSLVGYCISDDRRLLIYDYV 445
++V L+ ++++ L+++++
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL 84
>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
pdb|3EKN|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
Length = 307
Score = 30.4 bits (67), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 24/89 (26%), Positives = 38/89 (42%), Gaps = 7/89 (7%)
Query: 375 LGEGGFGSVYKGYLPD------GREVAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVS 427
LG+G FG VY+G D VA+K + ER EF E ++ H+V
Sbjct: 26 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHG 456
L+G L++ + + + L +L
Sbjct: 86 LLGVVSKGQPTLVVMELMAHGDLKSYLRS 114
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 30.4 bits (67), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 18/82 (21%), Positives = 43/82 (52%), Gaps = 3/82 (3%)
Query: 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIHHR 423
+ F +GEG +G VYK G VA+K++++ A E+ ++ ++H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 424 HLVSLVGYCISDDRRLLIYDYV 445
++V L+ ++++ L+++++
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL 84
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 30.4 bits (67), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 18/82 (21%), Positives = 43/82 (52%), Gaps = 3/82 (3%)
Query: 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIHHR 423
+ F +GEG +G VYK G VA+K++++ A E+ ++ ++H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 424 HLVSLVGYCISDDRRLLIYDYV 445
++V L+ ++++ L+++++
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL 83
>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
pdb|3ETA|B Chain B, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
Length = 317
Score = 30.4 bits (67), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 24/89 (26%), Positives = 38/89 (42%), Gaps = 7/89 (7%)
Query: 375 LGEGGFGSVYKGYLPD------GREVAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVS 427
LG+G FG VY+G D VA+K + ER EF E ++ H+V
Sbjct: 24 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHG 456
L+G L++ + + + L +L
Sbjct: 84 LLGVVSKGQPTLVVMELMAHGDLKSYLRS 112
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 30.4 bits (67), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 18/82 (21%), Positives = 43/82 (52%), Gaps = 3/82 (3%)
Query: 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIHHR 423
+ F +GEG +G VYK G VA+K++++ A E+ ++ ++H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 424 HLVSLVGYCISDDRRLLIYDYV 445
++V L+ ++++ L+++++
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL 83
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 30.4 bits (67), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 18/82 (21%), Positives = 43/82 (52%), Gaps = 3/82 (3%)
Query: 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIHHR 423
+ F +GEG +G VYK G VA+K++++ A E+ ++ ++H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 424 HLVSLVGYCISDDRRLLIYDYV 445
++V L+ ++++ L+++++
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL 84
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 30.4 bits (67), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 19/91 (20%), Positives = 46/91 (50%), Gaps = 3/91 (3%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIH 421
+ + F +GEG +G VYK G VA+K++++ A E+ ++ ++
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 422 HRHLVSLVGYCISDDRRLLIYDYVPNNTLYF 452
H ++V L+ ++++ L+++++ + F
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKF 91
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 30.4 bits (67), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 18/82 (21%), Positives = 43/82 (52%), Gaps = 3/82 (3%)
Query: 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIHHR 423
+ F +GEG +G VYK G VA+K++++ A E+ ++ ++H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 424 HLVSLVGYCISDDRRLLIYDYV 445
++V L+ ++++ L+++++
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL 83
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 30.4 bits (67), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 18/82 (21%), Positives = 43/82 (52%), Gaps = 3/82 (3%)
Query: 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIHHR 423
+ F +GEG +G VYK G VA+K++++ A E+ ++ ++H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 424 HLVSLVGYCISDDRRLLIYDYV 445
++V L+ ++++ L+++++
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL 84
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 30.4 bits (67), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 18/82 (21%), Positives = 43/82 (52%), Gaps = 3/82 (3%)
Query: 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIHHR 423
+ F +GEG +G VYK G VA+K++++ A E+ ++ ++H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 424 HLVSLVGYCISDDRRLLIYDYV 445
++V L+ ++++ L+++++
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL 83
>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5-
Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide
Length = 325
Score = 30.4 bits (67), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 16/56 (28%), Positives = 30/56 (53%), Gaps = 1/56 (1%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSLV 429
LG+G FG VYK + +A ++ + E E + E++I++ H ++V L+
Sbjct: 45 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 100
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 30.4 bits (67), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 19/89 (21%), Positives = 45/89 (50%), Gaps = 3/89 (3%)
Query: 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIHHR 423
+ F +GEG +G VYK G VA+K++++ A E+ ++ ++H
Sbjct: 4 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 424 HLVSLVGYCISDDRRLLIYDYVPNNTLYF 452
++V L+ ++++ L+++++ + F
Sbjct: 64 NIVKLLDVIHTENKLYLVFEFLHQDLKKF 92
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 30.4 bits (67), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 19/89 (21%), Positives = 45/89 (50%), Gaps = 3/89 (3%)
Query: 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIHHR 423
+ F +GEG +G VYK G VA+K++++ A E+ ++ ++H
Sbjct: 7 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 424 HLVSLVGYCISDDRRLLIYDYVPNNTLYF 452
++V L+ ++++ L+++++ + F
Sbjct: 67 NIVKLLDVIHTENKLYLVFEFLHQDLKKF 95
>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded
Form)
Length = 325
Score = 30.4 bits (67), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 16/56 (28%), Positives = 30/56 (53%), Gaps = 1/56 (1%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSLV 429
LG+G FG VYK + +A ++ + E E + E++I++ H ++V L+
Sbjct: 45 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 100
>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (
Diphosphorylated Form) Bound To 5- Amino-3-((4-(
Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide
Length = 325
Score = 30.4 bits (67), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 16/56 (28%), Positives = 30/56 (53%), Gaps = 1/56 (1%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSLV 429
LG+G FG VYK + +A ++ + E E + E++I++ H ++V L+
Sbjct: 45 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 100
>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma
Viral Oncogene Homologue (V-Fes) In Complex With
Staurosporine And A Consensus Peptide
Length = 377
Score = 30.4 bits (67), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 20/73 (27%), Positives = 34/73 (46%), Gaps = 2/73 (2%)
Query: 375 LGEGGFGSVYKGYL-PDGREVAIKQLK-IGGGQGEREFKAEVEIISRIHHRHLVSLVGYC 432
+G G FG V+ G L D VA+K + + +F E I+ + H ++V L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 433 ISDDRRLLIYDYV 445
++ + V
Sbjct: 182 TQKQPIYIVMELV 194
>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue
pdb|2PMN|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp-Site
Inhibitor
pdb|2PMO|X Chain X, Crystal Structure Of Pfpk7 In Complex With Hymenialdisine
Length = 348
Score = 30.4 bits (67), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 14/51 (27%), Positives = 29/51 (56%)
Query: 400 KIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL 450
KI +FK E++II+ I + + ++ G + D +IY+Y+ N+++
Sbjct: 80 KISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSI 130
>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)
pdb|3CBL|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (v- Fes) In Complex With Staurosporine And A
Consensus Peptide
pdb|4E93|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)in Complex With Tae684
Length = 377
Score = 30.4 bits (67), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 20/73 (27%), Positives = 34/73 (46%), Gaps = 2/73 (2%)
Query: 375 LGEGGFGSVYKGYL-PDGREVAIKQLK-IGGGQGEREFKAEVEIISRIHHRHLVSLVGYC 432
+G G FG V+ G L D VA+K + + +F E I+ + H ++V L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 433 ISDDRRLLIYDYV 445
++ + V
Sbjct: 182 TQKQPIYIVMELV 194
>pdb|1S3P|A Chain A, Crystal Structure Of Rat Alpha-parvalbumin S55d/e59d
Mutant
Length = 109
Score = 30.4 bits (67), Expect = 2.4, Method: Composition-based stats.
Identities = 16/55 (29%), Positives = 30/55 (54%), Gaps = 5/55 (9%)
Query: 362 LVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEI 416
L K DGF D++ LG S+ KG+ D R+++ K+ K G+++ ++ +
Sbjct: 50 LDKDKDGFIDEDELG-----SILKGFSSDARDLSAKETKTLMAAGDKDGDGKIGV 99
>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX
Length = 361
Score = 30.4 bits (67), Expect = 2.4, Method: Compositional matrix adjust.
Identities = 21/96 (21%), Positives = 43/96 (44%), Gaps = 6/96 (6%)
Query: 373 NLLGEGGFGSVYKGYLPD-GREVAIKQLKIGG-----GQGEREFKAEVEIISRIHHRHLV 426
++G+G F V + + G++ A+K + + G + K E I + H H+V
Sbjct: 32 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 91
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLHGKWQLGF 462
L+ SD ++++++ L F + + GF
Sbjct: 92 ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGF 127
>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form
pdb|3C0G|B Chain B, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form
pdb|3C0H|A Chain A, Cask Cam-Kinase Domain- Amppnp Complex, P1 Form
pdb|3C0H|B Chain B, Cask Cam-Kinase Domain- Amppnp Complex, P1 Form
pdb|3C0I|A Chain A, Cask Cam-Kinase Domain- 3'-Amp Complex, P212121 Form
Length = 351
Score = 30.0 bits (66), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 21/96 (21%), Positives = 43/96 (44%), Gaps = 6/96 (6%)
Query: 373 NLLGEGGFGSVYKGYLPD-GREVAIKQLKIGG-----GQGEREFKAEVEIISRIHHRHLV 426
++G+G F V + + G++ A+K + + G + K E I + H H+V
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLHGKWQLGF 462
L+ SD ++++++ L F + + GF
Sbjct: 90 ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGF 125
>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 635
Score = 30.0 bits (66), Expect = 3.3, Method: Compositional matrix adjust.
Identities = 24/100 (24%), Positives = 47/100 (47%), Gaps = 12/100 (12%)
Query: 354 RSMFTYEELVKATDGFADQNLL-------GEGGFGSVYKGYLPDGREVAIKQLKIGGGQG 406
S F E ++ + + D+ LL G G FG+V KGY + V +KI +
Sbjct: 349 ESPFADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA 408
Query: 407 -----EREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441
+ E AE ++ ++ + ++V ++G C ++ L++
Sbjct: 409 NDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVM 448
>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A60|B Chain B, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A61|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form Ii)
Length = 327
Score = 29.6 bits (65), Expect = 3.8, Method: Compositional matrix adjust.
Identities = 23/90 (25%), Positives = 41/90 (45%), Gaps = 8/90 (8%)
Query: 374 LLGEGGFGSVYKGY----LPDGREVAIKQLK----IGGGQGEREFKAEVEIISRIHHRHL 425
+LG+GG+G V++ G+ A+K LK + + KAE I+ + H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 426 VSLVGYCISDDRRLLIYDYVPNNTLYFHLH 455
V L+ + + LI +Y+ L+ L
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGELFMQLE 113
>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1
Length = 327
Score = 29.6 bits (65), Expect = 3.8, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 41/89 (46%), Gaps = 8/89 (8%)
Query: 374 LLGEGGFGSVYKGY----LPDGREVAIKQLK----IGGGQGEREFKAEVEIISRIHHRHL 425
+LG+GG+G V++ G+ A+K LK + + KAE I+ + H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 426 VSLVGYCISDDRRLLIYDYVPNNTLYFHL 454
V L+ + + LI +Y+ L+ L
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGELFMQL 112
>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase
1)
Length = 294
Score = 29.6 bits (65), Expect = 4.1, Method: Compositional matrix adjust.
Identities = 22/99 (22%), Positives = 43/99 (43%), Gaps = 2/99 (2%)
Query: 349 GLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGRE-VAIKQLKI-GGGQG 406
+ H R V + F + +G+G FG VYKG +E VAIK + +
Sbjct: 1 SMAHLRGFANQHSRVDPEELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDE 60
Query: 407 EREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445
+ + E+ ++S+ ++ G + + +I +Y+
Sbjct: 61 IEDIQQEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYL 99
>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex
With N-(4-
(5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h-
Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide
Length = 446
Score = 29.3 bits (64), Expect = 5.2, Method: Compositional matrix adjust.
Identities = 36/137 (26%), Positives = 53/137 (38%), Gaps = 12/137 (8%)
Query: 323 IKTQSSAPL-IGSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFG 381
+K Q++A + SG SD + + L + T E F LLG+G FG
Sbjct: 110 LKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNE-------FEYLKLLGKGTFG 162
Query: 382 SV-YKGYLPDGREVAIKQLKIGGGQGEREFK---AEVEIISRIHHRHLVSLVGYCISDDR 437
V GR A+K LK + E E ++ H L +L + DR
Sbjct: 163 KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR 222
Query: 438 RLLIYDYVPNNTLYFHL 454
+ +Y L+FHL
Sbjct: 223 LCFVMEYANGGELFFHL 239
>pdb|1XVJ|A Chain A, Crystal Structure Of Rat Alpha-Parvalbumin D94sG98E MUTANT
pdb|1XVJ|B Chain B, Crystal Structure Of Rat Alpha-Parvalbumin D94sG98E MUTANT
Length = 109
Score = 29.3 bits (64), Expect = 5.4, Method: Composition-based stats.
Identities = 15/55 (27%), Positives = 30/55 (54%), Gaps = 5/55 (9%)
Query: 362 LVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEI 416
L K GF +++ LG S+ KG+ D R+++ K+ K G+++ ++E+
Sbjct: 50 LDKDKSGFIEEDELG-----SILKGFSSDARDLSAKETKTLMAAGDKDGSGKIEV 99
>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2-
Phenylcyclopropyl)urea
Length = 293
Score = 29.3 bits (64), Expect = 5.6, Method: Compositional matrix adjust.
Identities = 19/72 (26%), Positives = 37/72 (51%), Gaps = 5/72 (6%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQG-----EREFKAEVEIISRIHHRHLVSLV 429
LG G FG+V KGY + V +KI + + E AE ++ ++ + ++V ++
Sbjct: 35 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 430 GYCISDDRRLLI 441
G C ++ L++
Sbjct: 95 GICEAESWMLVM 106
>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Pyrazolylbenzimidazole Inhibitor 416
pdb|3VF9|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Thienopyrazolylindole Inhibitor 027
pdb|3TUC|A Chain A, Crystal Structure Of Syk Kinase Domain With
1-Benzyl-N-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-2-Oxo-1,
2-Dihydropyridine-3- Carboxamide
pdb|3TUD|A Chain A, Crystal Structure Of Syk Kinase Domain With
N-(4-Methyl-3-(8-Methyl-7-
Oxo-2-(Phenylamino)-7,8-Dihydropyrido[2,
3-D]pyrimidin-6-Yl)phenyl)-3- (Trifluoromethyl)benzamide
Length = 299
Score = 29.3 bits (64), Expect = 5.6, Method: Compositional matrix adjust.
Identities = 19/72 (26%), Positives = 37/72 (51%), Gaps = 5/72 (6%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQG-----EREFKAEVEIISRIHHRHLVSLV 429
LG G FG+V KGY + V +KI + + E AE ++ ++ + ++V ++
Sbjct: 35 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 430 GYCISDDRRLLI 441
G C ++ L++
Sbjct: 95 GICEAESWMLVM 106
>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 28.9 bits (63), Expect = 5.7, Method: Compositional matrix adjust.
Identities = 19/72 (26%), Positives = 37/72 (51%), Gaps = 5/72 (6%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQG-----EREFKAEVEIISRIHHRHLVSLV 429
LG G FG+V KGY + V +KI + + E AE ++ ++ + ++V ++
Sbjct: 19 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 430 GYCISDDRRLLI 441
G C ++ L++
Sbjct: 79 GICEAESWMLVM 90
>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain
Length = 313
Score = 28.9 bits (63), Expect = 5.8, Method: Compositional matrix adjust.
Identities = 16/28 (57%), Positives = 19/28 (67%), Gaps = 1/28 (3%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLK 400
LLG GGFGSVY G + D VAIK ++
Sbjct: 43 LLGSGGFGSVYSGIRVSDNLPVAIKHVE 70
>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Pyrrolo[2,3- A]carbazole Ligand
pdb|3QF9|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Furan- Thiazolidinedione Ligand
pdb|4GW8|A Chain A, Human Proto-Oncogene Serine Threonine Kinase (Pim1) In
Complex With A Consensus Peptide And Leucettine L41
Length = 313
Score = 28.9 bits (63), Expect = 5.8, Method: Compositional matrix adjust.
Identities = 16/28 (57%), Positives = 19/28 (67%), Gaps = 1/28 (3%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLK 400
LLG GGFGSVY G + D VAIK ++
Sbjct: 44 LLGSGGFGSVYSGIRVSDNLPVAIKHVE 71
>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
pdb|2ACX|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
Length = 576
Score = 28.9 bits (63), Expect = 5.9, Method: Compositional matrix adjust.
Identities = 28/100 (28%), Positives = 47/100 (47%), Gaps = 4/100 (4%)
Query: 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQ---GEREFKAEVEIISRIHH 422
+ F +LG+GGFG V + G+ A K+L+ + GE E +I+ +++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 423 RHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGKWQLGF 462
R +VSL + D L+ + L FH++ Q GF
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGF 283
>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A Sulfonamidopyrazine Piperidine Inhibitor
pdb|4DFN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
An Adamantylpyrazine Inhibitor
Length = 274
Score = 28.9 bits (63), Expect = 6.0, Method: Compositional matrix adjust.
Identities = 19/72 (26%), Positives = 37/72 (51%), Gaps = 5/72 (6%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQG-----EREFKAEVEIISRIHHRHLVSLV 429
LG G FG+V KGY + V +KI + + E AE ++ ++ + ++V ++
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 430 GYCISDDRRLLI 441
G C ++ L++
Sbjct: 75 GICEAESWMLVM 86
>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Naphtho-Difuran Ligand
Length = 313
Score = 28.9 bits (63), Expect = 6.0, Method: Compositional matrix adjust.
Identities = 16/28 (57%), Positives = 19/28 (67%), Gaps = 1/28 (3%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLK 400
LLG GGFGSVY G + D VAIK ++
Sbjct: 44 LLGSGGFGSVYSGIRVSDNLPVAIKHVE 71
>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand I
pdb|3CY2|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand Ii
Length = 314
Score = 28.9 bits (63), Expect = 6.0, Method: Compositional matrix adjust.
Identities = 16/28 (57%), Positives = 19/28 (67%), Gaps = 1/28 (3%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLK 400
LLG GGFGSVY G + D VAIK ++
Sbjct: 44 LLGSGGFGSVYSGIRVSDNLPVAIKHVE 71
>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With
Ly333531
Length = 312
Score = 28.9 bits (63), Expect = 6.0, Method: Compositional matrix adjust.
Identities = 16/28 (57%), Positives = 19/28 (67%), Gaps = 1/28 (3%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLK 400
LLG GGFGSVY G + D VAIK ++
Sbjct: 43 LLGSGGFGSVYSGIRVSDNLPVAIKHVE 70
>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its
Consensus Peptide Pimtide
pdb|2BZJ|A Chain A, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru3
pdb|2BZK|B Chain B, Crystal Structure Of The Human Pim1 In Complex With Amppnp
And Pimtide
pdb|2C3I|B Chain B, Crystal Structure Of Human Pim1 In Complex With
Imidazopyridazin I
pdb|2BZH|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru1
pdb|2OI4|X Chain X, Crystal Structure Of Human Pim1 In Complex With
Fluorinated Ruthenium Pyridocarbazole
pdb|3BWF|A Chain A, Crystal Structure Of The Human Pim1 In Complex With An
Osmium Compound
Length = 313
Score = 28.9 bits (63), Expect = 6.0, Method: Compositional matrix adjust.
Identities = 16/28 (57%), Positives = 19/28 (67%), Gaps = 1/28 (3%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLK 400
LLG GGFGSVY G + D VAIK ++
Sbjct: 43 LLGSGGFGSVYSGIRVSDNLPVAIKHVE 70
>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 28.9 bits (63), Expect = 6.0, Method: Compositional matrix adjust.
Identities = 19/72 (26%), Positives = 37/72 (51%), Gaps = 5/72 (6%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQG-----EREFKAEVEIISRIHHRHLVSLV 429
LG G FG+V KGY + V +KI + + E AE ++ ++ + ++V ++
Sbjct: 19 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 430 GYCISDDRRLLI 441
G C ++ L++
Sbjct: 79 GICEAESWMLVM 90
>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And
The Jnk Inhibitor V
Length = 314
Score = 28.9 bits (63), Expect = 6.0, Method: Compositional matrix adjust.
Identities = 16/28 (57%), Positives = 19/28 (67%), Gaps = 1/28 (3%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLK 400
LLG GGFGSVY G + D VAIK ++
Sbjct: 44 LLGSGGFGSVYSGIRVSDNLPVAIKHVE 71
>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With
4-(4-
Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One
pdb|3T9I|A Chain A, Pim1 Complexed With A Novel 3,6-Disubstituted Indole At
2.6 Ang Resolution
Length = 328
Score = 28.9 bits (63), Expect = 6.1, Method: Compositional matrix adjust.
Identities = 16/28 (57%), Positives = 19/28 (67%), Gaps = 1/28 (3%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLK 400
LLG GGFGSVY G + D VAIK ++
Sbjct: 58 LLGSGGFGSVYSGIRVSDNLPVAIKHVE 85
>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261
pdb|2BZI|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru2
Length = 313
Score = 28.9 bits (63), Expect = 6.1, Method: Compositional matrix adjust.
Identities = 16/28 (57%), Positives = 19/28 (67%), Gaps = 1/28 (3%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLK 400
LLG GGFGSVY G + D VAIK ++
Sbjct: 43 LLGSGGFGSVYSGIRVSDNLPVAIKHVE 70
>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2-
Phenylaminopyrimidines As Potent Inhibitors Of Spleen
Tyrosine Kinase (Syk)
Length = 291
Score = 28.9 bits (63), Expect = 6.1, Method: Compositional matrix adjust.
Identities = 19/72 (26%), Positives = 37/72 (51%), Gaps = 5/72 (6%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQG-----EREFKAEVEIISRIHHRHLVSLV 429
LG G FG+V KGY + V +KI + + E AE ++ ++ + ++V ++
Sbjct: 33 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 430 GYCISDDRRLLI 441
G C ++ L++
Sbjct: 93 GICEAESWMLVM 104
>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|B Chain B, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|C Chain C, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|D Chain D, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
Length = 273
Score = 28.9 bits (63), Expect = 6.2, Method: Compositional matrix adjust.
Identities = 16/28 (57%), Positives = 19/28 (67%), Gaps = 1/28 (3%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLK 400
LLG GGFGSVY G + D VAIK ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVE 38
>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors
Length = 273
Score = 28.9 bits (63), Expect = 6.2, Method: Compositional matrix adjust.
Identities = 16/28 (57%), Positives = 19/28 (67%), Gaps = 1/28 (3%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLK 400
LLG GGFGSVY G + D VAIK ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVE 38
>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With
Inhibitor
pdb|3BGP|A Chain A, Human Pim-1 Complexed With A Benzoisoxazole Inhibitor Vx1
pdb|3BGQ|A Chain A, Human Pim-1 Kinase In Complex With An Triazolo Pyridazine
Inhibitor Vx2
pdb|3BGZ|A Chain A, Human Pim-1 Kinase In Complex With Diphenyl Indole
Inhibitor Vx3
Length = 333
Score = 28.9 bits (63), Expect = 6.2, Method: Compositional matrix adjust.
Identities = 16/28 (57%), Positives = 19/28 (67%), Gaps = 1/28 (3%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLK 400
LLG GGFGSVY G + D VAIK ++
Sbjct: 63 LLGSGGFGSVYSGIRVSDNLPVAIKHVE 90
>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836
Length = 273
Score = 28.9 bits (63), Expect = 6.3, Method: Compositional matrix adjust.
Identities = 19/72 (26%), Positives = 37/72 (51%), Gaps = 5/72 (6%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQG-----EREFKAEVEIISRIHHRHLVSLV 429
LG G FG+V KGY + V +KI + + E AE ++ ++ + ++V ++
Sbjct: 13 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 430 GYCISDDRRLLI 441
G C ++ L++
Sbjct: 73 GICEAESWMLVM 84
>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation
Length = 293
Score = 28.9 bits (63), Expect = 6.3, Method: Compositional matrix adjust.
Identities = 16/28 (57%), Positives = 19/28 (67%), Gaps = 1/28 (3%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLK 400
LLG GGFGSVY G + D VAIK ++
Sbjct: 15 LLGSGGFGSVYSGIRVSDNLPVAIKHVE 42
>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R01|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R02|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R04|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3VBQ|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBT|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBV|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBW|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBX|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBY|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VC4|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
Length = 299
Score = 28.9 bits (63), Expect = 6.3, Method: Compositional matrix adjust.
Identities = 16/28 (57%), Positives = 19/28 (67%), Gaps = 1/28 (3%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLK 400
LLG GGFGSVY G + D VAIK ++
Sbjct: 16 LLGSGGFGSVYSGIRVSDNLPVAIKHVE 43
>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
pdb|3JY0|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
pdb|3JYA|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
Length = 294
Score = 28.9 bits (63), Expect = 6.3, Method: Compositional matrix adjust.
Identities = 16/28 (57%), Positives = 19/28 (67%), Gaps = 1/28 (3%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLK 400
LLG GGFGSVY G + D VAIK ++
Sbjct: 16 LLGSGGFGSVYSGIRVSDNLPVAIKHVE 43
>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
pdb|4ALW|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
Length = 328
Score = 28.9 bits (63), Expect = 6.4, Method: Compositional matrix adjust.
Identities = 16/28 (57%), Positives = 19/28 (67%), Gaps = 1/28 (3%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLK 400
LLG GGFGSVY G + D VAIK ++
Sbjct: 58 LLGSGGFGSVYSGIRVSDNLPVAIKHVE 85
>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYN|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYO|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
pdb|3NYO|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
Length = 576
Score = 28.9 bits (63), Expect = 6.4, Method: Compositional matrix adjust.
Identities = 28/100 (28%), Positives = 47/100 (47%), Gaps = 4/100 (4%)
Query: 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQ---GEREFKAEVEIISRIHH 422
+ F +LG+GGFG V + G+ A K+L+ + GE E +I+ +++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 423 RHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGKWQLGF 462
R +VSL + D L+ + L FH++ Q GF
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGF 283
>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1)
pdb|3I7B|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Nm-Pp1
pdb|3N51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor
Rm-1-95
pdb|3SX9|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-132
pdb|3SXF|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-89
pdb|3T3U|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-130
pdb|3T3V|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-87
pdb|3UPX|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1300
pdb|3UPZ|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumpless Bki Analog Uw1243
pdb|3V51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Rm-1-176
pdb|3V5P|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1288
pdb|3V5T|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1299
Length = 484
Score = 28.9 bits (63), Expect = 6.4, Method: Compositional matrix adjust.
Identities = 26/103 (25%), Positives = 50/103 (48%), Gaps = 15/103 (14%)
Query: 335 GPGSDFVNSPQDPGG-LGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVY--KGYLPDG 391
GPGS + PG + HS ++F+ D + Q +LG+G FG V K + G
Sbjct: 1 GPGSMMDHLHATPGMFVQHSTAIFS--------DRYKGQRVLGKGSFGEVILCKDKIT-G 51
Query: 392 REVAIK---QLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
+E A+K + ++ + EV+++ ++ H +++ L +
Sbjct: 52 QECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF 94
>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor
Length = 276
Score = 28.9 bits (63), Expect = 6.5, Method: Compositional matrix adjust.
Identities = 16/28 (57%), Positives = 19/28 (67%), Gaps = 1/28 (3%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLK 400
LLG GGFGSVY G + D VAIK ++
Sbjct: 14 LLGSGGFGSVYSGIRVSDNLPVAIKHVE 41
>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa
Length = 300
Score = 28.9 bits (63), Expect = 6.5, Method: Compositional matrix adjust.
Identities = 16/28 (57%), Positives = 19/28 (67%), Gaps = 1/28 (3%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLK 400
LLG GGFGSVY G + D VAIK ++
Sbjct: 30 LLGSGGFGSVYSGIRVSDNLPVAIKHVE 57
>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution
pdb|1XR1|A Chain A, Crystal Structure Of Hpim-1 Kinase In Complex With Amp-Pnp
At 2.1 A Resolution
Length = 300
Score = 28.9 bits (63), Expect = 6.5, Method: Compositional matrix adjust.
Identities = 16/28 (57%), Positives = 19/28 (67%), Gaps = 1/28 (3%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLK 400
LLG GGFGSVY G + D VAIK ++
Sbjct: 30 LLGSGGFGSVYSGIRVSDNLPVAIKHVE 57
>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From
Crystallographic Fragment Screen
Length = 301
Score = 28.9 bits (63), Expect = 6.5, Method: Compositional matrix adjust.
Identities = 16/28 (57%), Positives = 19/28 (67%), Gaps = 1/28 (3%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLK 400
LLG GGFGSVY G + D VAIK ++
Sbjct: 31 LLGSGGFGSVYSGIRVSDNLPVAIKHVE 58
>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine
pdb|1YI3|A Chain A, Crystal Structure Of Pim-1 Bound To Ly294002
pdb|1YI4|A Chain A, Structure Of Pim-1 Bound To Adenosine
Length = 273
Score = 28.9 bits (63), Expect = 6.6, Method: Compositional matrix adjust.
Identities = 16/28 (57%), Positives = 19/28 (67%), Gaps = 1/28 (3%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLK 400
LLG GGFGSVY G + D VAIK ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVE 38
>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From
Crystallographic Fragment Screen
pdb|2XIZ|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-3 From
Crystallographic Fragment Screen
pdb|2XJ1|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inibitor
pdb|2XJ2|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inhibitor
Length = 301
Score = 28.9 bits (63), Expect = 6.6, Method: Compositional matrix adjust.
Identities = 16/28 (57%), Positives = 19/28 (67%), Gaps = 1/28 (3%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLK 400
LLG GGFGSVY G + D VAIK ++
Sbjct: 31 LLGSGGFGSVYSGIRVSDNLPVAIKHVE 58
>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of
P27kip1 Carboxy-Terminal Peptide
Length = 320
Score = 28.9 bits (63), Expect = 6.6, Method: Compositional matrix adjust.
Identities = 16/28 (57%), Positives = 19/28 (67%), Gaps = 1/28 (3%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLK 400
LLG GGFGSVY G + D VAIK ++
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVE 77
>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain
pdb|1XBB|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Gleevec
pdb|1XBC|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Staurosporin
pdb|3FQE|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
Ym193306
pdb|3FQH|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQH|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQS|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
R406
pdb|4FL1|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
pdb|4FYN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
3-(8-{4-
[ethyl-(2-hydroxy-ethyl)-amino]-phenylamino}-imidazo[1,
2-a]pyrazin-5- Yl)-phenol
pdb|4FYO|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
N-{(s)-1-
[7-(3,4-dimethoxy-phenylamino)-thiazolo[5,
4-d]pyrimidin-5-yl]- Pyrrolidin-3-yl}-terephthalamic
Acid
pdb|4FZ6|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
[6-((s)-2-
Methyl-pyrrolidin-1-yl)-pyridin-2-yl]-(6-phenyl-
imidazo[1,2- B]pyridazin-8-yl)-amine
Length = 291
Score = 28.9 bits (63), Expect = 6.7, Method: Compositional matrix adjust.
Identities = 19/72 (26%), Positives = 37/72 (51%), Gaps = 5/72 (6%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQG-----EREFKAEVEIISRIHHRHLVSLV 429
LG G FG+V KGY + V +KI + + E AE ++ ++ + ++V ++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 430 GYCISDDRRLLI 441
G C ++ L++
Sbjct: 85 GICEAESWMLVM 96
>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target
Of Aberrant Somatic Hypermutations In Diffuse Large Cell
Lymphoma
pdb|1YXT|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With Amppnp
pdb|1YXU|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|B Chain B, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|C Chain C, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|D Chain D, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXV|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With
3,4-Dihydroxy-1- Methylquinolin-2(1h)-One
pdb|1YXX|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With
(3e)-3-[(4- Hydroxyphenyl)imino]-1h-Indol-2(3h)-One
pdb|2O3P|A Chain A, Crystal Structure Of Pim1 With Quercetin
pdb|2O63|A Chain A, Crystal Structure Of Pim1 With Myricetin
pdb|2O64|A Chain A, Crystal Structure Of Pim1 With Quercetagetin
pdb|2O65|A Chain A, Crystal Structure Of Pim1 With Pentahydroxyflavone
Length = 293
Score = 28.9 bits (63), Expect = 6.8, Method: Compositional matrix adjust.
Identities = 16/28 (57%), Positives = 19/28 (67%), Gaps = 1/28 (3%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLK 400
LLG GGFGSVY G + D VAIK ++
Sbjct: 15 LLGSGGFGSVYSGIRVSDNLPVAIKHVE 42
>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From
Crystallographic Fragment Screen
Length = 301
Score = 28.9 bits (63), Expect = 6.8, Method: Compositional matrix adjust.
Identities = 16/28 (57%), Positives = 19/28 (67%), Gaps = 1/28 (3%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLK 400
LLG GGFGSVY G + D VAIK ++
Sbjct: 31 LLGSGGFGSVYSGIRVSDNLPVAIKHVE 58
>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546
Length = 308
Score = 28.9 bits (63), Expect = 7.0, Method: Compositional matrix adjust.
Identities = 16/28 (57%), Positives = 19/28 (67%), Gaps = 1/28 (3%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLK 400
LLG GGFGSVY G + D VAIK ++
Sbjct: 38 LLGSGGFGSVYSGIRVSDNLPVAIKHVE 65
>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small
Molecule Inhibitor
pdb|3UMX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indol-3-Yl)methylene]-7-(Azepan-1-Ylmethyl)-6-
Hydroxybenzofuran- 3(2h)-One
pdb|4ENX|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
Inhibitor (2e,5z)-2-
(2-Chlorophenylimino)-5-(4-Hydroxy-3-
Nitrobenzylidene)thiazolidin-4- One
pdb|4ENY|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
(2e,5z)-2-(2-
Chlorophenylimino)-5-(4-Hydroxy-3-
Methoxybenzylidene)thiazolidin-4- One
pdb|3UMW|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indazol-3-Yl)methylene]-6-Methoxy-7-(Piperazin-1-
Ylmethyl)benzofuran- 3(2h)-One
Length = 298
Score = 28.9 bits (63), Expect = 7.0, Method: Compositional matrix adjust.
Identities = 16/28 (57%), Positives = 19/28 (67%), Gaps = 1/28 (3%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLK 400
LLG GGFGSVY G + D VAIK ++
Sbjct: 16 LLGSGGFGSVYSGIRVSDNLPVAIKHVE 43
>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A
Ruthenium Organometallic Ligand Ru1
pdb|2IWI|B Chain B, Crystal Structure Of The Human Pim2 In Complex With A
Ruthenium Organometallic Ligand Ru1
Length = 312
Score = 28.9 bits (63), Expect = 7.4, Method: Compositional matrix adjust.
Identities = 15/25 (60%), Positives = 20/25 (80%), Gaps = 1/25 (4%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIK 397
LLG+GGFG+V+ G+ L D +VAIK
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIK 62
>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 636
Score = 28.5 bits (62), Expect = 8.5, Method: Compositional matrix adjust.
Identities = 19/72 (26%), Positives = 37/72 (51%), Gaps = 5/72 (6%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQG-----EREFKAEVEIISRIHHRHLVSLV 429
LG G FG+V KGY + V +KI + + E AE ++ ++ + ++V ++
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 430 GYCISDDRRLLI 441
G C ++ L++
Sbjct: 438 GICEAESWMLVM 449
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 28.5 bits (62), Expect = 9.2, Method: Compositional matrix adjust.
Identities = 17/82 (20%), Positives = 42/82 (51%), Gaps = 3/82 (3%)
Query: 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIHHR 423
+ F +GEG +G VYK G VA+ ++++ A E+ ++ ++H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 424 HLVSLVGYCISDDRRLLIYDYV 445
++V L+ ++++ L+++++
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL 84
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 28.5 bits (62), Expect = 9.2, Method: Compositional matrix adjust.
Identities = 17/82 (20%), Positives = 42/82 (51%), Gaps = 3/82 (3%)
Query: 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIHHR 423
+ F +GEG +G VYK G VA+ ++++ A E+ ++ ++H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 424 HLVSLVGYCISDDRRLLIYDYV 445
++V L+ ++++ L+++++
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL 83
>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha
Complex
pdb|2WTK|F Chain F, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha
Complex
Length = 305
Score = 28.5 bits (62), Expect = 9.3, Method: Compositional matrix adjust.
Identities = 18/75 (24%), Positives = 40/75 (53%), Gaps = 9/75 (12%)
Query: 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG-------QGEREFKAEVEIISRIHHRHL 425
+LLGEG +G V + + D + + +KI GE K E++++ R+ H+++
Sbjct: 11 DLLGEGSYGKVKE--VLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68
Query: 426 VSLVGYCISDDRRLL 440
+ LV +++++ +
Sbjct: 69 IQLVDVLYNEEKQKM 83
>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2
pdb|3NYV|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Non-Specific Inhibitor
Whi-P180
Length = 484
Score = 28.5 bits (62), Expect = 9.5, Method: Compositional matrix adjust.
Identities = 26/103 (25%), Positives = 49/103 (47%), Gaps = 15/103 (14%)
Query: 335 GPGSDFVNSPQDPGG-LGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVY--KGYLPDG 391
GPGS + PG + HS ++F+ D + Q +LG+G FG V K + G
Sbjct: 1 GPGSXXDHLHATPGXFVQHSTAIFS--------DRYKGQRVLGKGSFGEVILCKDKIT-G 51
Query: 392 REVAIK---QLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
+E A+K + ++ + EV+++ ++ H ++ L +
Sbjct: 52 QECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYEF 94
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.320 0.143 0.438
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 6,842,500
Number of Sequences: 62578
Number of extensions: 283491
Number of successful extensions: 1179
Number of sequences better than 100.0: 493
Number of HSP's better than 100.0 without gapping: 102
Number of HSP's successfully gapped in prelim test: 391
Number of HSP's that attempted gapping in prelim test: 986
Number of HSP's gapped (non-prelim): 496
length of query: 479
length of database: 14,973,337
effective HSP length: 103
effective length of query: 376
effective length of database: 8,527,803
effective search space: 3206453928
effective search space used: 3206453928
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.8 bits)
S2: 53 (25.0 bits)